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H3.3-SPECIFIC HISTONE CHAPERONES HIRA AND DAXX

Simon Elsässer, Ph.D.
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Histones are architectural proteins that wrap approximately two turns of DNA
around their octameric core structure, constituting the fundamental packaging unit
of eukaryotic chromatin – the nucleosome. Beyond their structural role, they
regulate virtually all processes that act on or depend on DNA, such as replication,
gene expression and maintenance of centromeres and telomeres. Despite the high
conservation of the four core histones, H3, H4, H2A and H2B, throughout all
eukaryotes, histone variants have emerged with variable degree of divergence from
their canonical counterparts. These variants are thought to expand the regulatory
repertoire of chromatin.

The histone replacement variant H3.3 is implicated in the formation and
maintenance of specialized chromatin structure in metazoan cells. H3.3-containing
nucleosomes are assembled in a replication-independent manner by means of
dedicated histone chaperone proteins. By purifying H3.3-containing nuclear
complexes from HeLa cells, I have identified proteins that mediate this replicationindependent deposition of H3.3. I have been able to single out the death-associated
protein Daxx as an bona fide histone H3.3 chaperone. Furthermore, I show that Daxx

cooperates with an ATP-dependent chromatin remodeler, ATRX, in depositing
histone H3.3 at telomeres in vivo (Chapter 2). I show that an evolutionary conserved
histone binding domain of Daxx interacts directly with variant-specific residues of
the H3.3 core. I further identify homologies with the centromere-specific histone
chaperone HJURP that hint to a conserved mechanism used across replicationindependent chromatin assembly pathways (Chapter 3). I report crystallization of a
complex of the Daxx histone binding domain and histones H3.3-H4 with the aim of
solving the cocrystal structure to reveal how Daxx can tell the subtle differences in
H3 variants apart. (Chapter 4).

Through a more detailed biochemical fractionation and genetic analysis, I found that
Daxx constitutes a histone deposition pathway independent of the previously
described HIRA histone chaperone complex (Chapter 5), corroborating the notion
that distinct replication-independent chromatin assembly pathways maintain
specialized chromatin at distinct genomic locations. To facilitate the study of histone
H3 variants across biological model organisms, I have developed universal, variantspecific antibodies (Chapter 6). I showcase their application in deriving a semiquantitative histone variant landscape in murine embryonic stem cells, on the basis
of which the functions of H3.3 and replication-independent chromatin assembly can
be studied in new detail.

In the light of recent findings that place Daxx and ATRX in the roles of potent tumor
suppressors for a subset of neuroendocrine cancers, my studies will help to elucidate
the molecular etiology of replication-independent chromatin assembly pathways in
human disease.

© Sean Taverna, reprint with permission
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1 Introduction
1.1 Chromatin is the physiologic state of eukaryotic genomes
The nuclear genome of every eukaryotic cell is organized into
chromosomes, large nucleoprotein – chromatin – entities that contain a single
linear,

double-stranded

deoxyribonucleic

acid

(DNA)

molecule.

The

extraordinary dynamic compaction of few to many megabases of DNA into the
limited nuclear volume is achieved through an intricate interplay of fractal
globule folding and ordered repetitive spooling. The fundamental repeating unit
of chromatin is the nucleosome, in which histones proteins create an octameric
core structure that wraps approximately two superhelical turns of DNA (Figure
1.1A) (Luger et al., 1997). A wealth of discoveries in the last decades has
transformed the image of histones from static scaffolding proteins to dynamic
modulators of virtually all processes that act on or depend on DNA, such as
replication, gene expression and maintenance of centromeres and telomeres.
Histones are subject to a wide variety of posttranslational modifications (PTMs)
such as lysine acetylation and methylation many of which are characteristic of
active or repressed gene states, as well as DNA replication, recombination,
damage or repair events. The resulting variety of modification patterns constitute
a 'histone code' that has the potential for cellular memory and transmission of
epigenetic information through cell divisions (Bernstein et al., 2007; Ruthenburg
et al., 2007; Strahl and Allis, 2000).
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Figure 1.1: The eukaryotic genome is packaged in chromatin.
(A) The fundamental repeating unit of chromatin is the nucleosome, in which ~147 base
pairs of DNA are wrapped around a histone octamer core (a H3-H4 tetramer,
blue/green, flanked by two H2A/H2B dimers, gray). Perhaps unexpectedly given their
seemingly strict structure (see crystal structure inset, PDB 1KX5) and monotonous
repetitive appearance along the chromatin fiber, the arrangement and properties of
nucleosomes allow for highly variable chromatin states. ‘Euchromatin’ describes an
open,

transcriptionally

active

chromatin

state,

whereas

silent,

condensed

‘heterochromatin’ is formed through nucleosome packing and the help of nucleosomeassociated protein such as the linker histones and heterochromatin protein 1 (HP1). (B)
Such and more subtle variation in chromatin states are thought to be dependent on
posttranslational modification (PTMs) of the histones, the activity of ATP-dependent
chromatin remodelers and the switching of the histone identity through introduction of
histone variants. These mechanism are further integrated with modification of the DNA
itself (methylation and hydroxymethylation of cytosine) and non-coding RNAs to create
potentially heritable, or ‘epigenetic’, information.
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Apart from the four major-type histones (H3, H4, H2A and H2B), metazoans
have a number of histone variants. Like histone posttranslational modifications
and nucleosome positioning and remodeling, the use of histone variants, such as
centromeric H3, H3.3, H2A.X and H2A.Z, contributes to the regulatory repertoire
of chromatin (Figure 1.1B).

1.1.1 Organization of eukaryotic chromosomes
The overall chromosome architecture can be observed most clearly during
mitosis, when the highly compacted duplicate DNA molecules (sister
chromatids) line up along the metaphase plate (Figure 1.1, A). The sister
chromatids touch at the so-called centromere, which serves as kinetochore
attachment for their subsequent separation. Telomeres, the tips of each sister
chromatid, are specialized structures that protect the ends of the linear DNA
molecule (Blackburn, 1991; Cleveland et al., 2003).
“Euchromatin is genicly active, heterochromatin genicly passive.
Heterochromatic chromosomes or pieces of chromosomes contain no genes
or somehow passive genes” – Emil Heitz, 1929

Two fundamentally distinct compartments of eukaryotic chromatin, euchromatin
and heterochromatin, were recognized not long after the discovery of
chromosomes themselves in the 1880s (Zacharias, 1995). Heterochromatin has
been defined as those parts of chromosomes that do not decondense in
interphase and had been traced to the centers and distal ends of the
chromosomes by Emil Heitz (Figure 1.2A, heterochromatin stains dark). From
the linear arrangement of genes on chromosomes that explained genetic linkage
3

	
  

(first described by Thomas Hunt Morgan), Emil Heitz concluded that genes must
be concentrated in the euchromatic ‘arms’ of chromosomes where the majority of
linkage phenomena had been observed. The constitutively condensed
centromeres and telomeres, on the other hand, would consequently be devoid of
genes.
This notion has been corroborated and dissected in much more detail
through

cytogenetic

studies,

for

example

on

the

Drosophila

polytene

chromosomes. Gene activity and silencing has been found to be much more
dynamic than the clear-cut distinction of euchromatin and heterochromatin
could explain. One seminal finding was the facultative silencing of genes
depending on their distance from centromeric or telomeric heterochromatin
domains, so-called position-effect variegation (PEV), originally described by
Hermann J Muller (Muller, 1930). The variegated or mosaic ‘ON’ or ‘OFF’
switching of genes placed in the neighborhood of heterochromatin is a pivotal
example of a heritable phenotype that does not involve DNA mutation, a
phenomenon therefore termed epigenetic.
It should be noted that, while histones and their modifications are often
loosely attributed to carry ‘epigenetic’ information, there is consent in the field
that this term should be reserved to describe proven heritable variation beyond
DNA sequence changes that can rely on – or work independent of – chromosome
inheritance (Bonasio et al., 2010; Henikoff and Shilatifard, 2011; Jenuwein and
Allis, 2001; Strahl and Allis, 2000).
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Figure 1.2: Chromosome structure and compartements as exemplified by histone variants.
(A) Carmine staining of chromosomes as used to visualize heterochromatin (dense) and
euchromatin (light stain), also called C banding. An original drawing by Heintz (top) and a
contemporary photograph of fish chromosome carmine stain (bottom; C Ozouf-Costaz),
with pericentric heterochromatin stained most darkly (B) Schematic of a chromosome.
Heterochromatin locates to the region around the centromere (pericentromere) and to the
ends of chromosomes (telomeres). Euchromatin on the ‘arms’ of chromosomes is gene-rich
and transcriptionally active. However large regions of euchromatin can be silenced, giving
rise to facultative heterochromatin. (C) H3 variants H3.3 and centromeric H3 (cenH3)
localize to characteristic regions of chromosomes (murine ESC metaphase spread, DAPIstained DNA blue, H3.3 green; A Goldberg). H3.3 is enriched at euchromatic arms of
chromosomes (i.e., to one side of acrocentric murine ESC chromosomes shown here). Inset
shows telomeric enrichment of H3.3 on the transcriptionally inactive Y-chromosomes.
CenH3 defines centromeres and is absent from other regions of the chromosome (S2 cell
metaphase spread, DAPI stained DNA blue, cenH3 purple; S. Erhardt).
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Nevertheless, many chromatin components have been discovered in screens for
modifiers of epigenetic states (Henikoff, 1990). Today, we know much about the
identity of these modifiers and how they reversibly affect chromatin through
histone PTMs, ATP-dependent remodeling or the use of histone variants. They
therefore are implicated in encoding chromosome-bound heritable information
(Figure 1.1B).
Of note, the two histone H3 variants that I will discuss in great detail
throughout my thesis, H3.3 and cenH3, visibly localize to specific chromosomal
regions: H3.3 localizes to the active arms of chromosomes and is broadly absent
from heterochromatin except for discrete foci at telomeres in murine ESC (Figure
1.1C, left). CenH3, on the other hand, marks the centromeres but not adjacent
pericentric heterochromatin.
Modern genome-wide mapping technologies, in particular next-gen
sequencing, have changed our view from a birds-eye perspective of
chromosomes to the macro level of individual base pair resolution. Those
techniques now refine and redefine chromosomal domains through the analysis
of the landscape of histone variants and PTMs, transcription machinery and
other chromatin-associated proteins along the linear chromosomal arrangement.
In particular, it has become clear that euchromatin and heterochromatin are not
two uniform entities but can be subdivided into distinct classes as a function of
their characteristic chromatin properties. Consequently, two pioneering
publications recently proposed a Technicolor update of Heitz’ black-and-white
C-bands, delineating 5 (Filion et al., 2010) or 9 (Kharchenko et al., 2011) principal
states or ‘colors’ of chromatin that capture fundamentally different subtypes of
euchromatin and heterochromatin. In keeping with this metaphor, we can expect
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the need for more technological advances before we will be able to see chromatin
in its full color.
In my thesis work, I have been exploring the contribution of a particular
histone variant, H3.3, to the properties of both eu- and hetero- chromatin. I have
discovered a novel pathway for H3.3 to be incorporated into chromatin (Chapter
2) and made progress towards understanding how it’s specificity for this variant
is achieved (Chapter 3 and 4), as well as why animals might require distinct
pathways for the same variant (Chapter 5). With novel immunological tools I
gained a more detailed insights how histone H3 variants are distributed within
euchromatin and heterochromatin, introducing a new nuance to the color
spectrum (Chapter 6).

1.2 Replacement histone H3.3: new functions for an old variant‡
1.2.1 Preface
The description of the identity of the four core histones and their
oligomeric arrangement in the nucleosome dates to the 1960s and 1970s
(Kornberg and Thomas, 1974; Lewis, 1976; van Holde, 1988). Intriguingly, even
in purified nucleosome core particle more than four non-identical protein species
could be discerned if electrophoresis was carried out in the presence of non-ionic
detergents (Zweidler, 1978). These species turned out to be related to, but not
identical to the major-type histones H3, H2A, H2B and were therefore termed

‡

Parts of this chapter have been published in Elsaesser, S. J., Goldberg, A. D., and Allis, C. D.

(2010). New functions for an old variant: no substitute for histone H3.3. Curr Opin Genet Dev 20,
110–117.
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variants (Franklin and Zweidler, 1977). Histone variants have subsequently been
isolated from many organisms including the protozoan Tetrahymena, that
features unconventional separation of euchromatin in macronuclei from
heterochromatin retained in micronuclei by large-scale somatic genomic
rearrangements. This nuclear dimorphism facilitated biochemical fractionation of
chromatin and lead to the striking finding that specific histone variants were
exclusively associated with the transcriptionally active macronucleus (Allis et al.,
1980). Only the cloning of histones genes from a number of species revealed that
the histone variants hv1 and hv2 associated with euchromatin in Tetrahymena
(Allis et al., 1986; Allis et al., 1982) have functional counterparts in metazoans.
Metazoan and yeast H2A.Z is a true ortholog of Tetrahymena hv1, whereas the
functional ortholog of hv2 was found to be H3.3 (Ahmad and Henikoff, 2002c).

1.2.2 Histone H3 variants have distinct sequences and expression
patterns
In metazoans, three main classes of histone H3 genes encode distinct H3
proteins: the major-type, replication-dependent (RD) histone H3, the replicationindependent (RI) variant H3.3, and the centromeric H3 (cenH3 hereafter) variant
CENP-A (Figure 1.3A). Apart from the major type histone H3 shared by all
metazoans (systematically called H3.2), mammals possess another RD variant,
H3.1, with a single amino acid substitution at position 96.
Two major, highly conserved distinctions account for unique functions of
H3.3: differential expression during the cell cycle and amino acid variation in
residues 87-90 of the histone core region (Figure 1.3A). Most higher eukaryotes
organize their genes for all four major-type histones in repeats with a total of 108

	
  

50 intronless copies of each histone gene (Marzluff et al., 2002; Rooney et al.,
2002). Organisms at the base of the metazoan tree, such as Trichoplax adhearens,
have only one or few copies of H3.2 (Figure 1.3D). H3.1/2 transcripts from
histone clusters lack a poly(A) tail but share a conserved 3’ stem loop (Dominski
and Marzluff, 1999). These atypical mRNA features are thought to be responsible
for the tight restriction of replication-dependent histone gene expression to S
phase (Harris et al., 1991).
In contrast, H3.3 genes are present in single copies, often contain introns,
and give rise to classical polyadenylated mRNAs. Unlike H3.1/2, the expression
of H3.3 genes is replication-independent, and H3.3 has long been established as
the predominant H3 variant in quiescent, G1, and G2 cells (Wu et al., 1982)
Consequently, its cell cycle-independent expression enables H3.3 to serve as a
substrate for histone replacement processes that occur outside of S phase.
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Figure 1.3: Protein sequences and gene complements of the non-centromeric
histone H3 variants in fungi and metazoans.
(A) Schematic representation of the major human histone H3 variants, their
expression timing during cell cycle and their mode of incorporation (RD
replication-coupled, RI replication-independent) (B) Schematic representation of
the major non-centromeric histone H3 protein sequences from human, mouse
and Trichoplax adhearens (one of the most basal metazoan species), as well as
budding and fission yeast. Amino acids that distinguish variants are highlighted
with residue numbers, additional differences are indicated as dots. H3.1 only
exists in mammals and only differs in position 96 from H3.2 present in all
metazoans. H3.2 and H3.3 are distinguished by one amino acid difference at
position 31 in the histone tail and three in amino acids 87-90 in the core histone
fold. (C) Phylogenetic relationship of the respective histone H3 genes. An
unrooted parsimony tree was constructed based on representative coding
sequences (consensus tree of 100 bootstraps, excluding the wobble bases). The H3
genes of S. pombe and S. cerevisiae cluster with metazoan H3.3. (D) Schematic
overview of the major non-centromeric gene complements of the indicated
species. The placozoan Trichoplax adhearens is has only one gene for H3.2 and
H3.3 each, while higher metazoans have greatly expanded H3.1/2 gene
complements.
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1.2.3 H3.3 is the evolutionary conserved, universal histone H3
Given the overwhelming number of synonymous RD histone genes in higher
metazoans, one might be tempted to explain the generation of minor variants by
transfer of one or more histone gene from the genomic clusters into an orphan
location and subsequent evolution of a variant sequence. Such case can be made
for the testis-specific, H3.2-like variant H3t in humans (Franklin and Zweidler,
1977; Witt et al., 1996). For the relationship of H3.1/2 and H3.3, phylogenetic
analysis with lower metazoans draw a different picture of variant evolution that
places histone H3.3 at the root of the evolutionary tree: Unlike metazoans and
multicellular fungi, the yeasts S. cerevisiae and S. pombe only have a single noncentromeric H3 variant. Protein and DNA sequence analysis suggests that yeast
H3 is related to the metazoan H3.3. As yeasts share some of the same replicationdependent and independent chromatin assembly pathways (see Figure 1.5), H3.3
might be considered as an ancestral histone H3 that is compatible with both
major assembly pathways. This is in contrast to the metazoan H3.1/2, whose
function seems to be largely restricted to the replication-dependent pathway.
Nucleotide sequence alignments suggest that H3 variants have arisen or
have already been present at the root of metazoans – RD and RI genes form two
separate clades in a maximum-likelihood tree, with RI genes sharing significant
homology to the yeast H3 (Figure 1.3B,C). As expected, the simplest metazoan
organism identified to date, the placozoan Trichoplax adhearens, branches off at
the root of this tree, most closely related to the histone genes of the fungi lineage.
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Figure 1.4: Convergent evolution of non-centromeric histone H3 variants in all
kingdoms of life.
A phylogenetic tree was created based on a Kimura distance matrix of representative
coding sequences (excluding the wobble base) with the PHYLIP package (Felsenstein,
1989). Length of the branches corresponds to evolutionary distance. Dotted lines
represent branches that are not supported by bootstrap values >= 0.8 (therefore,
branches at the base of the tree cannot be accurately positioned). Branch color by
kingdom; fungi brown, plants green, animals blue. Amino acid sequences in the
chaperone recognition domain (CRD) is shown for selected branches (all other divergent
positions are not shown but included in the phylogenetic analysis). Red stars represent
switches in the CRD to the RD variant (all switches are supported by bootstrapping
values > 0.8). The isolated appearance of RD variants within each kingdom suggests
convergent evolution from the H3.3-like RI ancestor.
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Interestingly, T. adhearens possesses only one gene per variant, arguing for a later
expansion of the RD genes into the canonical histone gene clusters that we
observe in higher animals (Figure 1.3D). It is tempting to speculate that it is the
dramatically expanding genome size in metazoan evolution that triggered the
multiplication of histone genes and potentially also led to the evolution and
fixation of the RD variant (H3.1/2) sequence that restricts its use to packaging
the newly replicated genome.
Extending my phylogenetic analysis to all three kingdoms – animals,
plants and fungi, I found evidence that RD variants have appeared
independently in all three kingdoms by convergent evolution (Figure 1.4A).
While evolutionary pressure on the protein sequence has restricted amino acid
variation to a level that does not allow inference of evolutionary relationships,
the mostly synonymous mutations occurring in the coding sequence of histones
permit meaningful phylogenetic analysis: A distance matrix-based tree
(Felsenstein, 1989) constructed from the coding sequence of a representative set
of RD and RI histones in fungi, plants and animals places each respective RI
species (H3.3) at a common root. RD species branch off at the root of each
multicellular speciation. In the case of multicellular fungi, residues 87-90 of the
RD histone H3 are synonymous with the animal H3.1/2, despite the substantially
divergent nucleotide sequences. It can therefore be concluded that the particular
‘SAVM’ motif has been selected for by convergent evolution.
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1.2.4 H3.3 is enriched at active genes, promoters, and regulatory
elements
As discussed above, major-type histones are incorporated in bulk during
DNA replication. Once assembled into nucleosomes, the vast majority of H3-H4
tetramers has been observed to remain chromatin-bound over several cell
generations, whereas a substantial amount of H2A-H2B dimers is exchanged
within hours (Kimura, 2005). In the absence of replication, histone H3 has been
reported to extremely stable with a half-life of ~150 days (Piña and Suau, 1987).
Despite the slow turnover of bulk histones, pioneering cytological studies
of H3 variant deposition in Drosophila provided evidence for rapid H3-H4
exchange at specific loci in euchromatin (Ahmad and Henikoff, 2002c). While
low levels of H3.3 are likely deposited together with H3.2 during replication,
H3.3 was specifically enriched within actively transcribed genes by a replicationindependent replacement process dependent on active transcription (Ahmad and
Henikoff, 2002c; Schwartz and Ahmad, 2005). Conversion of the H3.3 variant
region 87-90 (‘AAIG’) to the H3.1/2 sequence ‘SAVM’ abolished replicationindependent incorporation (Ahmad and Henikoff, 2002c). These findings
underscore the importance of the variant H3.3 sequence in addition to its cellcycle independent expression. Interestingly, the single replacement of a Ser with
an Ala at position 31 of the histone H3 tail did not have any influence on the
deposition pathway, suggesting that H3.3 S31 and its phosphorylation do not
play a role in H3.3 deposition (Ahmad and Henikoff, 2002c; Hake et al., 2005).
Recent advances in chromatin immunoprecipitation (ChIP) technologies
have allowed a more detailed map of H3.3 deposition, revealing specific H3.3
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incorporation throughout the gene body of transcribed genes as well as highly
enriched foci at the promoter region in Drosophila and mammalian cells (Figure
1.5A) (Chow et al., 2005; Daury et al., 2006; Janicki et al., 2004; Jin et al., 2009;
Mito et al., 2005, 2007; Nakayama et al., 2007; Sutcliffe et al., 2009; Tamura et al.,
2009; Wirbelauer et al., 2005). H3.3 enrichment at promoter regions has been
observed not only at active genes but also at inactive genes, possibly accounting
for a ‘poised’ state of these genes (Mito et al., 2007; Tamura et al., 2009).
Furthermore, H3 replacement occurs at genic and intergenic regulatory regions
in various metazoans (Figure 1.5A) (Goldberg et al., 2010; Jin et al., 2009; Mito et
al., 2007; Nakayama et al., 2007).

1.2.5 H3 replacement in yeast
Despite relying on a single H3.3-like species, both replication-dependent and
replication-independent H3 deposition pathways are found in yeast: in S. pombe,
H3 expressed outside of S phase is preferentially incorporated in euchromatin
(Choi et al., 2005; Takayama and Takahashi, 2007). A number of studies in S.
cerevisiae detected H3 replacement at active (Jamai et al., 2007) and also inactive
(Dion et al., 2007; Rufiange et al., 2007) promoters, but only to a small extent
throughout transcribed gene bodies. Genetic studies in yeast delineated a
pathway comprising the chromatin remodeler Snf2 and the histone chaperone
Asf1, as well as Hir1 or Spt6 for H3 exchange at the promoter region (Adkins and
Tyler, 2004, 2006; Gkikopoulos et al., 2009; Rufiange et al., 2007; Schermer et al.,
2005). H3 deposition at the gene body required active transcription, Hir1, and
Asf1 (Dion et al., 2007; Kim et al., 2009; Rufiange et al., 2007). Hir1, Hir2, Hir3
and Hpc2 constitute the yeast HIR repressor complex (an overview of histone
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chaperones is found in Section 1.3, Table 1.1) that has been shown to catalyze
replication-independent histone deposition together with the H3-H4 chaperone
Asf1 in vitro (Green et al., 2005; Prochasson et al., 2005). Spt6 has also been shown
to facilitate nucleosome assembly in vitro (Bortvin and Winston, 1996). Therefore,
chromatin remodelers, histone chaperones and deposition factors cooperate in
the eviction of old and deposition of new histones in yeast (Figure 1.5B).
Interestingly, the elongation complex FACT (Spt16/ Pob3) redeposits H3-H4
units in the wake of RNAPII, favoring recycling of ‘old’ histones over exchanging
them with ‘new’ H3-H4 (Jamai et al., 2009). When Spt16 is deleted, a Hir1dependent pathway takes over to deposit more ‘new’ H3 (Formosa et al., 2002;
Jamai et al., 2009). In conclusion, yeast genetics of replication-independent
histone exchange processes might yield clues to yet undiscovered components of
metazoan H3.3-deposition pathways (Figure 1.5B).
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Figure 1.5: Transcription-associated histone dynamics in metazoan and yeast.
A Schematic map of an active and inactive gene locus comprising an upstream
regulatory element (RE), transcription start site (Promoter) and transcription end
site (TES). The distribution of histone H3.3 across the locus is shown in green,
with representative H3.3 and H3.1/2 nucleosomes, as well as RNA polymerase II
(RNAP). (b) Summary of the known factors involved in replication-dependent
(right, S phase) and replication-independent (left, Interphase) chromatin
assembly pathways, in metazoans and yeast. Replication-coupled assembly is
thought to be mediated by the CAF1 complex and Asf1 proteins in the wake of
DNA polymerase (DNAP). H3.3-enrichment at telomeres is dependent on ATRX.
Replication-independent deposition at promoters, regulatory elements and genic
regions in metazoans requires HIRA, CHD1, and/or other factors, analogous to
pathways in yeast mediated by Snf2, Asf1, HIR complex and/or Spt6. The FACT
complex (Spt16 and Pob3/Ssrp1) might contribute to incorporation of new or
recycling of old histones.
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1.2.6 Mechanism of H3.3-specific deposition in metazoans
HIRA, the homolog of yeast Hir1 in higher eukaryotes, has been shown to
assemble chromatin independent of replication and to interact specifically with
ASF1a/b in a multisubunit complex specific for H3.3 (Ray-Gallet et al., 2002;
Tagami et al., 2004). HIRA and the SWI/SNF family chromatin remodeler CHD1
have also been implicated in H3.3 deposition in vivo (Konev et al., 2007).
Interestingly, H3.3 continues to be incorporated into chromatin even in the
absence of HIRA or CHD1 (Bonnefoy et al., 2007; Konev et al., 2007). Therefore,
an imminent question at the time I started my thesis work was if these identified
factors were only mediating H3.3-deposition at a subset of genomic locations or
if yet unknown pathways would compensate for their loss. Indeed, studies by
my colleagues subsequently showed HIRA mediated H3.3 deposition at
transcribed regions and a subset of regulatory elements (Goldberg et al., 2010).
Furthermore, H3.3-enrichment at murine ESCs was not dependent on HIRA but
not on the ATP-dependent chromatin remodeler ATRX (Goldberg et al., 2010;
Wong et al., 2010). Despite these first insights into locus-specific chromatin
assembly pathways, many questions remained about the precise mechanisms of
H3.3 replacement: Are HIRA and ATRX bona fide deposition factors for histone
H3.3 or do they orchestrate the incorporation of H3.3 by indirect means. What
are the histone chaperones that can distinguish the subtle differences between
H3.3 and H3.1/2, and how do they achieve site-specific deposition? Importantly,
neither HIRA nor ATRX had been shown to interact directly with histone H3.3
and structural details on the molecular recognition of H3.3 were lacking.
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1.2.7 H3.3 function: a balancing act between facilitating and repressing
transcription?
As a highly conserved replacement variant, does H3.3 have a conserved
function at promoters, coding regions, and regulatory elements? Two recent
studies assessing inducible gene expression suggest that incorporation of H3.3
promotes initial gene activation (Placek et al., 2008; Tamura et al., 2009). One
possibility is that nucleosome eviction and H3.3 deposition may serve as a
mechanism for the rapid removal of inhibitory histone posttranslational
modifications and/or replacement with activating marks (Ahmad and Henikoff,
2002c). However, even though nucleosomal H3.3 is enriched in activating
modifications such as H3K4me3, these modifications in particular seem to be
established only after nucleosomal deposition (Loyola et al., 2006; McKittrick et
al., 2004). Rather than introducing a particular set of PTMs, ongoing histone
exchange could therefore contribute to a highly dynamic steady state of
establishment and removal of histone PTMs at specific genomic locations
(Ahmad and Henikoff, 2002c; Deal et al., 2010). Continuous histone exchange
and H3.3-incorporation at boundaries of chromatin domains has therefore been
proposed to limit the spreading of certain histone modifications (Dion et al.,
2007; Mito et al., 2007).
Based on the apparent lability of H3.3 nucleosomes in chromatin extracts,
it has been proposed that nucleosome-destabilizing properties could help
promote and propagate an active chromatin state (Jin and Felsenfeld, 2007; Jin et
al., 2009). As in vitro studies found little stability difference in recombinant
H3.1/2 and H3.3 nucleosome (Flaus et al., 2004; Thakar et al., 2009), this effect
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might be potentiated by histone PTMs or inherent to CG-rich promoter DNA
sequences that often coincide with H3.3-enrichment (Ramirez-Carrozzi et al.,
2009). Furthermore, cooperative effects with H2A.Z and exclusion of the linker
histone H1 could account for some of the properties of H3.3-containing
nucleosomes (Braunschweig et al., 2009; Kim et al., 2007).

Is H3.3 a general marker of active chromatin? Notably, the HIR complex
has been shown to have a repressive role on transcription in yeast (Anderson et
al., 2009; Blackwell et al., 2004; Fillingham et al., 2009; Kim et al., 2007; Sharp et
al., 2001; Sherwood et al., 1993). Hir1 was first identified as a potent repressor of
the canonical histone genes in S. cerevisiae (Sherwood et al., 1993), and recently its
repressor function in S. pombe has been mapped to a large number of promoters
and also to suppression of cryptic transcripts from within coding regions
(Anderson et al., 2009), likely by repopulating nucleosome-free regions
(Schermer et al., 2005). It is tempting to speculate that replication-independent
H3.3 deposition in metazoans is similarly used to replenish nucleosome-free
regions. Indeed, H3.3 knockdown leads to a slight decrease in nucleosome
density (Braunschweig et al., 2009).
Apart from its unresolved effect on gene expression from euchromatin,
cumulative evidence from others and our studies supported a role for H3.3 in
facultative and constitutive, highly repetitive heterochromatic regions. HIRA,
ASF1a and the mammalian Hir2 homolog Ubinuclein-1 have been implicated in
the formation of facultative heterochromatin (Banumathy et al., 2009; Zhang et
al., 2007a), and H3.3 has been observed in pericentric heterochromatin and at
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telomeres (Drané et al., 2010; Goldberg et al., 2010; Hake et al., 2005; Lewis et al.,
2010; Wong et al., 2009).

1.2.8 Biological significance of replication-independent H3.3 deposition
Clues for the in vivo functional significance of H3.3 come from genetic
studies in flies and mice. Loss of both genes of H3.3 in flies leads to complete
sterility, mild transcriptional defects, particularly at highly expressed genes, and
partial but incomplete lethality (~42% viability) (Sakai et al., 2009). Intriguingly,
the grossly normal development to adulthood of the surviving H3.3-deficient
flies indicates that H3.3 is not absolutely required for transcription and
development (Hödl and Basler, 2009; Sakai et al., 2009). Indeed, while gene
expression of a subset of genes in adults was perturbed, the precisely timed and
localized expression of developmental key factors was not affected in H3.3deficient flies. Similarly, although HIRA is required for fertility, adult HIRA null
flies have no phenotypic abnormalities (Bonnefoy et al., 2007). In mice, targeted
mutagenesis of HIRA resulted in gastrulation defects and patterning
abnormalities of mesendodermal derivatives prior to early embryonic lethality
(Roberts et al., 2002), suggesting a more prominent role for replicationindependent chromatin assembly during mammalian development. Although
HIRA may have various H3.3-independent functions, H3.3 itself is also
important for mammalian development: a retroviral gene trap insertion into the
murine H3.3A gene generated an H3.3 hypomorph that caused developmental
defects and neonatal lethality (Couldrey et al., 1999).
How do flies compensate so well for the loss of H3.3 or HIRA? Intriguingly, an
unknown mechanism seems to allow the cells to sense overall histone levels, as
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replication-dependent histone H3.2 genes are upregulated in H3.3-deficient flies.
Furthermore, upregulated endogenous replication-dependent histone gene
transcripts were found to be polyadenylated to some extent, likely achieved by a
previously

described

alternative

histone

mRNA

processing

mechanism

(Akhmanova et al., 1997; Sakai et al., 2009). Importantly, viability and wild type
expression of most genes are fully restored when an additional H3.2 transgene is
introduced (Sakai et al., 2009). Thus, elevated levels of H3.2 can largely rescue
the transcriptional phenotype in adult H3.3 null flies. In rapidly dividing cells,
replication-dependent deposition of H3.1/2 could compensate for loss of
nucleosomes during transcription (Figure 1.6A). Alternatively, replicationindependent pathways could tolerate H3.1/2 as substrates in the absence of H3.3
(Figure 1.6B). Interestingly, global H3K4me3 levels in flies lacking H3.3 were
comparable to wild-type but drastically reduced in flies with a H3.3K4A
transgene (Sakai et al., 2009), indicating that only in the absence of H3.3, H3.2
becomes the major carrier for this mark. I therefore speculate that in the absence
of a replacement variant, re-deposition of histones in cis partially substitutes for
replication-independent incorporation of new histones (Bell and Schübeler,
2009), which is analogous to the competing pathways for ‘new’ and ‘old’ histone
observed in yeast (Figure 1.6C)(Jamai et al., 2009). Thus, if no ‘new’ histones are
available, more ‘old’ histones with ‘old’ marks might be retained.
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Figure

1.6:

Putative

compensatory

mechanisms for the loss of H3.3.
(A) Absence of H3.3 as substrate for
replication-independent

chromatin

assembly could create nucleosome-free
regions. In rapidly dividing cells, these
gaps could be filled during the next S
phase

via

canonical

replication-

dependent chromatin assembly. (B)
Elevated levels of H3.1/2 throughout
the cell cycle could provide substrate
for replication-independent chromatin
assembly factors that are not restricted
to H3.3. (C) In the absence of de-novo
chromatin

assembly,

the

FACT

complex could favor transient eviction
and redeposition of histone units in cis.

25

	
  

1.2.9 Histone replacement by H3.3 is essential for reproduction in
metazoans
Despite potential compensatory mechanisms, HIRA and H3.3 play critical
roles in sexual reproduction in all studied metazoans (Bonnefoy et al., 2007; Hödl
and Basler, 2009; Sakai et al., 2009). Both male and female H3.3 null flies are
sterile. In mammals, the hypomorphic gene trap of H3.3A described above also
led to male sub-fertility (Couldrey et al., 1999). Strikingly, H3.3 is substrate for
several large-scale chromatin remodeling events during metazoan reproduction,
in particular gametogenesis and fertilization (Figure 1.7, see also (Banaszynski et
al., 2010)). With the discovery of the metazoan-specific histone chaperone Daxx,
another potential player in these chromatin remodeling events will need to be
considered.
Meiotic sex-chromosome inactivation in mammalian male germ cells also
involves massive incorporation of H3.3 into the X and Y chromosomes and
subsequent silencing (van der Heijden et al., 2007), a process that could be
mechanistically related to the formation of facultative heterochromatin
(Banumathy et al., 2009; Zhang et al., 2007a). Meiosis is partly impaired in H3.3
null flies due to a defect in chromosome segregation (Sakai et al., 2009). After
meiosis, the condensation of sperm chromatin requires removal of most histones
and replacement with protamines, although some pool of H3.3 is retained in
mammalian and C. elegans sperm chromatin (Ooi et al., 2006; van der Heijden et
al. 2007).
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Figure 1.7: Large-scale replication-independent histone-exchange in the germ line.
Early in mammalian spermatogonia differentiation, both X and Y chromosomes are
condensed and remain silent throughout spermatogenesis. Condensation appears to be
brought about by chromosome-wide remodeling that includes H3.3 incorporation (van
der Heijden et al., 2007). Both HIRA and Daxx localize to the XY body at this stage
(Rogers et al., 2004; van der Heijden et al., 2007). ATRX is required for faithful meiotic
chromosome segregation (de La Fuente et al., 2004). Upon fertilization, H3.3 is
incorporated into the paternal pronucleus concomitant with protamine removal whereas
no H3.3 is detected in the maternal pronucleus (Bonnefoy et al., 2007; Konev et al., 2007;
Ooi et al., 2006; Torres-Padilla et al., 2006; van der Heijden et al., 2005). This asymmetric
histone variant incorporation correlates with an earlier onset of transcription on the
paternal pronucleus. Both the histone chaperone HIRA and the chromatin remodeler
CHD1 have been shown to be required for protamine removal, decondensation and H3.3
incorporation in flies (Bonnefoy et al., 2007; Konev et al., 2007).
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After fertilization, a maternal pool of H3.3 is used to rechromatinize the paternal
genome in the male pronucleus (Bonnefoy et al., 2007; Konev et al., 2007; Ooi et
al., 2006; Torres-Padilla et al., 2006). This asymmetrical distribution of H3
variants could be important in epigenetic distinction of maternal and paternal
information.
Critically, all remodeling events in the germline seem to be exquisitely
specific to H3.3, as a H3.2 transgene under the H3.3 promoter cannot rescue the
fly’s sterility (Hödl and Basler, 2009; Sakai et al., 2009). It is therefore likely that
the phenotype is a direct consequence of impaired large-scale chromatin
remodeling rather than a secondary effect due to gene expression changes
related to transcriptional defects in the absence of H3.3. Consistent with this
notion, H3.3 incorporation in the male pronucleus precedes onset of transcription
and relies on HIRA and CHD1 activity (Bonnefoy et al., 2007; Konev et al., 2007).
The essential germline functions of H3.3 therefore likely created the strong
evolutionary pressure that drove the exceptional conservation of the H3.3
protein in higher eukaryotes.

1.2.10 Conclusions
Why is the use of H3.3 so diverse and widespread while not all of its
functions are essential in metazoans? I speculate that both germline and somatic
functions of H3.3 have evolved from the single H3.3-like ancestor present in
unicellular organisms. Differential timing of H3 gene expression might have
allowed some tailoring of H3 variants for replication-dependent and
independent functions, but ultimately the diversification of H3.1/2 amino acid
sequence efficiently excluded these replication-dependent histones from H3.328

	
  

specific pathways. The separation of replication-dependent and -independent
pools of H3-H4 might have allowed subsequent multiplication of the replicationdependent histone genes to fuel the growing need for bulk histones during
replication of larger genomes without affecting fine-tuned histone replacement
processes. We will need more detailed studies on how these H3.3-specific
pathways affect chromatin structure and function to ultimately understand why
metazoans evolved this exquisite specificity. Of note, wherever H3 variants have
been studied in non-metazoan organisms, plants and the protozoans Ustilago,
Tetrahymena and Trypanosoma brucei, similar patterns of RD and RI incorporation
have been observed (Allis et al., 1980; Anju et al., 2011; Siegel et al., 2009;
Waterborg, 1993). This strongly suggests an overarching theme in chromatin
regulation by histone variants.
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1.3 Histone chaperones‡
1.3.1 The structure of the nucleosome
Core histone proteins are structurally defined by the presence of a histone fold,
composed of approximately 65 amino acids (Luger et al., 1997). These amino
acids adopt a three 〈-helix structure in the presence of a partner histone, yielding
the heterodimers H3-H4 and H2A-H2B. Two H3-H4 dimers further associate via
a four 〈-helix bundle to form a (H3-H4)2 tetramer (Figure 1.8B,C). In the
nucleosome, this (H3-H4)2 tetramer is flanked by an H2A-H2B dimer on either
side (Figure 1.8A). DNA is held around this histone octamer through multiple
direct contacts (Richmond and Davey, 2003). These include at least one saltbridge between a backbone phosphate of each DNA strand and each histone
(Richmond and Davey, 2003). The disordered histone tails protrude between or
in close proximity to the DNA gyres from the somewhat circular nucleosome
core (Figure 1.8A). All four core histones belong to the most conserved proteins
amongst mono- and multicellular eukaryotic organisms. Conservation of H2A,
H2B, H3 and H4 extends beyond the core histone fold to peripheral 〈-helices and
disordered N-terminal tails (also C-terminal in H2A). The variants of higher
eukaryotes substitute only one subunit of the heterodimer, H3 and H2A, while
their hetero-dimerization partners H4 and H2B are invariant with few exceptions
(reviewed in Malik and Henikoff, 2003).

‡

Parts of this chapter have been published as: Elsässer, S. J., and D'Arcy, S. (2011). Towards a

mechanism for histone chaperones. Biochim Biophys Acta.
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Figure 1.8 Nucleosome structure.
(A), (H3-H4)2 tetramer (B) and H2A-H2B dimer (C). Cartoons were rendered from PDB
1KX5. DNA is white, H3 is blue, H4 is green, H2A is yellow and H2B is red. Missing
residues at the N-terminus of H2B are shown by a dotted line. In B and C, an N indicates
the proteins N-terminus, and the representation on the right shows only the core histone
fold. The four 〈-helix bundle that mediates H3-H4 tetramer formation and the second 〈helix of H3 are indicated.

These variants have high sequence similarity to their major-type counterpart in
the histone fold domain, containing few amino acid substitutions or short
insertions confined to specific histone surfaces. Consequently, the overall
structure of the histone fold is almost invariant, but contacts between the H3-H4
tetramer and the H2A-H2B dimer or DNA interactions can be affected (Luger et
al., 1997; Suto et al., 2000; Tachiwana et al., 2011).Conservation of histone protein
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family members alludes to heavy structural constraints imposed by nucleosome
formation, and is evidence that histone sequence, structure and function are
highly inter-dependent and major contributors to organism fitness.

1.3.2 Histones are post-translationally modified
Histones are extensively post-translationally modified by diverse
enzymatic activities including phosphorylation, acetylation, methylation and
ubiquitination (Kouzarides, 2007). Histones can be a substrate as part of the
nucleosome or when in a non-nucleosomal complex, depending on the enzyme
and the location of the modified residue (Loyola and Almouzni, 2007). Posttranslational modifications (PTMs) occur predominantly in the lysine/argininerich histone tails, but also in the core histone fold (Cosgrove et al., 2004). A
number of specific lysine acetylations directly influence histone biochemistry,
particularly in the context of nucleosome assembly and stability (Andrews et al.,
2010; Cosgrove, 2007). Many studies have been dedicated to identifying the
enzymes involved in histone PTM and PTM-removal, as well as to deciphering
the function of histone PTMs alone and in combinations (Kharchenko et al., 2011;
Kouzarides, 2007; modENCODE Consortium et al., 2010; Ruthenburg et al., 2007;
Strahl and Allis, 2000; Taverna et al., 2007).

1.3.3 Prerequisites of nucleosome formation
The structure of the nucleosome with its octameric histone core is in
keeping with the many biochemical studies on recombinant histone proteins. H3H4 heterodimer exists in equilibrium with the (H3-H4)2 tetramer at physiological
ionic strength in the absence of other protein or DNA factors (Baxevanis et al.,
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1991; Donham et al., 2011). Contacts between the H2A-H2B dimer and (H3-H4)2
tetramer to form a stoichiometric octamer, also occur in solution, albeit only at
high ionic strength which, like the vicinity of polyanionic DNA, neutralizes some
of the positive charges of the histones. Nucleosome assembly is a
thermodynamically favored process due to the many strong electrostatic
interactions that can be formed between the histone octamer and DNA.

Figure 1.9: Model of sequential nucleosome assembly.
The (H3-H4)2 tetramer (or two H3-H4 dimers) binds to DNA to form the tetrasome. This
is followed by the addition of two H2A-H2B dimers. The intermediate, a tetrasome plus
a single H2A-H2B dimer, is described as a hexasome. This process is reversible in salt
gradient experiments as indicated. A similar sequence of events has been delineated for
Nap1 nucleosome assembly in vitro.

Perhaps the integral observation in histone biochemistry is that salt
gradients (high to low) of equimolar histone-DNA mixtures, induce nucleosome
formation (Thomas and Butler, 1977) and circumvent the observed precipitation
of histone-containing mixtures at physiological ionic strength (Laskey et al.,
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1978a). Analysis of salt-dependent in vitro nucleosome reconstitution lead to a
model of sequential nucleosome assembly (Figure 1.9). The sequential model
postulates that the (H3-H4)2 tetramer (or two H3-H4 dimers) is first deposited
onto DNA, followed by the addition of two H2A-H2B dimers.
The ability of (H3-H4)2 tetramer to bind DNA at higher ionic strength than
H2A-H2B dimer supports this model (Oohara and Wada, 1987; Wilhelm et al.,
1978). While this model has been confirmed in vitro and is reversible (Bohm et al.,
2011; Mazurkiewicz et al., 2006), evidence for its relevance in vivo is somewhat
indirect (Smith and Stillman, 1991; Worcel et al., 1978). The distinct exchange
rates of H2A-H2B (fast) and H3-H4 (slow) in chromatin are consistent with the
model, although these may be a result of specific cellular variables and not
generally applicable (Jamai et al., 2007; Kimura and Cook, 2001). It can also be
argued that the superhelical arrangement of the DNA makes it difficult to
envision deposition of an intact histone octamer, the only other stable histone
complex detected in vitro (Andrews et al., 2010). Cross-linked octamers, however,
do assembly into nucleosomes with the same efficiency as uncross-linked
histones in vitro (Stein et al., 1977; Stein et al., 1979). In the context of the
sequential model, exchange of the central (H3-H4)2 tetramer, for example for
incorporation of replication-independent H3 variants, would require the
complete disassembly of the nucleosome.

In the cell, multiple steps have to precede the productive formation of
nucleosomes. Histones are synthesized and folded in the cytoplasm, before being
imported into the nucleus and recruited to subnuclear territories and ultimately
the sites of deposition at the DNA (Figure 1.10). This flow of histones has to be
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highly facilitated and regulated to meet the supply and demand of DNAtemplated processes. Proteins that catalyze one or more of these steps are termed
‘histone chaperones’.

Figure 1.10: Prerequisites of nucleosome formation and contexts of histone chaperone
activity.
Histone chaperones may facilitate nucleosome formation by being involved in some or
all of the processes I-VI indicated. Histones may be transferred between chaperones to
complete all these processes in a regulated manner.
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1.3.4 A framework of histone chaperone function
Even before the definition of molecular folding ‘helpers’, the term ‘chaperone’
was applied to a protein involved in nucleosome formation in the late seventies
(Laskey et al., 1978a): Laskey recognized that the complete instruction manual
for nucleosome assembly in vitro is contained in the histones and DNA. He thus
proposed that histone chaperones function by preventing promiscuous histoneDNA interactions. Studies by Laskey and colleagues identified the acidic protein
NPM in Xenopus laevis egg extracts able to bind histones and facilitate
nucleosome formation in an ATP-independent manner (Laskey et al., 1978a;
Laskey et al., 1977). It is remarkable that these two properties remain the only
shared and thus defining characteristics of histone chaperones today (Figure
1.11). It should be reinforced that histone chaperones possess both histonebinding and ATP-independent nucleosome assembly activity, but are not stable
constituents of the final nucleosome product. This distinguishes them from
proteins with histone PTM-recognition domains, such as bromodomains or PHD
fingers, as well as from ATP-dependent nucleosome remodelers. Histone
association is routinely assayed both in vitro and in vivo using standard binding
assays, while nucleosome assembly is frequently only assessed by in vitro
experiments on linear or circular DNA. A protein involved in any one of the
aforementioned prerequisites is likely to have in vitro nucleosome assembly
activity. Experiments involving yeast genetics or cell-free extracts are more
stringent tests of so-called direct nucleosome assembly in vivo.
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Figure 1.11: Laskey’s histone chaperone definition.
The founding definition of a molecular chaperone as a catalytic factor in chromatin
assembly by Ron, 1997 (Laskey et al., 1978b)

Efforts by many laboratories employing diverse experimental strategies have
identified conserved histone chaperones in yeast and metazoans (see Table 1.1
and (Koning et al., 2007) for a more thorough description of individual
chaperones). Cytosolic H2A-H2B and H3-H4, for example, are bound by Nap1
and NASP, Asf1 respectively, and might remain bound during translocation to
the nucleus (Campos et al., 2010; Drané et al., 2010; Mosammaparast et al., 2002;
Osakabe et al., 2010; Tagami et al., 2004). Nap1 and Asf1 also function in the
nucleus, where the histones are channeled into distinct pathways associated with
DNA metabolic events. These events are typically classified as DNA replicationdependent or independent. CAF1 is thought to be a replication-dependent
chaperone, while HIRA activity is replication-independent (Goldberg et al., 2010;
Kaufman et al., 1995; Tagami et al.). Many chaperones are functionally linked to
transcriptional regulation, such as FACT, which facilitates eviction of H2A-H2B
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from the nucleosome (Bortvin and Winston, 1996; Han et al., 2010; Kundu et al.,
2011; Orphanides et al., 1999). NPM represents a storage chaperone insofar as it
binds the large pool of histones that will be used for packaging newly replicated
DNA in the X. laevis egg (Laskey et al., 1977). Homologous NPM chaperones also
act as sinks for histones removed during sperm development and fertilization
(Philpott and Leno, 1992; Philpott et al., 1991). Linker histone chaperone activity
has been described as additional feature of NAP1, sNASP and NPM1, potentially
regulating higher order chromatin structure in vivo (Finn et al., 2008; Gadad et
al., 2011; Kepert et al., 2005; Shintomi et al., 2005).
The sheer number of histone chaperones and histone-binding proteins
identified to date supports the long-held view of there being little or no free
histones at any given time or locus in the cell. Implicit in the idea that most
histones are nucleosomal or chaperone-bound, is the transfer of histones from
one chaperone to another (hereafter a ‘hand-off’). The recent description of
distinct, ordered complexes associated with newly synthesized histones suggests
that this notion is applicable to H3-H4 (Campos et al., 2010). Biochemical analysis
of H3-H4 purified from either the cytoplasm or nucleus, failed to detect free or
unbound histones (Campos et al., 2010; Drané et al., 2010; Elsaesser and Allis,
2010; Lewis et al., 2010; Tagami et al., 2004). Rather, H3-H4 was found in
different histone chaperone-containing complexes. Details of the temporal
hierarchy of these complexes, as well as a similar study for H2A-H2B, are eagerly
awaited. The localization of bona fide chaperones in both the nucleus and the
cytoplasm (e.g. (Mosammaparast et al., 2002)), as well as the often stoichiometric
amounts of histone chaperones and histones (Elsaesser and Allis, 2010; Tagami et
al., 2004), also attest to a small or absent population of free histones in the cell.
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Table 1.1:
Brief overview of major histone chaperones and their biological functions.
Homologs in selected species are given where confirmed (blue background) or
putative (blue diagonal stripes). Described functions are highlighted (‘main’
function purple, additional observed or implied functions in purple stripes). For
references see main text.
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Shuttling-Storage

ASF1a
ASF1b

Transcription

Asf1

Replication-independent

Asf1

Replication/Repair

Mammals

Asf1

Specificity

Xenopus

Asf1

Drosophila

Name

Putative Function

S. cerevisiae

Homologues

H3-H4

H3-H4 dimer chaperone with low nM affinity

RBBP4-7

(Cac3)

p55

p46
p48

p46
p48

H4
(H3-H4)

H3-H4 chaperone, also cenH3-H4 chaperone

CAF1

Cac1
Cac2
Cac3

p180
p105
p55

p150
p60
p46-48

p150
p60
p46-48

H3.1/2-H4
(yeast H3-H4)

Replication-dependent H3.1-H4 histone chaperone

HIRA

Hir1
Hir2
Hir3
Hpc2

HIRA
HIRA
?
Yema

HIRA
HIRA
?
Ubn1

HIRA
HIRA
Cabin1
Ubn1

H3.3-H4
(yeast H3-H4)

Replication-independent H3.3-H4 histone chaperone, associated with transcription

Daxx

-

DLP

Daxx

Daxx

H3.3-H4

HJURP

CENPA-H4

Replication-independent histone chaperone

HJURP

Scm3

HJURP

HJURP

Centromere-specific, replication-independent histone chaperone

FACT

Spt16
Pob3

Spt16
SSRP1

Spt16
SSRP1

Spt16
SSRP1

H3-H4
H2A-H2B

Facilitates transcription through chromatin by H2A/H2B removal, Ssrp1 and Spt16 Peptidase
domain also bind H3-H4

Spt6

H3-H4

Transcriptional elongation factor, also shown to contain histone chaperone activity

NASP

(Hif1)

NASP

N1/N2

sNASP
tNASP

H3-H4

Associated with nuclear and cytosolic H3-H4, also in vitro chromatin assembly activity

Rtt106

Rtt106

-

H3-H4

H3-H4 histone chaperone in yeast

Nucleoplasmin/Nucleophosmin/NPMs

H2A-H2B, H3H4

Histone storage chaperone for sperm and oocyte

NAP1

Nap1
Vps75

Nap1

Nap1

NAP1L
SET
(APLF)

H2A-H2B, H3H4

Histone H3-H4 and H2A-H2B chaperone

Chz1

H2A.Z-H2B

Histone chaperone associated with replication-independent variant H2A.Z
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1.3.4.1 Applicability of in vitro results in vivo
Another challenge in determining histone chaperone mechanism is the
interpretation of factor-dependent in vitro nucleosome reconstitution assays.
These assays determine if a particular factor promotes nucleosome formation in
histone-DNA mixtures at less than 250 mM salt and pH 7.5 to 8.0. These ionic
and pH conditions allow recapitulation of general chromatin properties observed
in vivo. If precipitation is avoided and nucleosomes are formed, then the factor is
said to have nucleosome assembly activity and consequently thought to deposit
histones in vivo. Such assembly activity is often assumed to stem from direct
deposition of histones onto DNA by the histone chaperone. A recent
thermodynamic study of Nap1-mediated nucleosome assembly however,
reinforces that such a direct mechanism is not required in vitro or in vivo
(Andrews et al., 2010). The results of this study and others (e.g. (Mazurkiewicz et
al., 2006)) indicate that any histone-binding protein (or other chemical factor)
with an affinity in the range of the respective histone-DNA complex product can
potentially facilitate nucleosome assembly in vitro. In vivo, these histone-binding
proteins may however function in steps that precede ultimate deposition on
DNA. Asf1 is an example of a histone chaperone with nucleosome assembly
activity only under certain in vitro conditions (Donham et al., 2011; Munakata et
al., 2000; Umehara et al., 2002) that does not directly assemble nucleosomes in a
X. laevis extract system (Koning et al., 2007; Ray-Gallet et al., 2007). Thus the
ability to assemble nucleosomes in vitro may simply reflect an ability to bind
histones tightly and avoid non-nucleosomal interactions.
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The somewhat artificial scenario of the in vitro reconstitution assay is further
indicated by experiments showing that poly-glutamic acid or poly-aspartic acid
successfully assembly nucleosomes (Stein et al., 1979). Unlike Nap1, however,
they do this by stabilizing the histone octamer even in the absence of DNA (Stein
et al., 1979). This alludes to a purpose for the acidic stretches often found in
histone chaperones and highlights that in vitro nucleosome reconstitution can in
fact be informative. In particular, it is useful to identify potential pathways of
nucleosome formation and to see how they are influenced by particular factors.
Another difficulty in interpreting in vitro mechanistic data for in vivo
function relates to the specificity of a histone chaperone for particular histones.
Nap1, for example, binds H2A-H2B and H3-H4 equally well in vitro (Andrews et
al., 2008). Chz1 is also thought to be H2A.Z-H2B-specifc, and yet the co-structure
fails to identify any H2A.Z-specific contacts (Zhou et al., 2008). It is thus more
likely that specificity is achieved through direct competition or temporal and
spatial regulation of histone chaperone activity in vivo. The fact that histone
chaperones are often found in complex with other factors suggests that spatial
and temporal regulation could be achieved by accessory subunits. Furthermore,
it is still uncertain to what extent activities from biochemically independent, nonhomologous histone chaperones are redundant in the cell.

1.3.5 Models of histone chaperone function
An important principle emerges from these introductory remarks: histone
chaperones are mechanistically diverse. Mechanistic diversity reflects the many
types of histone proteins (e.g. major-type, centromeric, replacement histones), the
many contexts of ‘chaperoning’ activity, and the structural heterogeneity of
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histone chaperone proteins. These physical and contextual variances ultimately
make it extremely difficult to define histone chaperones from a mechanistic
standpoint. I will therefore outline models for histone chaperone function based
on known structural and biochemical data.

1.3.6 Histone chaperone structural diversity
Given the common task, a surprising number of unrelated structural
motifs are found throughout known histone chaperones. While many full-length
or multimeric histone chaperone structures are outstanding, several have been
solved (e.g. (Daganzo et al., 2003; Dutta et al., 2001; Park and Luger, 2006;
VanDemark et al., 2006; Zhou et al., 2008)). Structures of Nap1, Asf1 and NPM
are illustrative examples. Nap1 adopts a homo-dimeric earmuff fold that is
characterized by a non-coiled coil motif and two composite 〈/ domains (Park
and Luger, 2006). Asf1 and NPM, however, have -sandwich architectures with
immunoglobulin-like and jelly roll topologies, respectively (Daganzo et al., 2003;
Dutta et al., 2001). The Nap1 fold has only been found in functionally similar
homologues such as Vps75 and SET (Muto et al., 2007; Park and Luger, 2008),
while Asf1 and NPM folds have been observed in proteins with varied functions.
Further, in both solution and in the crystal, Nap1 is an obligate homo-dimer,
while Asf1 is a monomer and NPM is a homo-pentamer or decamer (Daganzo et
al., 2003; Dutta et al., 2001). These oligomeric states are thought to persist in vivo.
Hetero-oligomeric chaperones also exist with examples including FACT,
composed of SSRP1 and SPT16; and CAF1, composed of p150, p60 and RbAp48,
in humans. The latter two subunits adopt yet another structural motif, a -

43

	
  

propeller fold (Lejon et al., 2011; Song et al., 2008). This diversity in basic
structure and oligomeric state suggests that each histone chaperone evolved
independently to serve a specialized function in the cell.
Although histone chaperone structure is varied, one commonality
somewhat widespread is the presence of regions rich in glutamic and aspartic
acids. These acidic stretches are often found near the chaperones C-terminus and
are presumably disordered, at least in the absence of a binding partner. A
shortlist of chaperones containing such acidic regions includes Nap1, Asf1,
Rtt106, Chz1, NPM, DAXX (not at the C-terminus) and the SPT16 subunit of
FACT (Belotserkovskaya, 2003). Unlike the folded domains of histone
chaperones, these acidic stretches are not necessarily conserved. Fungal Asf1, for
examples, contains these stretches, while human Asf1 does not (Daganzo et al.,
2003). Similarly, the length and composition of these stretches varies between the
many Nap1-like proteins in humans, as well as between yeast and Drosophila
melanogaster Nap1. The latter is intriguing as the acidic stretches in D.
melanogaster Nap1 contain sites of polyglutamylation (Regnard et al., 2000). This
PTM may compensate for a less acidic composition.
1.3.6.1 Interactions between histones and their chaperones
For many histone chaperones, a missing link in the elucidation of
mechanism is the absence of structural detail regarding their interaction with
histones. While numerous chaperone-only structures are available, they often
lend little insight into the mode of histone binding. Major-type co-structures
solved to date include human and yeast Asf1 with H3-H4 (Agez et al., 2007;
English et al., 2006; Natsume et al., 2007), and the homologous p46/p55 subunits
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of human and D. melanogaster CAF1 respectively with a H4 peptide (Murzina et
al., 2008; Song et al., 2008). Even though p46 paralog p48 assembles centromeric
H3 nucleosomes in vitro (Furuyama and Henikoff, 2009), the significance of the
latter in terms of histone chaperone mechanism is vague. This is because
p46/p55 is a member of several complexes involved in histone biochemistry
(Suganuma et al., 2008). It is interesting to note however that the insertion of the
H4 histone fold 〈-helix into the binding groove of p46/p55 requires a
conformational rearrangement in the H3-H4 heterodimer. In the Asf1-H3-H4 costructure, Asf1 binds at the H3 interface required for (H3-H4)2 tetramer
formation (Figure 1.12C). The C-terminal -strand of H4 also extends away from
the H3-H4 dimer and inserts into a hydrophobic pocket in Asf1. In the
nucleosome or histone octamer, this strand folds back and aligns with the Cterminal -strand of H2A. Both large and small conformational differences in the
co-structures attest to a degree of plasticity in the arrangement of histone protein
secondary structures, particularly when the histones are non-nucleosomal. Such
plasticity, as well as the involvement of intrinsically unstructured regions, may
account for the lack of co-structures available for the many other histone
chaperones.
The insight provided by the Asf1-H3-H4 structure is testimony to the
information that may be gleaned from co-structures. Asf1 binding to an obligate
H3-H4 dimer has implications for the nucleosome assembly and disassembly
mechanism,

histone

PTMs

(as

Asf1,

like

Vps75,

activates

histone

acetyltransferase Rtt109 (Tsubota et al., 2007)) and a potential H3-H4 hand-off
(see (Koning et al., 2007) for a more complete discussion). Overall, the Asf1-H345

	
  

H4 co-structure clearly indicates that binding to histone chaperones and
nucleosome formation, are mutually exclusive. This idea is echoed in other costructures available involving variant histones. These include Chz1 with H2A.ZH2B (Zhou et al., 2008), and HJURP/Scm3 with cenH3-H4 (Cho and Harrison,
2011; Hu et al., 2011; Zhou et al., 2011). HJURP and Scm3 are cenH3-H4-specific
chaperones in human and yeast respectively. Histone-binding by HJURP/Scm3
is incompatible with the histone-DNA interactions observed in the nucleosome
(Figure 1.12C).
Like Asf1, HJURP and Scm3 preclude (cenH3-H4)2 tetramer formation,
albeit through a different mechanism.In HJURP-cenH3-H4, the interface required
for (cenH3-H4)2 tetramer formation is sterically occluded, while in Scm3-cenH3H4 it is also distorted. Another common feature of these co-structures is the
presence of extended hydrophobic interactions at the histone interface. This
reinforces that histone chaperones are likely to be doing more than just
mimicking salt.
The co-structures of HJURP and Scm3 with cenH3-H4 have also yielded
insight into histone chaperone discrimination of H3 variants. Both HJURP and
Scm3 contain a long 〈-helix that runs anti-parallel to the central 〈-helix of the
cenH3 histone fold. Overall affinity is achieved through interlinking
hydrophobic residues flanked by salt bridges, reminiscent of a coiled-coil
interaction. Variant-specificity is conferred through small highly conserved
alterations in the hydrophobic surface, but also through neighboring loop-loop
contacts, spanning the region of cenH3 disparate in sequence to major-type H3. It
is interesting to note that variations in the same hydrophobic surface occur in
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mammalian variants H3.1, H3.2 and H3.3. As this region does not make crucial
contacts in the histone octamer, it may have evolved novel functions more easily.

47

	
  

Figure 1.12: Nature of histone-DNA and histone-histone chaperone interactions.
(A) A vacuum electrostatic surface charge map of (H3-H4)2 with 72 base pairs of
DNA from PDB 1KX5. Basic surfaces (blue) accompany the path of DNA. The
top, bottom and inner surfaces are partly involved in inter-histone interactions
and are more hydrophobic. The four 〈-helix bundle of the (H3-H4)2 tetramer is
buried in (A). H3-H4 dimers in (B) and (C) are shown in an identical orientation
to (A). (B) Asf1 (cartoon) binds along the four 〈-helix bundle interface and
prevents (H3-H4)2 tetramer formation (PDB 2HUE). (C) HJURP (cartoon) binds
along 〈2 of CENP-A, disrupting (cenH3-H4)2 tetramer formation. HJURP also
blocks DNA binding through a C-terminal -sheet domain (PDB 3R45). (D)
Schematics of NAP1- and NPM-histone interaction, basic surfaces are thought to
mediate electrostatic interactions (indicated in red).
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1.3.6.2 Mechanistic implications of distinct histone-binding modes
Based on in vitro experiments, unbound or free H3-H4 and H2A-H2B units
are presumed to be ‘sticky’ in the cell. The excess positive surface charges of free
histones limits the formation of the histone octamer, as well as the (H3-H4)2
tetramer at physiological conditions (Stein et al., 1979). As a consequence,
normally protected, hydrophobic histone-histone interfaces become solventexposed outside of the nucleosomal octameric arrangement (Banks and Gloss,
2003, 2004; Baxevanis et al., 1991; Eickbush and Moudrianakis, 1978; Karantza et
al., 1996). In this state of high potential energy, the histones readily engage in
non-specific interactions , electrostatic or hydrophobic in nature, with nucleic
acids, proteins or other cellular components (Andrews et al., 2010; Stein, 1979)
(see also Figure 1.13). The putative detriment of these non-nucleosomal
complexes to nucleosome formation has been illustrated by a study with Nap1
(Andrews et al., 2010). Based on available structural and biochemical data, we
propose that histone chaperones exhibit two alternative histone-binding modes
that, by distinct mechanisms, can both prevent promiscuous histone interactions.
It remains to be seen if both modes can be employed by a single histone
chaperone.
The first mode involves neutralizing excess positive charge by
providing acidic residues to alleviate charge repulsion, as exemplified by the
well-studied histone chaperones NAP-1 and NPM (Figure 1.12D) This mode
seems to provide little selectivity for H2A-H2B or H3-H4 (and in some cases the
linker histone family), and alludes to a purpose of the large negatively charged
surfaces found in numerous histone chaperones. The acidic residues may be
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structured or unstructured in the apo-histone chaperone, and may form either
tight or transient interactions with the histones. Phosphorylation of non-acidic
residues will also contribute to this mode, as observed for NPM (Cotten et al.,
1986; Taneva et al., 2008). The involvement of PTMs that regulate chaperonehistone affinity might be crucial to ensure that chaperone activity occurs in the
applicable biological context. While alleviation of electrostatic repulsion favors
self-association of histone hetero-dimers into (H3-H4)2 tetramers and potentially
histone octamers, steric constraints imposed by chaperone architecture would
confer additional specificity. For example, the symmetric geometry of Nap1 and
Vps75 facilitates binding of an obligate (H3-H4)2 tetramer (Bowman et al., 2011).
The mechanistic benefits of electrostatic shielding stem from the histone
chaperones ability to directly compete with non-specific electrostatic interactions,
particularly with DNA. Under favorable thermodynamic conditions, pre-formed
(H3-H4)2 tetramers, H2A-H2B dimers or histone octamers can be ‘presented’ to
the recipient DNA or other histone chaperones.
The second, fundamentally different mode is to block histone hydrophobic
surfaces. This mode is evident in the co-structures of Asf1-H3-H4 (Figure 1.12B),
HJURP-cenH3-H4 (Figure 1.12C), Scm3-cenH3-H4 and Chz1-H2A.Z-H2B
(English et al., 2006; Hu et al., 2011; Natsume et al., 2007; Zhou et al., 2008; Zhou
et al., 2011). This mode is likely to be more specific as surface-exposed amino
acids are divergent between H2A-H2B and H3-H4. In fact, subtle variations in
the hydrophobic surfaces of the H3-H4 dimer may form the basis of the histone
variant specificity observed for a number of histone chaperones. Histone
chaperones that employ this mode are expected to retain histone-binding at high
ionic strength. Indeed, Asf1, DAXX, HJURP and Scm3 histone complexes are
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stable at high salt, with hydrophobic contacts outweighing salt bridges and
hydrogen bonds (Drané et al., 2010; Hu et al., 2011; Lewis et al.; Natsume et al.,
2007; Zhou et al., 2011). While the most immediate effect of this mode
counteracts aggregation via hydrophobic histone surfaces, the chaperone can
also prevent nucleosome formation through steric occlusion. As described
previously, Asf1 and HJURP/Scm3 prevent (H3-H4)2 tetramer formation and
occlude part of the DNA-binding site of the H3-H4 dimer (Figure 1.12) (English
et al., 2006; Hu et al., 2011; Natsume et al., 2007; Zhou et al., 2011). Promiscuous
histone interactions are thus efficiently prevented, despite retaining some of the
excess positive charge in the chaperone-histone complex.
The use of diverse and somewhat complementary histone-binding modes
reinforces the variety of mechanisms employed by histone chaperones to
accomplish the seemingly simple task of preventing aggregation. This diversity,
however, sets the stage for the formation of multi-chaperone complexes.
Histones may be passed between chaperones within these complexes before
eventually being made available for nucleosome assembly. Other components of
these complexes may be integral in fine-tuning histone-binding and -release onto
DNA or other pre-nucleosomal complexes. This resolves the conundrum of
histone chaperones essentially rendering the histones inert for any (specific or
non-specific) interactions with other histones or DNA.
1.3.6.3 Thermodynamic and kinetic components of histone chaperone activity
Potential mechanisms of histone chaperones can be illustrated using
simplified reaction diagrams such as those shown in (Figure 1.13). These
diagrams are based on thermodynamic constants of complexes involving histone
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chaperones, histones and/or DNA. As described earlier, free histones readily
engage in electrostatic interactions with DNA. These interactions can be specific
and associated with nucleosome formation (Figure 1.13, right) or so-called nonspecific resulting in irreversible precipitation in vitro (Figure 1.13, left). The
specific complexes may be (H3-H4)2 tetramer bound to DNA (tetrasome),
tetrasome plus one copy of H2A-H2B dimer (hexasome), or the nucleosome. In
the absence of a histone chaperone, the predominant reaction product will be the
non-specific complexes because the specific complexes involve only a small
subset of all potential histone-DNA interactions (Figure 1.13A).
A histone chaperone may promote specific complex formation by
lowering the free energy of the histones (Figure 1.13B). Free energy is lowered by
the formation of a chaperone-histone complex that is thermodynamically favored
over non-specific histone-DNA complexes. This mechanism has been proposed
for Nap1, which binds either H3-H4 or H2A-H2B with nano-molar affinity in
vitro (Andrews and Luger, 2011). Through these interactions, Nap1 assembles
nucleosomes

via

tetrasome

and

hexasome

intermediates

(Figure

1.9)

(Mazurkiewicz et al., 2006). The two key measurements are the affinities of H2AH2B for DNA (non-specific), and H2A-H2B for the tetrasome (specific) (Andrews
et al., 2010). The absolute affinities vary depending on the DNA sequence, with a
high-affinity sequence (the so-called Widom 601) measuring 44 ± 5 nM and 13 ± 3
nM correspondingly (Andrews et al., 2010). These numbers fit well with the
Nap1 affinity for H2A-H2B of 7.8 ± 0.4 nM insofar as H2A-H2B will prefer to
bind Nap1 over DNA (7.8 < 44 nM), but binds to Nap1 or tetrasome at similar
affinity (7.8 ~ 13 nM).
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Figure 1.13: Models of histone chaperone function illustrated as free-energy
reaction diagrams.
The change in free-energy is plotted along the reaction coordinate as the
substrate (DNA and histones, middle) becomes the product (precipitate, left, or
tetrasome, right). Analogous to a standard chemical reaction, substrates are
postulated to go through a 'transition state' of highest free-energy (‡) before
forming the product. The transition state represents a kinetic barrier for the
reaction. (A) shows that in the absence of histone chaperones, non-specific
interactions of histones (here H3-H4) with DNA are favored (left) over the
tetrasome formation (right). Tetrasome formation requires histones and DNA to
encounter in a non-random orientation. (B) shows that a Nap1-type chaperone
binds histones with a free-energy similar to the final tetrasome product. In the
chaperone-bound state, non-specific interaction with DNA (left) is costly, and
thus the tetrasome formation (right) is favored. (C) shows an alternative mode of
chaperone action. The chaperone binds to form a 'transition state' that is
competent to directly deposit histones onto DNA. This state might represent a
chaperone-histone-DNA trimeric complex, or a conformationally activated
histone moiety that is primed to form nucleosomal DNA contacts (right).
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When generalized to other histone chaperones with nano-molar histone
affinities, it seems that chaperones may make histones available for nucleosome
formation (Figure 1.13B, right) by disfavoring non-specific histone-DNA
complexes (Figure 1.13B, left). Unfortunately, as little is known about the kinetics
of chaperone-histone complexes, it is unclear if the substrates of nucleosome
assembly are the chaperone-histone complexes or the small proportion of free
histones in dynamic equilibrium.
Histone chaperones may also guide nucleosome assembly in a more
directed fashion by presenting the histones in the ‘correct’ orientation (Figure
1.13C, right). In contrast to the case above (Figure 1.13B), the chaperone does not
necessarily lower the free energy of the histones. Instead, it is involved in a
transient chaperone-histone-DNA complex that is resolved by DNA wrapping
and chaperone dissociation. By increasing the likelihood of specific interactions
between histone and DNA, the chaperone skews the reaction kinetics towards a
specific histone-DNA complex (i.e. tetrasome, hexasome or nucleosome) (Figure
1.13C, right). The formation of a transient ternary complex causes an apparent
decrease in activation energy to be surmounted for nucleosome formation,
favoring it over non-specific histone-DNA interactions (Figure 1.13, left). While
such ternary complexes have not been observed directly, as expected by their
transient nature, they can be inferred in a few in vitro cases. Asf1, for example,
facilitates formation of a disome [(H3-H4)1-DNA] opposed to the tetrasome
formed in the absence of chaperone (Donham et al., 2011). Similarly, for the
reverse, nucleosome disassembly reaction, chaperone-nucleosome complexes
may occur for FACT (Orphanides et al., 1999) and Nap1 (Park et al., 2005). It
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should also be noted that a transient, ternary complex may also be involved in
preventing non-specific histone-DNA interactions. If histone chaperones do
directly deposit histones, how is the transition made kinetically and
thermodynamically more favorable? One possible answer is that histone
chaperones exploit the conformational flexibility of the histone fold. Costructures involving p46/p55 and Scm3 suggest that the histone fold can be
distorted upon chaperone binding (Murzina et al., 2008; Song et al., 2008; Zhou et
al., 2011). These conformational changes may represent high-energy ‘transition’
states resolved by nucleosome formation upon encounter of DNA.
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1.3.6.4 Nucleosome assembly versus disassembly
One might wonder if nucleosome disassembly is a direct reversal of a
given assembly pathway. Chaperone-histone affinities range from micromolar to
nanomolar and are thus equivalent of the nanomolar free energy of a nucleosome
(Andrews et al., 2010). As such, it has been speculated that histone chaperones
can directly facilitate histone eviction. This notion is supported by excess Nap1
removing H2A-H2B dimers from a preformed nucleosome in vitro (Park et al.,
2005). As discussed previously, affinities of H2A-H2B for tetrasome and Nap1
are matched to allow assembly reactions to be driven in both directions. The
actual direction will depend on the abundance of Nap1, histones and DNA.
FACT has also been shown to be competent to remove H2A-H2B from a
nucleosome in the context of transcription (Belotserkovskaya, 2003). It is
important to note however that the energy required to evict H2A-H2B (and in
fact H3-H4) depends on nucleosome conformation and stability, with histone
PTMs, DNA sequence and buffer all being influential variables (Andrews et al.,
2010). These variables most likely contribute to the likelihood of histone
chaperone-mediated nucleosome disassembly in vivo.
In contrast to H2A-H2B, the (H3-H4)2 tetramer has higher dissociation
energy and more potential to be kinetically trapped. In the context of the
nucleosome, kinetically trapped simply means that the DNA does not visit an
‘unwrapped’ conformation for long enough to allow the histones to dissociate.
This is indicated by excess Asf1 failing to disassemble nucleosomes or tetrasomes
at physiological salt concentration (Donham et al., 2011). Thermodynamics alone
would predict that Asf1 would disassembly nucleosomes, given its nanomolar
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affinity that is comparable to the tetrasome energy (Donham et al., 2011).
Interestingly, thermal unwinding of the DNA still does not allow Asf1 to
compete for H3-H4 dimer, likely because at least half of the tetrasome DNA
would need to be unwrapped to uncover its binding site (Donham et al., 2011). In
light of nucleosomes being kinetically trapped, it seems probable that histone
chaperones alone cannot directly disassemble nucleosomes in vivo. However,
they may facilitate disassembly alongside ATP-dependent remodelers, as
hydrolysis of two to three ATP molecules would theoretically provide sufficient
energy to completely dissociate all histone-DNA interactions within the
nucleosome (Saha et al., 2006). Furthermore, mechanical stress imposed by DNAtemplated processes such as the positive super-coils induced by traveling RNA
polymerase, might destabilize nucleosomes sufficiently to allow direct
disassembly (Schwabish and Struhl, 2006). Therefore, the dynamic environment
in vivo will alleviate some of the kinetic barriers observed in vitro and allow a
direct competition of histone chaperones and DNA for histones. Nucleosome
density could therefore be controlled by mass action of histone chaperones (with
high affinity such as Asf1 for H3-H4 and NAP1 for H2A-H2B).
The acidic stretches found in many histone chaperones may also function
in nucleosome disassembly. That is, they may initiate the unwrapping of the
nucleosomal DNA (or stabilize it in an ‘open’ state) to allow ATP-dependent
chromatin remodeling activity or histone eviction (Park et al., 2005). This is
consistent with acidic stretches also being found in other chromatin modifying
enzymes, such as the histone methyltransferase SET1, as well as ATP-dependent
remodelers such as SWR1 and ATRX. An accessory function accounts for the fact
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that these acidic stretches are sometimes dispensable and not necessarily
conserved.
1.3.6.5 Channeling histones along a histone chaperone pathway
The regulation of histone chaperone activity is also at the core of their in
vivo mechanism. How do histone chaperones ensure that the thermodynamic
flow of histones is regulated in an ordered fashion? This is particularly important
as there is evidence that chromatin assembly pathways compete for histone
supply (Lewis et al., 2010). A theme emerging from recent literature is the
regulation of histone hand-offs by histone PTMs (Figure 1.14). For example, the
acetylation of H4-lysine 5 and H4-lysine 12 is well-established and promotes
histone association with nuclear import complexes (Alvarez et al., 2011).

Figure 1.14: Ordered hand-offs in a chromatin assembly pathway.
A series of histone chaperones mediates the shuttling of histones from their synthesis to
incorporation into the nucleosome. Histone acetyl transferases (such as HAT1 and p300)
transiently acetylate H3 and H4. These acetylations are thought to facilitate the ordered
hand-off or creating checkpoints along the pathway. For details see main text.
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H3 is further acetylated at lysine 56 before chromatin assembly (Li et al., 2008;
Masumoto et al., 2005; Recht et al., 2006). The histone chaperone Asf1 is a
required cofactor in the acetylation of H3 at lysine 56 (Das et al., 2009; Tang et al.,
2011). The multiple acetylation of H3-H4 in turn facilitates nuclear import and
may enhance H3 affinity for CAF1 thereby promoting chromatin assembly
(Barman et al., 2008; Das et al., 2009; Glowczewski et al., 2004; Li et al., 2008).
Following incorporation, H3-lysine 56 is deacetylated, potentially creating a
more stable nucleosome (Andrews et al., 2010). Similarly, a recent study
implicates phosphorylation of H3-serine 47 in modulating association with
histone chaperone complexes and chromatin assembly (Kang et al., 2011). A
series of histone hand-offs regulated by histone PTMs can thus be delineated.
Such series would fine-tune histone chaperone activity in the context of
chromatin homeostasis, essentially creating a series of checkpoints that keep the
histone traffic ordered (Barman et al., 2008; Glowczewski et al., 2004; Groth et al.,
2007; Rufiange et al., 2007; Sharp et al., 2005).
1.3.6.6 Outlook
Since their discovery, the unusual and unique biochemistry of the histone
proteins has continued to astound and amaze (Kornberg and Thomas, 1974;
Lewis, 1976; van Holde, 1988). A wealth of advances over the last decade has
transformed them from static to dynamic modulators of virtually all processes
that act or depend on DNA. Closely associated both figuratively and literally,
with the histones, is a network of histone chaperones. Through structural and
functional diversity, the histone chaperones facilitate nucleosome formation.
They are involved in all facets of histone biology, from folding in the cytoplasm
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to nuclear import, storage and deposition into chromatin. The precise
mechanisms of histone chaperone function, however, have remained elusive. The
lack of chaperone-histone co-structures, difficulties interpreting in vitro results in
an in vivo context, and a poor understanding of the biologically relevant
chaperone substrate and product, have hindered mechanism determination.
Even with these limitations, we can postulate several models of histone
chaperone mechanism by considering the thermodynamics of nucleosome
assembly and disassembly. These models relate to how histone chaperones bind
to their substrates, prevent promiscuous histone interactions and balance
nucleosome assembly and disassembly, the fate of chaperone-bound histones,
and the importance of histone hand-offs between different histone chaperones.
Testing these hypotheses will be the seed for future studies aimed at determining
histone chaperone mechanism.
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2 The H3.3-specific histone chaperone Daxx cooperates
with

ATRX

in

replication-independent

chromatin

assembly at telomeres‡
2.1 Introduction
The assembly of chromosomal DNA into nucleosomes represents the most
fundamental step in the formation of eukaryotic chromatin structure. The
assembly, remodeling and eviction of nucleosomes have been shown to be
important for a variety of DNA-templated processes such as replication, repair
and transcription. Histone deposition pathways are thought to play a critical role
in the establishment and maintenance of epigenetic information encoded by
histone modifications, nucleosome positioning and higher-order chromatin
structure (see also Section 1.1). As discussed in Section 1.2.6, higher eukaryotes
utilize separate chaperones and deposition pathways for the different histone H3
variants. Previous work identified two major pathways: replication coupled
deposition of H3.1/H3.2 by the CAF1 complex, and replication independent

‡

This chapter has been published as: Lewis, P. W.*, Elsaesser, S. J.*, Noh, K.-M., Stadler,

S. C., and Allis, C. D. (2010). Daxx is an H3.3-specific histone chaperone and cooperates with
ATRX in replication-independent chromatin assembly at telomeres. Proc Natl Acad Sci USA, 107,
14075–14080. Where primary data was contributed by others, the authorship is indicated in the
figure legend.
(* equal contribution)
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deposition of H3.3 by the HIRA complex (Ray-Gallet et al., 2002; Tagami et al.,
2004; Verreault et al., 1996).
While originally associated with euchromatic sites of active transcription, H3.3
has recently been found associated with regulatory elements and constitutive
heterochromatin at telomeres (Goldberg et al.; Jin et al., 2009; Mito et al., 2007;
Wong et al., 2009). We found that HIRA is required for localization of H3.3 to
actively transcribed regions, while the α-thalassemia X-linked mental retardation
protein ATRX is essential for H3.3 incorporation at telomeres. Apart from ATRX,
we also identified the death domain associated protein Daxx in H3.3
immunoprecipitations (IP) (Goldberg et al.). Daxx and ATRX have been shown to
form a complex (Tang et al., 2004) and colocalize at pericentric heterochromatin
and promyelocytic leukemia bodies (PML bodies) (Nan et al., 2007; Xue et al.,
2003). Loss of ATRX leads to epigenetic alterations, including abnormal levels of
DNA methylation at repetitive elements such as telomeres in murine cells
(Gibbons et al., 2000). Moreover, ATRX and H3.3 have essential roles in
maintaining telomere chromatin (Goldberg et al.; Wong et al., 2010).
To gain further insight into H3.3-specific deposition pathways, we sought
to identify the direct binding partner of H3.3. Here we show that Daxx binds
directly to H3.3, and importantly, this binding is specific for H3.3 and not H3.1.
We find that Daxx alone, or when present in the ATRX-Daxx complex, can
effectively assemble H3.3-containing nucleosomes. Additionally, we show that
ATRX recruits Daxx to telomeres and that both complex subunits are required
for H3.3 deposition at telomeric chromatin in murine ESCs.
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2.2 Results
2.2.1 Daxx associates specifically with H3.3
Having identified Daxx and ATRX as novel H3.3-associated factors, we
wanted to determine if either of these polypeptides binds directly to H3.3, but
not to H3.1. Using HeLa cells lines that stably express FLAG-HA-tagged H3.1 or
H3.3 (hereafter e-H3.1 and e-H3.3) (Tagami et al., 2004), I isolated minimal H3.1
and H3.3-containing complexes by tandem-affinity purification from soluble
nuclear extracts with a series of stringent salt washes of up to 1 M NaCl (Figure
2.1A). After sequential anti-FLAG and anti-HA IP, I consistently recovered a
single polypeptide band of ~100 kD apparent molecular weight that co-purified
with H3.3, but not H3.1 (see arrowhead next to lane 4); mass spectrometric
analysis of this band yielded a significant number of peptides matching Daxx.
Concurrent with previous results (Tagami et al., 2004), I also detected HIRA in
the first H3.3 co-IP step (Figure 2.2). While we recently found ATRX associated
with H3.3 in whole-cell preparations (Goldberg et al., 2010), it was only weakly
associated with H3.3 in soluble nuclear extracts (Figure 2.2).
As the tandem-affinity chromatography was performed on nuclear
extracts that did not contain chromatin, I reasoned that the H3.3 and H3.1
complexes purified from these soluble nuclear extracts likely represent a pool of
pre-deposition histones. We also sought to identify proteins that were enriched
with H3.3 in the chromatin fraction. To this end, my colleague Dr. Peter Lewis
solubilized oligonucleosomes from the tagged cell lines by brief digestion with
micrococcal nuclease (MNase) and isolated H3.1- and H3.3-enriched chromatin
by FLAG IP (Figure 2.1B).
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Figure 2.1: Identification of Daxx as an H3.3-specific binding protein.
(A) Silver stain of H3.1 and H3.3 associated proteins. Soluble nuclear extracts
were prepared from Hela cells that express e-H3.1 or e-H3.3. FLAG-M2
immunoprecipitation was performed on the nuclear extract (lanes 1,2). The
eluate from the FLAG immunoprecipitation was then subjected to HA
immunoprecipitation (lanes 3, 4). HA immunoprecipitation was performed on
untagged Hela nuclear extract as a control (lane 5). Protein bands from the HA
affinity column were then subjected to identification by mass spectrometry. (B)
Silver stain of FLAG eluate from H3.1 and H3.3 chromatin-associated fractions.
Nuclei from the e-H3.1 and e-H3.3 Hela cells were subjected to brief MNase
treatment.

Solublized

chromatin

was

clarified

and

FLAG

M2

immunoprecipitation was performed. (C) Immunoblot was performed on the
FLAG eluate with anti-Daxx, anti-ATRX, anti-CAF150, and anti-ASF1a/b sera.
(D) Fractionation scheme for H3.3 chromatin-associated proteins. (E) Eluate from
chromatin associated H3.3 was resolved by Mono Q chromatography.
Immunoblotting analysis was performed on the fractions with anti-Daxx, antiFLAG and anti-ATRX. (F) Immunoblot of anti-HA and control rabbit IgG
immunoprecipitation of e-H3.3 from pooled Mono Q complex I fractions (left
panel). Silver stain of immunoprecipitated material (right panel). (B-E)
contributed by P. Lewis.
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By immunoblot analysis, he found that both Daxx and ATRX were associated
with H3.3, but not H3.1 chromatin (Figure 2.1C). The p150 subunit of the
replication-coupled Chromatin Assembly Complex 1 (CAF1) was found
primarily but not exclusively associated with the H3.1-associated fraction. The
histone chaperone ASF1 was found in both e-H3.1 and e-H3.3 eluates. We further
fractionated proteins associated with H3.3 chromatin using Mono Q anionexchange chromatography (Figure 2.1D). Immunoblot analysis of the column
fractions revealed two biochemically distinct populations of Daxx. The majority
of Daxx eluted from the Mono Q column at ~0.4 M KCl, (complex I). While this
fraction contained H3.3 he did not detect any ATRX by immunoblot. The second
population of H3.3-bound Daxx eluted from the Mono Q column at higher salt
(0.75 M KCl). These fractions contained Daxx, ATRX and H3.3 (complex II).
The isolation of two distinct populations of Daxx provided further
evidence that Daxx is the direct binding partner of H3.3. In order to determine if
Daxx was bound to H3.3 in complex I, he performed HA-IP with pooled fractions
and immunoblotted for Daxx (Figure 2.1E). he found that Daxx coimmunoprecipitated H3.3 in these fractions. We failed to detect H2A, H2B, or
endogenous untagged histone H3 in the Mono Q fractions that contained
complex I. Immunoblot and silver stain analysis indicated that only epitope
tagged-H3.3 and endogenous H4 are present in complex I (Figure 2.1E). As
untagged H3 was not associated with Daxx, we concluded that the H3.3-Daxx
pre-deposition complex includes a heterodimer of H3.3-H4. Consistent with this
result, others had previously described purified pre-deposition complexes (eH3.1.com and e-H3.3.com) that contained H3-H4 heterodimers (Tagami et al.,
2004).
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Figure 2.2: ATRX association with H3.3 in soluble
nuclear extract is salt-dependent.
FLAG-M2 immunoprecipitation from e-H3.3 cell lines
were performed as in Figure 1A, washes were performed
with indicated NaCl concentrations. The FLAG eluates
were immunoblotted for ATRX, Daxx, HIRA, RBBP4/7,
FLAG.

2.2.2 Daxx directly binds the globular core of H3.3
We next carried out in vitro pull-downs to confirm the direct and variant-specific
interaction with Daxx and H3.3. Recombinant His6-tagged human histone
proteins were prepared from E. coli and recombinant human Daxx from insect
cells. Interestingly, a small fraction of the purified Daxx isolated from insect cells
was stably bound to endogenous histone H3-H4 (Figure 2.3A). Recombinant
Daxx protein bound our reconstituted H3.3-H4 tetramers over a wide range of
salt concentrations, demonstrating that Daxx is a novel histone-binding protein.
Notably, Daxx bound H3.1-H4 much less avidly at physiological, as well as high
salt concentrations (Figure 2.3A).
The 740 amino acid human Daxx is comprised of an N-terminal, overall
basic (pI 9.3), alpha-helical domain and an S/P/T-rich C-terminal fold connected
by a likely unstructured highly acidic linker region (Figure 2.3B). The N-terminal
domain contains a highly conserved region found in all metazoan Daxx proteins
(amino acids 183-417) with no homolog in yeast (Figure 2.4A).
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Figure 2.3: Daxx directly interacts with histone H3.3.
(A) Co-immunoprecipitation of H3.1 and H3.3 with recombinant FLAG-Daxx.
Recombinant H3.1-H4 or H3.3-H4 were mixed with Daxx and resulting
complexes captured on M2-FLAG agarose. Agarose bead were washed
extensively with buffers of indicated KCl concentrations. Eluates and inputs
were resolved by SDS-PAGE gel and stained with Coomassie Blue. (B) Domain
structure of human Daxx. Shaded boxes indicate highly conserved regions (Dark
gray: highly conserved in all metazoan Daxx, Light gray: highly conserved in
vertebrates). GST-fusion constructs corresponding to different domains of Daxx
are shown in black. (C) GST-pulldown experiment with Daxx fragments shown
in B) with H3.3-H4 or H3.1-H4. (D) Schematic showing amino acid differences
between H3.1 and H3.3. Relevant secondary structure features are indicated.
Solid lines represent histone deletion constructs use in E), biotinylated peptides
used in G) are shown below. (E) GST-Pulldown with the Daxx HBD (Δ4) and
H3.3-H4 tetramers with histone tail deletions and the H3.3-H4 octamer with
H2A/H2B. (F) Co-immunoprecipitation was performed with single H3 point
mutations as described in A). (G) Peptide pulldown with biotinylated peptides of
residues 80-94 or 86-97 of H3.1 and H3.3. SDS Elution of the streptavidin beads
and 5% input shown. (A) contr. by P. Lewis.
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The Glu/Asp-rich linker between N-and C-terminal domain is resembling
similar acidic stretches found in many histone chaperones including NAP1,
Asf1p, Rtt106, Vsp75, FACT, CAF1p150. Additionally, two hydrophobic motives
at the far N-and C-termini are conserved in vertebrates (Figure 2.4A). Guided by
conserved domains and secondary structure prediction, I designed a set of GSTfusion proteins that covered the N- and C-terminal domains. GST-pulldowns
with the Daxx fusion proteins and recombinant H3.3-H4 or H3.1-H4 were
performed (Figure 2.3C). I found that the fusion proteins containing the highly
conserved region in the N-terminus of Daxx all bound specifically to H3.3-H4. I
termed this region the ‘histone binding domain’ (HBD) of Daxx, necessary and
sufficient for histone binding (Figure 2.3C). The HBD is exceptionally conserved
throughout metazoans (Figure 2.4B). As a control, I found that a recombinant
GST-Asf1a protein bound equally well to both H3.1-H4 and H3.3-H4 (Figure
2.3C). I further investigated the Daxx-H3.3 interaction by making a series of
‘tailless’ recombinant H3.3-H4 (Figure 2.3D). I found that the Daxx HBD fusion
protein bound effectively to all H3.3-H4 tail deletions constructs (Figure 2.3E),
indicating that Daxx contacts H3.3-H4 via the histone globular domain.
Furthermore, the Daxx HBD did not bind to the H2A/H2B dimer (Figure 2.3E).
H3.1 and H3.3 differ in sequence at five residues; four residues found
within the histone-fold domain and an A31S substitution in the unstructured Nterminal histone tail. Three substitutions are clustered at the base of helix 2 of the
histone fold, and these residues were previously shown to confer binding
specificity for particular histone deposition pathways (Ahmad and Henikoff,
2002c; Tagami et al., 2004) (Figure 2.3B).
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Figure 2.4: Domain structure and conservation of Daxx homologs.
(A) Domain structure of Daxx homologs were analyzed for selected metazoan species
from the JGI Tree of Life (left schematic tree, not drawn to scale). The two blue central
regions forming the histone binding domain (HBD) are highly conserved in all Daxx
homologs. Red/orange regions are highly conserved among tetrapods and teleosts, but
less conserved or missing in non-vertebrates. The Caenorhabditis genus does not
identifiable Daxx homologs (light gray). (B) A multiple sequence alignment spanning
residues 216-389 of human Daxx and corresponding regions of other species as listed
show exceptionally conserved residues within histone binding domain.
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In order to identify which of the five residues are responsible for differential
binding by Daxx, I constructed a series of single point mutations in the unique
H3.1 or H3.3 residues. Each of these mutant H3-H4 complexes was subject to coIP with recombinant full length Daxx (Figure 2.3F). We found that no single
point mutation in H3.1 conferred markedly increased binding to Daxx. Similarly,
we found that no single mutation in H3.3 abrogated binding to Daxx,
demonstrating that single point mutations had little effect on the overall
interaction.
Mutants in position 31 had no effect on Daxx binding to H3.3, signifying
that the primary mode of recognition occurs via the globular domain. Mutation
of H3.3 Gly 90 to Met (the residue present in H3.1) had the largest single effect on
Daxx binding. To directly test if the interaction between Daxx and H3.3 occurs
via the unique 'AAIG' motif at the base of H3.3 helix 2, I performed pull-downs
with peptides that corresponded to the residues 80-94 and from 86-97 of either
H3.1 or H3.3 (Figure 2.3D). Peptides corresponding to residues 80-94 of H3.3, but
not H3.1, bound effectively, indicating that this region is necessary and sufficient
for interaction with Daxx (Figure 2.3G). H3 peptides spanning residues 86-97
failed to interact with Daxx in the pull-down assay.

2.2.3 Daxx is a histone H3.3-specific chaperone
The purification of Daxx in a nucleoplasmic complex with H3.3-H4
indicated that Daxx might act as a histone chaperone for the deposition of newly
synthesized H3.3. We saturated Daxx with excess H3.3-H4 and purified a stable
stoichiometric complex over a Mono Q ion exchange column (Figure 2.5A).
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Figure 2.5: Daxx is a histone H3.3 chaperone.
(A-C) A recombinant Daxx-H3.3-H4 complex assembles chromatin in vitro. Histone
deposition activity of an in vitro reconstituted and purified Daxx-H3.3-H4 complex (A)
was assessed in two assays: (B) chromatin-induced supercoiling was analyzed by
agarose gel electrophoresis in the absence (upper panel) and presence (lower panel) of
chloroquine; 0.25-2.5 µg Daxx-H3.3-H4 was mixed with 500 ng Topo-1 relaxed plasmid
DNA (lanes 3-6). Supercoiled input plasmid (lane 1) and Topo-1 relaxed plasmid (lane 2,
mock) were run as controls. (C) Tetrasome deposition by the Daxx-H3-H4 complex was
assayed on a 148 bp DNA fragment. The electrophoretic mobility shift was analyzed on
a native TBE gel. (D-F) Daxx preferentially assembles H3.3 chromatin. 2 µg recombinant
Daxx (D) or NAP-1 was preincubated with H3.1-H4 or H3.3-H4 tetramers (E) and added
to 300 ng Topo-1 relaxed plasmid. The resulting plasmid supercoiling was analyzed by
agarose gel electrophoresis (F). Histone tetramers or the chaperones alone did not
induce supercoiling (lanes 3-5, 8) While NAP-1 induced supercoiling with 250 ng H3.1H4 or H3.3-H4 to a similar extant (lanes 6, 7), Daxx assembled chromatin more
efficiently with H3.3-H4 than with H3.1-H4 at all tested concentrations (150, 200, 250 ng;
lanes 9-14). (A,D) contributed by P. Lewis.
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Next, I added this complex to a relaxed plasmid template and found that it
induced supercoiling in a concentration-dependent manner. The decreased
mobility of the products in the presence of chloroquine indicated negative
supercoiling characteristic for H3-H4 deposition onto the plasmid (Figure 2.5B).
Furthermore, a 148bp DNA fragment formed a tetrasome upon addition of the
Daxx-H3.3-H4 complex as indicated by a characteristic shift in electrophoretic
mobility of the DNA and co-migrating H3.3 (Figure 2.5C). These results show
that Daxx has intrinsic histone chaperone activity.Given the marked specificity of
Daxx for H3.3 in our in vitro binding experiments, I wondered if its histone
chaperone activity would be specific to H3.3, as well. I performed plasmid
supercoiling assays as described above, but with purified Daxx (Figure 2.5D) and
H3.1 or H3.3 (Figure 2.5E). While Daxx promoted some chromatin assembly in
the presence of both H3.1-H4 and H3.3-H4, it proved more efficient in depositing
H3.3-H4 tetramers (Figure 2.5F). In contrast, NAP-1-mediated assembly was
equally efficient with H3.1-H4 (Figure 2.6). I therefore identified Daxx as a bona
fide histone chaperone with intrinsic preference for H3.3.
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Figure 2.6: Daxx preferentially assembles H3.3 chromatin.
2 µg recombinant Daxx or NAP-1 was preincubated with H3.1-H4 or H3.3-H4 tetramers
and added to 300 ng Topo-1 relaxed plasmid. The resulting plasmid supercoiling was
analyzed by agarose gel electrophoresis. Histone tetramers or the chaperones alone did
not induce supercoiling (lanes 3-5, 8) While NAP-1 induced supercoiling with 250 ng
H3.1-H4 or H3.3-H4 to a similar extant (lanes 6, 7), Daxx assembled chromatin more
efficiently with H3.3-H4 than with H3.1-H4 at all tested amounts (150, 200, 250 ng; lanes
9-14).

2.2.4 The ATRX-Daxx complex has chromatin remodeling and H3.3deposition activity
ATRX localizes to telomeric chromatin, and ATRX-/- ESCs fail to
incorporate H3.3 into telomeres, suggesting that ATRX plays a direct role in
incorporating H3.3 into chromatin (Goldberg et al.). SNF2-family chromatin
remodeling proteins such as ATRX use ATP hydrolysis to translocate
nucleosomes along the DNA (Saha et al., 2006). Additionally, CHD1 and ISWI
family remodelers function alone or in the context of protein complexes to
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facilitate the assembly of extended, periodic nucleosome arrays (Ito et al., 1997;
Lusser et al., 2005). To investigate the histone deposition properties of the ATRXDaxx complex, we performed chromatin assembly assays with a completely
purified system containing recombinant ATRX-Daxx, recombinant Daxx and
recombinant H3.1-H4, H3.3-H4 and H2A/H2B and a DNA template that
contained a series of tandem Xenopus 5S rDNA nucleosome positioning
sequences. Micrococcal nuclease (MNase) digestion was used to analyze the
reaction products for nuclease-protected mono- or oligonucleosomal fragments
(Figure 2.7C, D). While we demonstrated above that Daxx has intrinsic histone
deposition activity (Figure 2.5), this analysis revealed that the ATRX-Daxx
complex catalyzed the formation of extended nucleosome arrays (Figure 2.7D).
We compared the assembly activity of the ATRX-Daxx complex to
recombinant human ACF complex and human Nap1. We found that the ATRXDaxx complex assembled H3.3-containing nucleosomes to a greater extent than
H3.1 nucleosomes, whereas ACF and NAP1 assembled both H3.1 and H3.3
nucleosomes equally. ATRX assembly in the absence of Daxx could not be
assessed, as we were unable to purify recombinant full-length ATRX alone. The
enhanced deposition of nucleosome arrays suggested that the ATRX-Daxx
complex contains remodeling activity in addition to its histone deposition
activity. Previously, purified ATRX-containing complexes have been shown to
have DNA-stimulated ATPase, DNA translocase and chromatin remodeling
activities (Emelyanov et al.; Tang et al., 2004; Xue et al., 2003). The p185 isoform
of Drosophila ATRX homolog (XNP) was found in a complex with HP1, and
exhibited in vitro chromatin-remodeling activity (Emelyanov et al.).
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Figure 2.7: ATRX-Daxx is a histone deposition and remodeling complex.
(A) Purification of recombinant ACF complex (ACF1 and SNF2H), recombinant hNAP1,
recombinant Daxx, recombinant H3.1-H4, H3.3-H4 and H2A/H2B. (B) SMART
Superdex 200 gel filtration fractionation of ATRX-Daxx complex. ATRX-Daxx complex
used in C)-E) was purified from free Daxx and Daxx-H3.3-H4 complex. (C) MNase
digestion of chromatin assembly reactions with H3.1-H4 or H3.3-H4 alone, or in
combination with NAP1 and ACF complex. A 123bp ladder is loaded in the marker lane
(D) MNase digestion of chromatin assembly reactions with H3.1-H4 or H3.3-H4 alone,
or in combination with Daxx and ATRX-Daxx complex. (E) Analysis of remodeling
activity of ACF and ATRX-Daxx complexes on H3.3 mononucleosomes by native
polyacrylamide gel electrophoresis. (B-D) contributed by P. Lewis.
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We investigated whether the ATRX-Daxx complex could mobilize a positioned
H3.3-containing nucleosome. Remodeling assays were carried out on a 194-bp
DNA template that contained a nucleosome positioning sequence. An H3.3histone octamer was assembled onto the DNA and incubated with ATRX-Daxx
and ATP. Analysis of the remodeled substrate by native gel electrophoresis
indicated that the ATRX-Daxx complex could effectively mobilize the
nucleosome along the DNA template (Figure 2.7E).

2.2.5 Daxx is required for H3.3 deposition at telomeres
Previously, we found that ATRX-/- ESCs exhibited a dramatic loss of H3.3
found at telomeres, indicating that ATRX may have a direct role in the
incorporation or maintenance of H3.3-containing nucleosomes (Goldberg et al.,
2010). We sought to determine if Daxx, like ATRX, is important for H3.3
deposition at telomeres.
We have earlier described the use of zinc finger nucleases to generate
murine ESC lines that carry one H3.3B allele tagged with a C-terminal HA
epitope (Goldberg et al.). We targeted the H3.3B locus in 129/SvEv ESCs and
Daxx -/- ESCs to generate cell lines that contained one HA-tagged allele of
H3.3B. The Daxx-/- ESCs were generated from the 129/SvEv cell line
(Michaelson et al., 1999). Immunoblot analysis of extract from the H3.3-HA
tagged ATRX-/-, Daxx-/- and C6 ESCs indicated that levels of H3.3-HA were
similar between the cell lines. Interestingly, we found that ATRX levels were
reduced in Daxx -/- ESCs, suggesting that Daxx may be required for ATRX
protein stability or expression (Figure 2.8A).
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Figure 2.8: ATRX-Daxx complex is required for H3.3-deposition at telomeres.
(A) Nuclear extract was prepared from wild type C6 ESCs, and from ATRX-/-, Daxx-/and C6 ESCs with HA-epitope tagged endogenous H3.3B. Immunoblots were performed
on extracts for Daxx, ATRX and H3.3-HA. Tubulin immunoblot served as a loading
control (B) HA-Immunoprecipitation from the extracts in A). Immunoprecipitated
material was immunoblotted for Daxx, ATRX and H3.3-HA. (C) Chromatin
immunoprecipitation of HIRA, ATRX and Daxx proteins was on 129/SvEv, Daxx-/-,
ATRX-Flox,

and

ATRX-/-

ESCs.

Dot

blot

analysis

was

performed

on

the

immunoprecipitated DNA using telomere and BamH1 repeat probes. (D) HA-H3.3
chromatin immunoprecipitation was performed on 129/SvEv, Daxx-/-, ATRX-Flox, and
ATRX-/- ESCs. Bar graph showing the input-normalized signal from the dot blot on
telomere and BamHI repeats with standard errors. (A,B) contributed by P. Lewis, (C,D)
contributed by K.M. Noh.

Immunoprecipitation of H3.3-HA was performed from nuclear extract from
these cell lines (Figure 2.8B). We found that H3.3-HA could efficiently co-IP Daxx
in ATRX-/- cells, suggesting that ATRX is not required for Daxx interaction with
H3.3. ATRX also failed to co-IP with H3.3-HA in Daxx -/- ESC. These data are
consistent with our previous experiments that indicated a direct contact between
Daxx and H3.3. Interestingly, the CAF1 p150 signal increased in Daxx -/- cells,
suggesting that in the absence of Daxx, H3.3 may associate with other histone
chaperone complexes.
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My colleague Dr. Kyung Min Noh performed ChIP on H3.3-HA in the Daxx-/ESCs to determine if Daxx, like ATRX, is required for H3.3 deposition at
telomeres (Figure 2.8C). The H3.3 signal was decreased to a similar degree in
both ATRX-/- and Daxx-/- ESCs. We performed ChIP with Daxx antiserum and
found that Daxx was bound to telomeric chromatin in wild type murine ESCs
(Figure 2.8D). Daxx failed to ChIP to telomeric chromatin in ATRX-/- ESCs,
suggesting that ATRX is required for targeting Daxx and H3.3 to telomeric
chromatin. We therefore conclude that the ATRX-Daxx complex localizes to
telomeres and directly mediates H3.3 deposition at telomeric chromatin.

2.3 Discussion
2.3.1 Daxx is a H3.3 chaperone
We demonstrated that Daxx forms stable complexes with H3.3-H4, but not
with H3.1-H4. We assessed Daxx histone chaperone activity alone and coupled
to ATP-dependent remodeling by ATRX and have observed preference for H3.3
in both deposition assays. Similar H3.3-specificity has been observed in a
minicircle assembly assay (Drané et al.).
I identified a minimal 234 amino acid segment of Daxx that specifically
interacts with H3.3-H4. The histone-binding domain also represents the most
highly conserved segment of Daxx, suggesting that the H3.3-specific binding and
chaperone activity may be conserved among Daxx homologs. Besides a polyGlu/Asp acidic stretch, the Daxx histone-binding domain lacks sequence
homology with any known histone binding proteins, suggesting that the Daxx
contains a novel histone chaperone domain (Figure 2.4).
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I have shown that Daxx distinguishes histone H3 variants through direct
interaction with the variant-specific residues 87-90 in the core histone fold of
H3.3 (Figure 2.3F, G). The three unique residues in the H3.3 'AAIG' motif
cooperatively confer specificity for binding as single point mutants only have a
modest effect. My in vitro binding data closely resembles the composite
specificity for replication-independent H3.3 deposition observed in Drosophila
cells (Ahmad and Henikoff, 2002c). While specific binding was achieved with a
15-residue peptide, it is conceivable that other surfaces of H3.3-H4 contribute to
the overall binding affinity. These shared regions likely account for the residual
binding to H3.1-H4 observed in all in vitro assays. We speculate that selectivity is
enhanced in vivo by the existence of competing chaperone complexes and
deposition pathways. In agreement with such a model, we found increased levels
of H3.3 association with CAF1 in Daxx-/- ESCs as compared to wild type (Figure
2.8B).
Our previous ChIP-Seq studies indicated that H3.3-nucleosomes at telomeres
and transcription factor binding sites (TFBS) were deposited independently of
HIRA (Goldberg et al.). While the ATRX-Daxx complex may account for the
HIRA-independent H3.3 deposition at telomeres, the factors involved in H3.3
deposition at TFBS remain unknown. Our purification of H3.3-bound proteins
from cell extracts yielded two biochemically distinct Daxx populations. We
speculate that Daxx may be recruited to TFBS and other genomic loci for
assembly of H3.3-nucleosomes.
Although Daxx has been studied extensively in many systems, its function
in transcriptional regulation is not well understood. In light of our findings, the
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mechanism by which Daxx influences transcription may be directly linked to
H3.3 deposition activity at TFBS or other regulatory elements.

2.3.2 ATRX has nucleosome remodeling activity
We demonstrated that recombinant ATRX-Daxx complex has chromatin
remodeling activity and can assist Daxx in the assembly of H3.3-nucleosomes.
Previously, immunoprecipitated human ATRX was shown to exhibit both DNA
translocase and mononucleosome disruption activity focused near the
nucleosome entry/exit site (Xue et al., 2003). The deposition of H3.3-H4 by Daxx,
followed by the mobilization of H3.3-nucleosomes by the ATP-dependent
remodeling activity of ATRX may serve an important role in the formation of
higher-order chromatin structure. Human ATRX is a homolog of the repair and
recombination protein, RAD54. In vitro studies found that other human RAD54
homologs displayed similar remodeling activities to the ISWI-type ATPdependent remodeler proteins near the entry and exit sites (Längst and Becker,
2001; Zhang et al., 2007b). These data are consistent with a model whereby
RAD54 family remodeling proteins mobilize the histone octamer, as opposed to
catalyzing the formation of DNA loops on the nucleosome surface.

2.3.3 ATRX-Daxx complex may assemble specialized heterochromatin
Our ChIP results indicate that the ATRX-Daxx complex is present at
telomeric chromatin in murine ESCs (Figure 2.8C). Moreover, we show that Daxx
localization to telomeres is dependent on ATRX, suggesting that ATRX may be
involved in recruitment of the complex to telomeres. While Daxx histone
chaperone activity is sufficient to assemble chromatin in vitro, H3.3-deposition at
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telomeres is additionally dependent on ATRX (Figure 2.8D), suggesting a dual
role in both complex recruitment and ATP-dependent chromatin remodeling.
In differentiated cells, H3.3 has been found to localize to pericentric
chromatin (Hake et al., 2005; Wong et al., 2009). Recent work performed in
murine embryonic fibroblasts (MEFs) found H3.3 deposited at pericentric DNA
repeats in an ATRX-Daxx-dependent manner (Drané et al.). ATRX-Daxx also
localizes to PML bodies, and ATRX has been shown to co-localize with
heterochromatin on both the inactive X chromosome and Y chromosome in mice
(Baumann and de La Fuente, 2009; Baumann et al., 2008). These findings raise the
intriguing possibility that the ATRX-Daxx complex may serve as a specialized
chromatin assembly pathway for repetitive regions such as telomeres,
centromeres and other regions of constitutive heterochromatin. In agreement
with this model, ATRX-depleted cells display centromere dysfunction indicated
by defective sister chromatid cohesion at the metaphase plate, as well as
abnormal chromosome alignment (de La Fuente et al., 2004; Ritchie et al., 2008).
Cells from ATR-X syndrome patients also display altered pericentric DNA
methylation (Nan et al.). Also, ESCs depleted for ATRX or H3.3 exhibited signs
of telomere dysfunction (Goldberg et al.; Wong et al., 2010). Drosophila xnp
mutants display a position-effect phenotype (PEV) and defects in pericentric
heterochromatin (Bassett et al., 2008; Emelyanov et al.; Schneiderman et al.,
2009).
Replication-independent histone deposition complexes help to fill in
nucleosome-free regions created by RNA polymerase passage and ATPdependent remodeling at transcribed genes and enhancer elements. Both
telomeric and centromeric sequences are transcribed to produce long non-coding
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RNAs (Luke and Lingner, 2009; Zaratiegui et al., 2007). Telomere repeatcontaining RNAs (TERRA) appear to affect telomere structure and replication
(Luke and Lingner, 2009), and centromeric RNA is important for pericentric
heterochromatin formation (Maison et al., 2002). While heterochromatic regions
are generally considered to have slow histone exchange rates, the intrinsic
repetitive features of telomeric and centromeric DNA may promote nucleosome
instability. Indeed, telomere repeats have a low propensity to form nucleosomes
in vitro (Cacchione et al., 1997), and deposition of H3.3 outside of S-phase may
help maintain a proper nucleosome density for heterochromatin formation.

2.3.4 Recruitment of the ATRX-Daxx complex
In addition to the chromatin remodeling SNF2-like ATPase domain, ATRX
contains an N-terminal ATRX-DMNT3L-DNMT3A (ADD) domain that consists
of an N-terminal GATA-like zinc finger and a PHD finger. The ADD domain of
DNMT3A and DNMT3L preferentially interact with the unmodified extreme Nterminus of histone H3 (Ooi et al., 2007; Otani et al., 2009). Very recent reports
now showed that the ATRX ADD domain, like the heterochromatin protein-1
(HP1) (Jacobs and Khorasanizadeh, 2002), prefers H3K9me3, leading to an
attractive model of ADD-dependent recruitment or stabilization of the ATRXDaxx complex to heterochromatin for remodeling and histone deposition
(Dhayalan et al., 2011; Eustermann et al., 2011; Iwase et al., 2011). Both telomeres
and pericentric regions are enriched in DNA methylation and heterochromatin
histone modifications such as H3K9me3 and H4K20me3 (Luke and Lingner,
2009; Schoeftner and Blasco, 2009), and these modifications may recruit the
ATRX-Daxx complex to facilitate H3.3 deposition. In support, loss of the
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H3K9me3 methyltransferase, Suv39h1, had similar phenotypes as a reduction of
ATRX, Daxx or H3.3: abnormal telomeres, aberrant chromosome segregation and
premature sister chromatid separation (García-Cao et al., 2004; Lehnertz et al.,
2003). In addition to histone modifications, DNA methylation may be a means to
recruit ATRX-Daxx to specific genomic loci through an interaction with the
methyl-CpG binding protein 2 (MeCP2) (Nan et al., 2007).

2.3.5 Functional significance of H3.3 incorporation
Viewed in the broader context, our results raise the question of whether
newly incorporated H3.3 serves a specialized role beyond simply replacing the
'old' histone H3. While it has been proposed that H3.3 nucleosomes are
intrinsically less stable (Jin and Felsenfeld, 2007), and promote transcription
(Tamura et al., 2009), the exact role of transcription in heterochromatin still
remains unclear and poorly defined. Others and we have observed mitotic
phosphorylation of H3.3 S31 at ESC telomeres, as well as pericentric
heterochromatin of differentiated cells (Hake et al., 2005; Wong et al., 2009).
Notably, S31 is unique to H3.3 as substituted by Ala in H3.1/2 and makes this
heterochromatin-associated mark strictly dependent on H3.3 incorporation.
Future studies will elucidate these unexpected heterochromatic functions of
histone variant H3.3, initially discovered as a marker of 'active' chromatin.
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3 Identification of a common histone binding helix in the
histone chaperones HJURP and Daxx
3.1 Introduction
3.1.1 Centromeric

histone

H3

variants

define

the

eukaryotic

centromeres
As introduced in Section 1.1, centromeres serve as attachment point on
chromosomes for the mitotic spindle. The cenH3 variant (CENP-A in humans,
CID in flies, Cse4 in yeast) is the defining protein component of functional
centromeres (Earnshaw and Migeon, 1985) that by yet unknown mechanisms
recruits the remaining CENP proteins (Howman et al., 2000). While the Nterminal, unstructured tail of CENP-A is quite divergent from H3, the histone
fold domain is conserved with the exception of a CENP-A specific chaperone
recognition domain (CRD) and preceding loop between helices α1 and α2
(Figure 3.1). Instead of the CRD region of cenH3 ,the loop and potentially other
amino acid substitutions in the histone fold is not used for variant discrimination
(Black et al., 2007). Like H3.3, cenH3 is incorporated independent of replication
(Ahmad and Henikoff, 2002b).
The overall architecture of centromeres and the underlying centromeredefining DNA sequences have diverged considerably between metazoans and
fungi.
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Figure

3.1:

recognition

The

chaperone

domain

distinguishes

(CRD)

histone

H3

variants.
(A) Xenopus H3.2 (blue), (B)
human H3.3 (purple) and (C)
human

CENP-A

(grayblue)

tetramers with H4 (green) from
respective nucleosome crystal
structures (PDB 1KX5, 3AV2,
3AN2) are shown. The CRD at
the

base

of

helix

α2

is

highlighted in bright red with
variant-specific

amino

acids

shown in boxes. Further amino
acid differences are colored in
dark red.
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The histone chaperones HJURP (human) and Scm3 (fungal) form predeposition
complexes with cenH3-H4 (Dunleavy et al., 2009; Foltz et al., 2009; Shuaib et al.,
2010) and mediate their direct deposition onto DNA (Bergmann et al., 2011;
Dechassa et al., 2011; Shivaraju et al., 2011).
Interestingly, targeting HJURP to a specific genomic region is sufficient to
create functional centromeres (Barnhart et al., 2011; Bergmann et al., 2011).
Recent reports on the structure of metazoan and fungal cenH3 variant
chaperones, HJURP and Scm3, respectively, have highlighted an evolutionarily
conserved binding mode shared amongst distant eukaryotes (Cho and Harrison,
2011; Hu et al., 2011; Zhou et al., 2011). This suggests a feedback loop of CENP-A
deposition by HJURP and recruitment of HJURP to CENP-A containing regions.
Centromeres can be propagated independent of the presence of a centromeric
DNA sequence. Therefore, establishment and inheritance of centromeres is
therefore a to date unique example of DNA sequence-independent, epigenetic
propagation (Black and Cleveland, 2011). Striking examples of this epigenetic
phenomenon are the formation and generational inheritance of neocentromers
following certain human chromosomal rearrangements (Choo, 2001).
The exact mechanism creating such a feedback loop is not yet well
understood. In particular, CENP-A is not incorporated into centromeres during
S-phase but in the next G1 phase, raising the question of how faithful
propagation of centromers is achieved through G2/M phase (Dunleavy, 2011)
and how HJURP is later recruited to the centromeres to replenish CENP-A. The
structural and biochemical insight gained from the HJURP-CENPA-H4 complex
helped to understand one part of the propagation mechanism – how CENP-A
can be enriched at specific genomic regions by recruitment of its cognate
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chaperone (Barnhart et al., 2011; Bergmann et al., 2011). These findings might
now also have implications for the mechanism of Daxx-dependent H3.3
enrichment at telomeric and centromeric repeat sequences (see Chapter 2 and
(Drané et al., 2010)).

Traditionally, centromeric and replacement histone chaperones have been
viewed to be unrelated, each highly specialized to its cognate histone variant.
However, the striking homology between both chaperone families discussed in
this chapter suggests common functional principles. Through amino acid motif
analysis and homology modeling, I have gathered evidence that the overall
binding mode observed for the cenH3 variant is also applicable to Daxx and
potentially HIRA, both chaperones specific to the histone replacement variant
H3.3. This suggests a fundamental role and common evolutionary origin of a
specific interaction surface of the H3-H4 dimer in replication-independent
chromatin assembly, irrespective of the H3 variant subspecification. Through
more detailed analysis of available crystal structures and homology models, I
find that this class of histone chaperones mimics inter-histone interactions,
allowing them to bind a H3-H4 dimer in its native conformation.
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3.2 Results
3.2.1 A C-terminal helix of the Daxx histone binding domain is
homologous to the histone-binding helix of HJURP.
Detailed inspection of the long 〈-helix of HJURP (histone-binding helix,
HBH hereafter), which contacts the 〈2-helix of CENP-A in the HJURP-CENPAH4 complex structure (Hu et al., 2011), revealed patterns of evenly spaced large
hydrophobic (leucine, isoleucin, valine) residues (every 3 to 4 amino acids,
corresponding to one helical turn). Such pattern is characteristic of a coiled-coil
structure between two adjacent helices (also called leucine zipper). Indeed, all
hydrophobic residues of the HJURP HBH interdigitate with corresponding
hydrophobic residues in the CENP-A 〈2-helix, forming the characteristic leucine
zipper (Hu et al., 2011). As coiled-coil interactions are predicted for at least two
helices in the Daxx histone binding domain (HBD) by the sequence-based Lupas
algorithm (Lupas et al., 1991), I aligned the HJURP HBH with all candidate Daxx
helices and found a significant match in the most C-terminal predicted helix of
the Daxx HBD (Figure 3.2A, aa 354-379). Importantly, residues involved in
histone contacts are almost completely conserved between the HJURP HBH and
this putative Daxx HBH, whereas residues with shifted register, pointing away
from the helix interface, are quite divergent (Figure 3.2B). The β–sheet fold
ensuing the HJURP HBH is not conserved in Daxx, consistent with its proposed
role in conferring specificity to the CENP-A variant (Figure 3.2B, C) (Hu et al.,
2011). Based on the sequence alignment, I constructed a homology model for the
Daxx HBH in complex with H3.3 and H4 (Figure 3.2D). I replaced the CENPA92

	
  

H4 moiety of the HJURP-CENPA-H4 complex with a H3-H4 dimer from the
nucleosome structure (PDB 1KX5) yielding a hybrid HJURP-H3-H4 structure.
The subsequent conversion of HJURP to Daxx (and H3 to H3.3) was carried out
in silico by automated amino acid mutagenesis and energy minimization by the
Rosetta Backrub routine (Das and Baker, 2008; Smith and Kortemme, 2008). In
the resulting model of the DaxxHBH-H3.3-H4 complex, all major contacts
between the Daxx HBH and H3.3-H4 are analogous to the HJURP–CENPA
interactions. The N-termini of both HJURP and Daxx HBH helices are anchored
via an aspartate residue and two adjacent leucine residues to the H3 α2-helix.
Approaching the C-terminal end of the HBH, two subsequent
hydrophobic residues contact H3 α2− and H4 α3–helices, followed by a salt
bridge between a lysine and glutamate and a tyrosine that packs against a
hydrophobic patch near the N-terminus of the H3 α2–helix. The overall binding
mode of Daxx could therefore be very similar to HJURP, despite the different
variants they associate with. As discussed below, other parts of Daxx and HJURP
likely contribute to specificity and affinity to their respective histone.
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Figure 3.2: Histone-binding helix (HBH) of HJURP and Daxx.
(A) Location of the homologous regions within the Daxx and HJURP proteins.
Graph illustrates coiled-coil prediction based on amino acid sequence (Lupas et
al., 1991). Gray areas designate conserved regions of Daxx including the 4-helix
bundle (4HB) and the histone binding domain (HBD). Orange area designates
the histone binding helices (HBH). No homology is observed outside of this
region. (B) Sequence alignment of HJURP N-terminus (1-80) and corresponding
residues of Daxx (340-431). Secondary structure derived from crystal structure
(C) is indicated. (C) Crystal structure of the HJURP-CENPA-H4 complex
(PDB 3R45), featuring residues involved in histone binding as stick models. (D)
Homology model of the Daxx-H3.3-H4 complex derived from (C).
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3.2.2 HJURP and Daxx histone binding helices mimick inter-histone
contacts
A comparison of the modeled DaxxHBH-H3.3-H4 complex with the nucleosomal
(H3-H4)2 tetramer suggests that the base of the HBH occupies the same position
as the C-terminal α3-helix of the second H3 in the tetramer in the H3-H3’
homodimerization interface (a 4-helix bundle). This explains why the binding of
Daxx or HJURP competes with tetramer formation (Figure 4.7) (Hu et al., 2010)).
Surprisingly, Daxx and HJURP HBH not only occupy the same space, but also
contact the H3 α2-helix with a set of residues identical to the H3’ α3-helix in H3H3 4-helix bundle. Indeed, sequence alignment reveals a shared motif between
the H3 α3-helix, HJURP and Daxx (Figure 3.3A, B). Another striking feature of
the HBH is the tyrosine at the far C-terminal end packing against the H3 α2helix. This aromatic residue has a functional counterpart in the H4 C-terminus
that, at least in the context of the nucleosome, folds back onto H3 in a similar
manner (Figure 3.3B, bottom right). It is surprising how closely both histone
chaperones have adopted existing motives to interact with histones. As discussed
in Section 1.3.1, most residues of the core histone fold are under high
evolutionary pressure as judged from the high identity of primary sequence even
between remote species and histone variants. Histone chaperone mechanism
therefore might have evolved on a mostly fixed histone scaffold, limiting the
potential for variation and skewing towards reutilizing existing structural
themes. A counter-example, however, is the histone chaperone Asf1, which also
interacts with the 4-helix bundle interface of the H3-H4 dimer, but with a unique
β-sheet fold (Adkins et al., 2007; Natsume et al., 2007).
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Figure 3.3: HJURP and Daxx mimick inter-histone interactions.
(A) Alignment of Daxx and HJURP with C-terminus of H3 (109-132). (B) Overlay of the
H3-H3’ inter-histone contacts in the (H3-H4)2 tetramer (PDB 1KX5) and the Daxx HBH
model. Polar and hydrophobic residues have similar arrangements (H3 blue, Daxx HBH
orange), the HBH therefore substitutes for the second H3-H4 dimer. Furthermore, Daxx
HBH Y379 occupies a hydrophobic patch analogous to F100 of the H4 C-terminus
(green).
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3.2.3 Widespread conservation of the histone binding helix motif in
centromeric and H3.3-specific histone chaperones in metazoans
and fungi
Despite widespread appearance in metazoans, no Daxx orthologs have
been identified in lower eukaryotes, fungi or plants (Lewis et al., 2010). HJURP is
found in many metazoan lineages but surprisingly it is missing from some wellstudied organisms, such as C. elegans and D. melanogaster. However, a functional
similar protein Scm3 is found in fungi (Mizuguchi et al., 2007). Homology
between HJURP and Scm3 is confined to a limited number of motives that
includes a highly conserved HBH (Sanchez-Pulido et al., 2009). Crystal and NMR
structures of Scm3HBH-H3-H4 complexes show overall similar complex
architecture despite somewhat divergent amino acid sequences (Cho and
Harrison, 2011; Hu et al., 2011; Zhou et al., 2011). Considering that distant Daxx
orthologs in fungi might be more similar to Scm3, I extended my HBH alignment
to fungal Scm3 species. Interestingly, the ‘middle’ region of the HBH is quite
diverse between Daxx, HJURP and Scm3, while the previously discussed
hydrophobic side chains that make direct histone contacts are mostly identical in
all available sequences (Figure 3.4A). The color-coded HBH model further
illustrates that only residues with direct histone contacts are conserved (Figure
3.4B).
Traditional sequence search engines (such as BLAST) perform poorly with
this apparent position-specific conservation, which might have left analogous
HBH motives in other histone chaperones unrecognized. I therefore turned to a
hidden markov model (HMM)-based homology search that takes position98

	
  

specific weights into account (Eddy, 1998). HMMs constructed from Daxx HBH
alignments returned HJURP and Scm3 proteins and vice versa with high
significance scores, as expected from the highly similar position scores (Figure
3.4B). A search with a composite HMM from all known HBH-containing proteins
returned the H3.3-specific histone chaperone HIRA in addition to the input set,
albeit with low significance.
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Figure 3.4: Bioinformatic search for more distant HBH-containing proteins.
(A) Alignment of a selection of HBHs from Daxx (top), HJURP and Scm3
proteins, as well as the novel candidate HIRA. (B) A HBH model colored with
conservation scores (purple=identity, yellow/white=intermediate, green=highly
variable) from Consurf (Ashkenazy et al., 2010) illustrates that only histoneinteracting residues are conserved across Daxx, HJURP and Scm3. (C) HMM for
individual alignments of all Daxx and HJURP proteins visualized with LogoMatP (Schuster-Böckler et al., 2004). Width of the column represents weight of the
position, height of each amino acid its individual weight. Amino acids are colorcoded by chemical property groups. (D) Comparison of the composite HMM of
all known Daxx, HJURP, Scm3 proteins, and the putative HBH in the HIRAB
domain of metazoan HIRA.
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A HMM based on an alignment of corresponding HIRA fragments (mapping
into the C-terminal HIRAB domain) did not return Daxx, HJURP or Scm3, but
comparison of position scores shows common patterns, such as the E/D-L-L
zipper and the N-terminal K/R-Y (Figure 3.4C). While attractive for its common
biology with Daxx, bioinformatic inference alone does not warrant the
conclusions that HIRA contains a bona fide HBH. A molecular model can be
derived from the HJURP-CENPA-H4 structure analogous to the in silico
procedure described for Daxx, however its accuracy is difficult to judge due to
the large number of mutations that need to be introduced. I am therefore in the
process of experimentally testing this hypothesis.

3.2.4 Biochemical and mutational analysis of the HBH-histone H3
interface
The detailed bioinformatic analysis of the Daxx HBD suggested that at
least part of its binding to histones is mediated through an HJURP-like HBH. To
test this hypothesis, I have designed experiments to characterize the putative
Daxx HBH in vitro and conduct mutagenesis, coimmunoprecipitation and
crosslinking studies of exogenous H3.3 and Daxx in the human 293T cell line.
These studies are ongoing and I will discuss preliminary in vitro and in vivo
results in this section.
To test if Daxx or HIRA bind via the predicted coiled-coil with the α2helix of H3.3, I introduced point mutants in FLAG-tagged H3.3, transiently
expressed in 293T cells. Based on the DaxxHBH-H3.3-H4 model, several classes
of point mutations might disrupt the coiled-coil interface (Figure 3.5A): (i) where
the backbones of both helices are predicted to be in close proximity, introduction
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of bulky, polar amino acids in place of small hydrophobic residues might disrupt
binding significantly. To this end, I generated H3.3 A91N and G102Q. (ii) The
leucine zipper motive relies on interdigitating large, uncharged residues. I either
mutated them to alanine (L109A H113A, data not shown), or introduced charge
(L109K). (iii) Flanking the hydrophobic core, several salt bridges and hydrogen
bonds seem to ‘staple’ the two helices together, adding additional affinity. I
reversed the charge of the hydrogen-bonded E94 (E94K) or neutralized two
subsequent negative charges at positions 105 and 106, (ED105QN).
FLAG-immunoprecipitation of transfected cells yielded H3-H4 and
associated proteins (Figure 3.5B, upper panel). Some of the H3.3 mutants and
associated H4 consistently shifted toward higher molecular weights. However,
the chemical nature of this shift has not been identified. Endogenous copurifying
Daxx or HIRA were detected by western blot. While insertion of bulky
hydrophobic amino acids into the putative coiled-coil interface (A91N and
G102Q) did not disrupt (and in the case of A91N slightly enhance) binding of
Daxx, mutants relying on the neutralization or introduction of repulsive charge
(ED105QN and E94K, L109K, respectively) markedly decreased association with
Daxx. These mutants are properly folded as judged by quantitative association
with H4 (Figure 3.5B, upper panel). As they are expressed at wild type level and
Daxx protein levels are unchanged (Figure 3.5B, bottom panel), I conclude that
these residues specifically abrogate association with Daxx. Although I gathered
in vitro evidence that the recombinant Daxx HBH directly binds to H3-H4 (Figure
3.5C), more indirect effects on the Daxx interaction evoked by this mutation in
vivo cannot be ruled out.
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Notably, mutation of the H3.3 CRD (87-AAIG-90) to the respective H3.2
residues (SAVM) completely abrogate Daxx binding. This is consistent with
previous results (Drané et al., 2010; Goldberg et al., 2010; Lewis et al., 2010). The
terminal tyrosine of the Daxx HBH, Y379, is predicted to contact H3.3 A91.
However, this interaction does not appear to be affected by the identity of the
adjacent amino acids in the model (Figure 3.5C).

Figure 3.5: H3.3 Mutagenesis to map Daxx and HIRA binding.
(A) Model of the DaxxHBH-H3.3-H4 complex (from Figure 3.2). Mutated residues in
H3.3 along the HBH shown in cyan, H3.3 CRD residues (AAIG) shown in red. (B)
Coimmunoprecipitation of H3.3 mutants from transiently transfected 293T cells (upper
panel), Pre-IP soluble extracts and whole-cell lysates (bottom panel). (C) Size exclusion
chromatography of a recombinant, in vitro refolded H3.3-H4-DaxxHBH complex.
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Therefore, the model fails to explain why the CRD swapping has such a large
effect on Daxx binding. CRD recognition must be attributed to other parts of the
Daxx HBD as discussed in Section 3.3.1. H3 K120 is surface-exposed in the H3H4 dimer and involved in the binding of the H3-H4 dimer chaperone Asf1
(Adkins et al., 2007; Natsume et al., 2007). K120E decreases binding of Daxx
despite its somewhat remote location from the HBH. This region, however, could
also be contacted by additional residues of the Daxx HBD, in particular the ones
immediately preceding the HBH.
Broadly, HIRA binding is affected by the mutations in H3.3 in a similar
manner as Daxx (Figure 3.5B): H3.3 A91N and G102Q still interact with HIRA,
whereas E94K and K120E mutants associate with HIRA to a lesser extent.
Curiously, wild type H3.3 associates with HIRA relatively weakly, potentially
because Daxx has a considerably higher affinity for wild-type H3.3 (see Figure
2.1). Given the potential competition of HIRA and Daxx for newly synthesized
H3.3, it is difficult to dissect the effects of point mutations that decrease Daxx
association simultaneously. I therefore plan to introduce reciprocal mutations for
H3.3 E94K in Daxx or HIRA by swapping the opposing charged residues that
form the salt bridge. The double mutation (E94 to K in H3.3, K102 to E in
Daxx/HIRA) should rescue at least some of the binding.
One point mutation, H3.3 L109K shows preferred association with HIRA
over wild-type H3.3. Whereas the Daxx HBH positions an arginine (R360) in
proximity of H3.3 L109, HIRA does not have a basic residue at the corresponding
position (Figure 3.4A) and might therefore tolerate the H3.3 L109K mutation.
One remaining question is whether other histone chaperones compensate
when interaction with Daxx or HIRA is specifically impaired. I have therefore
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assessed association of above mutants. With the CAF1 complex. As expected,
CAF1 subunit p60 does not associate with wild-type H3.3 and instead uniquely
binds H3.2 (Figure 3.5B), suggesting that the H3.2 CRD (SAVM) is necessary for
CAF1 binding. However, H3.3 L109K and to a lesser extent H3.3 G102Q interact
with CAF1, as well. It remains to be determined if these mutations stimulate
CAF1 interaction directly. Interestingly, H3.3 E94K, which loses significant
association with both Daxx and HIRA, does not interact with CAF1, either.
Further candidates for buffering predeposition histones such as Asf1, NASP or
NPM will need to be considered in future experiments.
In summary, Daxx and HIRA are sensitive to H3.3 mutations in the
interaction surface derived from sequence homology to the CENPA-HJURP
interaction. This finding corroborates bioinformatic evidence that three major
replication-independent histone chaperones for H3.3 and CENP-A, respectively,
use a similar binding mode and are functionally related.

3.3 Discussion
3.3.1 Additional affinity and histone variant specificity is conferred by
other parts of the Daxx and HJURP histone chaperones
It is self-evident that faithful discrimination of histone variants by their
cognate chaperones is intimately tied to their relevance in crucial biological
processes, such as the control of chromosome segregation in the case of CENP-A.
It can easily be imagined how misincorporation of CENP-A outside of
centromeres could interfere with proper kinetochore formation. Indeed,
overexpression of CENP-A prompts its chromosome-wide localization and
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subsequent chromosome segregation defects (Heun et al., 2006; Van Hooser et
al., 2001). Deletion of Scm3 in S. cerevisiae leads to cell cycle arrest in metaphase
(Camahort et al., 2007) and levels of cenH3 are tightly regulated by ubiquitinmediated proteolysis (Hewawasam et al., 2010; Ranjitkar et al., 2010).
It is therefore somewhat puzzling and even counter-intuitive to observe
such striking homologies between a centromeric and at least one unrelated RI
histone chaperone. High-resolution ChIP studies even corroborate the notion
that misincorporation of CENP-A relies on RI deposition pathways cognate to
H3.3 in yeast (Lefrançois et al., 2009) and flies (unpublished data, S. Henikoff,
AECOM Epigenomics Symposium, 2010). It would seem sensible that histone
variants or their chaperones would have diverged far enough to achieve
exquisite specificity if not forced to retain some common motives due to rigid
constrains imposed by nucleosome structure and assembly mechanism. It
remains elusive if the common HBH stems from a single ancestral histone
chaperone or if it evolved convergently. In either case, we can conclude that
CENP-A and H3.3 histone chaperones have a common central HBH for the
purpose of chaperone activity and evolved variant specificity in separate
domains.
To date, we only have insight into this histone H3 variant discrimination
from the HJURP-CENPA-H4 cocrystal structure (Hu et al., 2011): In this case, the
HJURP HBH is followed by a β-sheet domain that contacts the CENP-A α1-helix
(Figure 3.2C). Mutating the CENP-A specific Gln68 to Ser (present at this
position in all other H3s) abrogates binding of the entire HJURP fragment under
moderate in vitro conditions (300 mM NaCl). Similarly, partial deletion of the
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HJURP β-sheet domain disrupts histone binding (Shuaib, 2010). This suggests
that, despite the extended hydrophobic surface, the overall affinity of the HBH to
histone-chaperone interactions is limited. This might be explained with the fact
that the HBH directly competes with inter-histone contacts (as discussed in
Section 3.2.2), which might dominate at high histone concentrations.
Nevertheless, complexes with close to minimal Scm3 HBH have been amenable
for both solution NMR and crystal structure determination (Cho and Harrison,
2011; Zhou et al., 2011).
Similar ‘division of labor’ might hold true for the Daxx HBD. While I
observed some association of the Daxx HBH with H3.3-H4 on a size exclusion
column (Figure 3.5C), I have not been able to purify a biochemically stable
complex with this fragment. This is in stark contrast to the full Daxx HBD, which
forms an exquisitely stable complex with H3.3-H4 over a wider range of salt
concentration (see Chapter 4). Which regions of the Daxx HBD contribute this
additional affinity and is this additional binding sensitive to the H3.3 CRD?
Given the location of the H3.3 CRD (‘AAIG’) at the base of the 〈2-helix,
residues immediately following the Daxx HBH (aa 380-400) could make contacts
to this motive (compare Figure 3.5A and Figure 3.2). However, the Daxx HBH
itself is located at the C-terminal extreme of the highly conserved Daxx HBD (aa
180-400) and more C-terminal regions are poorly conserved and predicted to be
unstructured (Figure 3.2). The HBH could therefore alternatively be part of a
larger folded domain with additional histone contacts in the N-terminal part of
unknown structure (aa 180-350). In either case, only a molecular structure could
resolve the long-standing question of how specificity for H3.3 is achieved.
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4 Biochemical characterization and crystallization trials of
the DaxxHBD-H3.3-H4 complex
4.1 Introduction
Human Daxx is a 740 amino acid protein that divides into a structured Nterminal ~400 amino acid domain, an acidic disordered linker region and a Cterminal domain scarcely defined by predictable secondary structure (Figure 4.1).
The extreme N- and C-termini each contain a highly conserved SUMOinteracting motive, that might help to recruit it to specific subnuclear
localizations (Lin et al., 2006; Santiago et al., 2009). Close to the N-terminus, a 4helix bundle is formed by amino acids 59-129 as determined by solution NMR
(Escobar-Cabrera et al., 2010).
Since discovering that the highly conserved histone binding domain
(HBD) of Daxx is necessary and sufficient for interaction with histone H3.3-H4
(see section 0), I have focused my research on understanding its role in
deposition of histone H3.3-H4 as well as discriminating against other histone
variants. The approximately 234 amino acid HBD is small enough to be
recombinantely expressed in E. coli, allowing purification of milligram quantities
for biochemical and structural studies. Interestingly, the HBD carries an overall
positive charge (pI 9.2) that is opposed by a highly acidic, Glu/Asp-rich stretch
of ~100 amino acids C-terminal of the HBD (Figure 4.1). Within the HBD
boundaries, evolutionary conservation correlates well with predicted secondary
structure content, a total of 8 〈-helices connected by short linker sequences
(Figure 4.1). As described below, domain boundaries were also confirmed and
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refined experimentally. The central questions guiding my biochemical
characterization were how this domain interacts with histones, how its
chromatin assembly activity can be explained biochemically and how variantspecificity is integrated into the chaperoning mechanism.

Figure 4.1: Domain structure of human Daxx.
Domain boundaries are based on evolutionary conservation, primary sequence analysis
and experimental evidence. Secondary structure, coiled-coil, disorder predictions from
JPred (Cole et al., 2008), are shown, as well as a moving window charge average.
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4.2 Results
4.2.1 Coexpression of Daxx and H3.1/3-H4 in E. coli delineates a stable
proteolytic fragment that specifically binds H3.3.
The first evidence for a direct and variant-specific interaction of an Nterminal subdomain of Daxx with H3.3-H4 came from an initial coexpression
trial (Figure 4.2); I cloned full-length, N-terminally His-tagged Daxx into a
bacterial expression vector with a second, bicistronic ORF expressing H3.3 and
H4. Daxx was heavily proteolyzed in E. coli, and Ni-affinity purification from
lysates yielded a heterogeneous mix of His-tagged Daxx fragments - therefore
proteolyzed from the C-terminus (Figure 4.2A). Histones were predominantly
detected when H3.3 and not H3.1 was coexpressed. Subsequent removal of
aggregated protein and purification on a cation exchange column yielded three
major Daxx species. Importantly, the two large N-terminal Daxx fragments elute
at high salt concentration (~1 M NaCl) with H3.3, explained by the high pI of the
observed complex (Figure 4.2B), whereas no interaction with H3.1 was observed
on the cation exchange column as evident from the broad elution profile (Figure
4.2C). The apparent size of the largest Daxx fragment detected via its N-terminal
His-tag fit well with the approximate 81 kDa full-length protein (Figure 4.2B).
The smaller fragment coeluting with H3.3 was estimated to 48 kDa, suggesting a
proteolysis site ~420 amino acids from the His-tagged N-terminus. Tryptic
digestion and tandem mass spectrometric analysis of this band further refined
the C-terminus to residue 417. A smaller N-terminal fragment of about 20 kDa
eluted early on the Mono S column, suggesting that the N-terminal 150 amino
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acids do not bind histones. Design of subsequent Daxx fragments was therefore
centered on the region between residues 150 and 417.

Figure 4.2: Coexpression of full-length Daxx and H3-H4 in E. coli.
(A) Coexpression of Daxx-H3.3-H4 and Daxx-H3.1-H4 from a single plasmid (right), and
Ni-affinity purification via an N-terminal His-tag. (B) Cation exchange chromatography
of eluted Daxx coexpressed with H3.3-H4 and (C) H3.1-H4. Fractions from a ~250 mM –
1 M NaCl gradient are shown. The Coomassie-stained lane in (B) corresponds to the
right-most fraction shown in the western blot.
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4.2.2 In vitro refolding of DaxxHBD-H3.3-H4 yields large quantities of
homogenous, pure and stoichiometric complex.
In search of a reliable and robust method to express the DaxxHBD-H3.3H4 complex, I evaluated several methods to purify either Daxx HBD alone or
coexpressed with histones:
(i) His-tagged expression as exemplified in the previous section had
generally low yield and purity. In the absence of histones, any constructs that
included the Daxx HBD or parts of it were completely insoluble, even though the
N-terminal 4-helix bundle and the C-terminal domain were soluble when
expressed separately. Coexpression of histones improved solubility, but yields of
DaxxHBD-H3.3-H4 were small, likely due to unbalanced expression of the three
components.
(ii) GST-tagged Daxx HBD could be expressed solubly at low temperature,
albeit with low yield, and could be partially purified. However the fusion protein
aggregated upon further purification and, after cleavage of the GST-tag, the Daxx
HBD precipitated quantitatively. Furthermore, the E. coli folding chaperone DnaJ
was copurifying to significant amounts with GST-DaxxHBD. While including
ATP in the wash buffer efficiently removed DnaJ during glutathione (GSH)
affinity purification, its presence suggested that the Daxx HBD might be partially
unfolded in the fusion protein. Only saturating amounts of histone H3.3-H4
stabilized the GST-DaxxHBD fusion protein, allowing cleavage of the tag and
subsequent purification of a stoichiometric complex of DaxxHBD-H3.3-H4. At
least when recombinantly produced in E. coli, the Daxx HBD therefore is partially
unfolded but can form a native complex upon H3.3-H4 addition. This method
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allowed me to test a number of Daxx constructs containing the HBD for their
biochemical stability (Figure 4.3) and to conduct initial crystal trials (see also
Table 4.1). I included constructs that were shorter than the originally defined
HBD (Figure 4.2). However they did not bind H3-H4 with similar affinity as the
full HBD (Figure 4.3B) In general, this method yielded only limited amounts of
protein complex for crystal screening due to the low soluble expression of the
GST-Daxx HBD and a large amount of impurities (Figure 4.3B).

Figure 4.3: GST-tagged Daxx HBD constructs can be expressed soluble in E. coli and
reconstituted with histones to form a stable DaxxHBD-H3.3-H4 complex.
(A) Initial set of constructs used for DaxxHBD-H3.3-H4 complex reconstitution and
crystal trials. (B) Example of DaccHBD-H3.3-H4 complex reconstitutions: GST-tagged
Daxx HBD constructs were expressed in E. coli at 20°C for 12h. Lysate was applied to
glutathione resin. After washing, folded, recombinant H3.3-H4 was added in excess at
500 mM NaCl salt concentration. After further washing with 500mM NaCl, complexes
were eluted.

(iii) Given the abundant production of inclusion bodies from His-tagged
Daxx HBD, I considered purifying the unfolded protein in 6 M Guanidine·HCl
and refolding it in vitro by slow dialysis to a native buffer. A typical purification
is shown in Figure 4.4. His-tagged Daxx HBD was expressed and purified in
inclusion bodies, solubilized with 6 M Guanidine·HCl and further purified on Ni
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NTA resin (Figure 4.4A). As expected from the previous results, the Daxx HBD
did not fold into a well-behaved structure on its own. Size exclusion
chromatography shows that after dialyzing out the Guanidine·HCl, Daxx HBD
quantitatively forms aggregates (Figure 4.4B, C).

Figure 4.4: In vitro folding of the DaxxHBD-H3.3-H4 complex.
(A) Purification of His-tagged Daxx HBD from inclusion bodies. Inclusion bodies were
purified from bacterial lysate by differential centrifugation (left panel) and solubilized in
6 M Guanidine·HCl. Daxx HBD was further purified on Ni NTA resin under denaturing
conditions (right panel). Equimolar amounts of Daxx HBD, H3.3 and H4 were mixed in
6 M Guanidine·HCl and dialyzed to 50 mM MOPS pH7, 500 mM NaCl (rightmost lanes).
(B, C) Daxx HBD refolds into a stoichiometric complex with histones, whereas it runs as
an aggregate on a size exclusion column in the absence of histones. Lanes in (B)
correspond to the respective fractions taken from (C).
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However, when mixing equimolar amounts of recombinant H3.3 and H4 (Section
9.1) and Daxx HBD prior to dialysis, I was able to refold a stoichiometric,
trimeric DaxxHBD-H3.3-H4 complex in vitro, that eluted as a well-defined peak
from a size exclusion column (Figure 4.4B, C). The individual purification of all
three components under denaturing conditions yielded pure starting material,
which allowed the production of highly pure complexes in a single size exclusion
chromatography step after refolding. Furthermore, the method proved highly
versatile for reconstituting and purifying multiple combinations of Daxx HBD
and histone constructs (i.e. histone tail deletions and mutants) and became my
method of choice for producing mg amounts of DaxxHBD-H3.3-H4 for
crystallization trials.

4.2.3 DaxxHBD-H3.3-H4 is a constitutive heterotetrameric complex
With recent discoveries of obligatory H3-H4 dimer and tetramer
chaperones (Adkins et al., 2007; Bowman et al., 2011), it has been appreciated
that histone chaperone mechanisms must vary fundamentally between those
binding modes (see Section 1.3.6.2). In particular, chaperoning H3-H4 dimers
requires either sequential or concerted deposition of two independent H3-H4
units to form the (H3-H4)2 tetramer that is thought to be prerequisite for
subsequent H2A-H2B addition. Coomassie staining of the DaxxHBD-H3.3-H4
complex suggested an even stoichiometry. I sought to confirm this notion with
quantitative measurements. To this end, I separated the components of the
DaxxHBD-H3.3-H4 complex on a reversed-phase HPLC column and integrated
the 280 nm trace to calculate the molar ratio of the three peaks (Figure 4.5A).
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While the ratio is not exactly 1:1:1, it certainly does not support a 1:2:2 ratio
indicative of a complex with a (H3-H4)2 tetramer. An alternative quantification
can be derived from amino acid analysis. The complex was chemically degraded
into single amino acids and their abundance was quantified by HPLC. I
compared the reported amino acid frequencies to the hypothetical frequencies in
a 1:1:1 or 1:2:2 complex. Experimental values consistently matched a 1:1:1
stoichiometry. As both methods can only assess the relative stoichiometry, I
further wanted to investigate the oligomerization state of the DaxxHBD-H3.3-H4
complex. It is formally possible, for example, that two DaxxHBD bind to one
(H3.3-H4)2 tetramer or that the DaxxHBD homodimerizes to carry two separated
H3.3-H4 dimers. Both modes would have implications in how nucleosomes can
be assembled from the predeposition histones chaperoned by Daxx.

Figure 4.5: The Daxx HBD forms a stoichiometric complex with H3.3-H4.
(A) Reversed-Phase Chromatography of the Daxx HBD-H3.3-H4 complex. Molar ratio
was calculated by dividing the area under each peak by the extinction coefficient of the
protein. (B) Amino acid analysis of the complex. The experimentally determined number
of amino acids per complex was compared to the calculated composition of a 1:1:1 and
1:2:2 complex (where these are significantly different). Stars indicate experimental data
matching the 1:1:1 better than 1:2:2 with p < 0.05.
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There are very few methods that can accurately determine the native
composition of protein complexes. one of those is dynamic multi-angle light
scattering (MALS). Through measuring the intensity of scattered light at a range
of angles, the mass of the scattering object can be accurately determined. MALS
in combination with size exclusion chromatography (SEC-MALS) determines the
molecular mass of the eluting peak. This is particularly useful because the
retention on the size exclusion column is dependent on the hydrodynamic radius
of the complex rather than its molecular mass. I confirmed the accuracy of the
SEC-MALS by running a number of standard histone complexes (Figure 4.6A).
As expected, H3.3-H4 is tetrameric at 500 mM NaCl, dimeric in complex with
Asf1 and tetrameric when bound by NAP1. The experimentally determined mass
of 61 kDa for the DaxxHBD-H3.3-H4 complex matches the expected mass of a
54 kDa 1:1:1 heterotrimer reasonably well (Figure 4.6A). The Daxx HBD therefore
induces constitutive H3.3-H4 dimers. In the light of the HBH model discussed in
the previous chapter (see Section 3.2.2), this can be interpreted as a consequence
of Daxx binding within the H3-H3 homodimerization interface, disrupting the
tetramer. Comparison of the Asf1-H3-H4 and DaxxHBD-H3.3-H4 (Figure 4.6,
bottom panels) shows that the Daxx HBD complex runs much larger than the
ASF1 complex despite its smaller molecular weight. This indicates that the Daxx
HBD has a more extended conformation that occupies a larger solvent volume. A
non-globular shape might also explain the slight deviation of the measured
61 kDa mass from the calculated 54 kDa. In line with an extended shape,
dynamic light scattering (DLS, which is sensitive to hydrodynamic radius in
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solution rather than mass) of the complex yielded an apparent weight almost
twice the true mass of the heterotrimer.

Figure 4.6: Size exclusion chromatography-coupled multiangle dynamic light scattering.
SEC-MALS shows that the DaxxHBD-H3.3-H4 complex is a heterotrimer. (A) Reference
elution profiles and MALS-derived molecular masses of a number of histone and
histone-chaperone complexes. All experiments were carried out in 10 mM MOPS pH7,
1 M NaCl. H33-H4 is a tetramer of 53 kDa although its retention volume suggests a size
of 70-80 kDa (as compared to the 66 kDa BSA monomer, top left). A mutation in the H3H3 homodimerization interface, H3C110E, induces constitutive H3-H4 dimers (middle
left). ASF1 forms a heterotrimer of 70 kDa with H3-H4 (bottom left). NAP1 binds one
(H3-H4)2 tetramer. (B) DaxxHBD forms a 61 kDa heterotrimer with H3.3-H4.
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4.2.4 DaxxHBD blocks the formation of (H3.3-H4)2 tetramers
All size exclusion chromatography experiments above were carried out at
salt concentrations of 1 M NaCl as I have observed non-specific binding of the
complex to the column resin at lower salt concentrations. Furthermore, the
overall positive surface charge of both Daxx HBD (pI 9.2) and H3.3-H4 (pI 11.3)
suggested that higher salt concentrations would stabilize the complex in the
absence of counteracting acidic stretches found in the full-length Daxx protein
(Figure 4.1). As both inter-histone and histone-chaperone interactions might be
salt- and protein-concentration dependent (Banks and Gloss, 2003; Donham et
al., 2011), it was important to also assess the stoichiometry of the DaxxHBDH3.3-H4 complex at physiological salt concentration. I therefore directly tested
the oligomeric state of H3-H4 by chemical crosslinking.
In the center of the H3-H3 homodimerization interface, two cysteins (C110
on both H3 units) symmetrically face towards each other, bringing their
sulfhydryls sufficiently close to form a disulfide bond or to be bridged by a
bivalent Cys-reactive crosslinker. Conveniently, there are no other cysteins in
H3.3 or H4, minimizing background crosslinking. Crosslinking therefore leads to
the specific formation of stable H3 homodimers associated with a shift in
electrophoretic mobility on a SDS-PAGE gel. I incubated either H3.3-H4
tetramers or equimolar amounts of DaxxHBD-H3.3-H4 complex at physiological
salt concentration (150 mM NaCl) with either a mild oxidizing reagent (Figure
4.7A) or one of two bis-maleimide crosslinkers (Figure 4.7B). H3.3 homodimers
could be observed in the presence of oxidizing or crosslinking reagents for H3.3-
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H4 alone. However, the presence of the Daxx HBD efficiently inhibited the
formation of H3-H3' homodimers.

A

B

H3.3
S

S

S

S

H4

chemical crosslink?

_

_

BMOE

+

H4

oxidizable?

H3.3

_

_
_

_
+

_

_

_

Cu(II)P

+

+

+ DaxxHBD

+
H3.3-H3.3’
DaxxHBD
H3.3
H4

Figure 4.7: The Daxx HBD prevents formation of H3.3-H4 tetramers at physiological salt
concentrations.
(A) Crosslinking of H3C110 by bivalent bismaleimide crosslinkers of different lengths.
In the presence of Daxx HBD, H3C110 cannot be oxidized or crosslinked. (B) (H3-H4)2
Tetramer formation probed by oxidation of adjacent H3C110 residues located in the H3H3' homodimerization interface with excess Cu(II)-Phenanthroline. Resulting H3 dimers
are shifted on a non-reducing SDS-PAGE.

This result corroborates the notion that Daxx HBD forms a trimeric complex with
H3.3-H4 and furthermore directly proves that the Daxx HBD blocks the H3
homodimerization interface.

4.2.5 Crystallization of the DaxxHBD-H3.3-H4 complex
Despite the interesting insights that derive from the homology in the
HBHs of Daxx and HJURP (see Chapter 3), major questions about the overall fold
and histone contacts of the Daxx HBD, in particular the H3.3 specificity, can only
be elucidated by a de novo structure. Both X-ray crystallography and, to a lesser
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extent, solution NMR spectroscopy have been employed to gather structural
information on histone-chaperone interactions (Adkins et al., 2007; Black et al.,
2007; Cho and Harrison, 2011; Hu et al., 2011; Natsume et al., 2007; Zhou et al.,
2008 2008; Zhou et al., 2011 2008). While solution NMR has been elegantly used
to capture a solution state of the Scm3 HBH bound to cenH3-H4 (Zhou et al.,
2011), a complex of the full DaxxHBD with H3.3-H4 exceeds the typical limit for
NMR structures. Furthermore, major discrepancies between the NMR and crystal
structures of Scm3-CenH3-H4 complexes raised questions about the validity of
the single-chain fusion approach that was used to reduce the number of residues
and stabilize the complex for NMR measurements (Cho and Harrison, 2011;
Zhou et al., 2011). As I aimed to elucidate the structure and function of the entire
Daxx HBD, I decided to attempt crystallization of the DaxxHBD-H3.3-H4
complex.
4.2.5.1 Pre-crystallization tests and construct considerations
The cumulative biophysical data described above, in particular the
homogeneity of the complex as determined by size-exclusion chromatography,
MALS and DLS, suggested that the complex would be suited for crystallization
trials. Furthermore, while DLS measurements at salt concentrations lower than
500 mM NaCl indicated a tendency to form aggregates (data not shown), at
500 mM NaCl or above, the complex remained intact for weeks at 4˚C or flashfrozen at -80˚C, as determined by analytic size-exclusion chromatography.
Therefore, the protein complex was always purified and concentrated at 500 mM
to 1 M NaCl. To preserve a constant surface charge, pH 7 was used in most
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purifications, well below the pI of the complex (9-10.5, depending on the histone
and Daxx HBD constructs used)
Another often mentioned prerequisite for successful crystallization is the
absence of unstructured, highly mobile stretches within a protein, such as
extended loops or tails. Various segments of the N-terminal H3 and/or H4 tails
were therefore removed in some crystallization trials. However, it should be
noted that the presence of the histone tails did not impede high-resolution crystal
structure determination for several histone-chaperone complexes (Hu et al., 2011;
Natsume et al., 2007).
The first ~43 residues of H3 are unstructured in the nucleosome (Figure
1.8). While constituting the first (〈N)-helix of H3 in the nucleosome core, the
following residues 43 to 60 appear to be disordered in the context of H3-H4
tetramers (Adkins et al., 2007; Natsume et al., 2007; Sekulic et al., 2010). In an
earlier experiment, which initially characterized the Daxx-histone interaction, I
have found the first 60 residues of H3 and 20 of H4 to be dispensable for Daxx
HBD binding (Figure 2.3). Therefore, deletions of the first 28, 43, 57 and 60 amino
acids of H3 were tested in various crystal trials. Biophysical properties of the
DaxxHBD-H3-H4 complex were affected by H3 tail deletions beyond residue 40,
as evident from a greatly increased tendency to aggregate during complex
refolding and concentration. All deletions of the H4 tail, up to residue 20,
behaved normal.
In order to identify possible unstructured regions in the Daxx HBD, I
conducted limited proteolysis of the DaxxHBD-H3.3-H4 complex with a set of
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diverse proteases (Figure 4.8). Trypsin and subtilisin were the only proteases that
significantly digested the Daxx HBD.

Figure 4.8: Limited proteolysis of DaxxHBD-H3.3-H4 complex for crystallography.
(A) Incubation of the DaxxHBD-H3.3-H4 complex with indicated proteases for 4h at
37˚C at a 1:1000 or 1:100 (w/w) ratio. (B) Potential fragment corresponding to the
slightly faster migrating band in the Trypsin and Subtilisin digest. Tryptic digest and
MS/MS peptide fingerprinting of this band suggests the presence of the complete Cterminal sequence (peptides detected ending in LDSGE, data not shown) but the lack of
at least 8 amino acids on the N-terminus.

The resulting fragment was analyzed by MS/MS peptide mapping. Interestingly,
peptides from the far C-terminus (400-417) were found abundantly, suggesting
that it was not cut despite the fact that it was predicted to be unstructured
(Figure 4.1). Notably, the fragment found after full-length Daxx expression in E.
coli showed similar protease resistance up to residue 417 (Figure 4.2). This might
indicate that the far C-terminus of the Daxx HBD folds back onto the central
structured part. Given the intact C-terminus, the proteolytic trypsin/subtilisin
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fragment in Figure 4.8 must be cleaved near the N-terminus, which was further
corroborated by the absence of peptides mapping to this region in the lower,
proteolyzed band. Consequently, I included Daxx HBD constructs that started
after potential trypsin cleavage sites (i.e. 191-417) in my screening efforts.
4.2.5.2 The wild type DaxxHBD-H3.3-H4 complex could not be crystallized
Using the protocols outlined in Section 4.2.2, I reconstituted a variety of
DaxxHBD-H3.3-H4 complexes for crystallization trials (Table 4.1). All complexes
were purified and salt-exchanged into crystallization buffer (10 mM MOPS pH 7,
0.5–1 M NaCl, 0.5 mM EDTA, 5 mM DTT or 1 mM TCEP) over a final Superdex
200 size exclusion column and concentrated up to 30–50 mg/mL immediately
before manual or robotic screen set up. Despite prior assessment of biochemical
and biophysical homogeneity of the complex (see previous section), initial trials
did not yield any crystals. At high protein concentrations, many conditions
showed phase separation phenomena or abundant precipitation. Anecdotal
crystals or crystal-like conditions discovered in the primary screens proved to be
salt crystals or did not reproduce in subsequent refinement screens. Given the
large number of conditions that were sampled in the sum of the screens (the 183417 fragment of Daxx HBD was screened in at least 1000 unique conditions), I
had to consider that some intrinsic property of the complex prohibited ordered
crystal packing. This did not appear to stem from unstructured tails as trimming
of the constructs per se did not facilitate crystallization (Table 4.1). Therefore,
methods to address other potential obstacles intrinsic to the complex needed to
be evaluated.
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One detriment that I suspected was the large number of surface lysines
and argingines of the complex which generally add to a high surface entropy
through their charge and side chain flexibility (Derewenda, 2004).
Table 4.1: Summary of crystallization trials.
3-20 mg of purified and concentrated protein were produced in each trial and usually
screened against a set of 4-10 non-redundant primary 96-well plate screens. Crystals are
only indicated where they could be reproduced in a subsequent refinement screen. The
best diffraction values are given where available.
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While targeted mutations of surface residues could potentially interfere
with native contacts made between histones and chaperones, reductive
methylation of the preformed complex provided a non-destructive method to
increase the hydrophobicity or ‘stickiness’ of exposed lysines to facilitate crystal
packing (Kim et al., 2008). However, no improvement in crystallization behavior
was observed by this method (in combination with mutations described below, it
even inhibited crystal formation).
4.2.5.3 Stabilizating mutations in the histone fold allow crystallization of the
DaxxHBD-H3.3-H4 complex
I considered another source of entropy that prevented ordered crystal
packing to come from the histone fold itself. This hypothesis is based on an
interesting observation made by Dr. Ben Black and colleagues (Black et al., 2004;
Sekulic et al., 2010): using hydrogen/deuterium exchange-mass spectrometry,
they detected considerable proton exchange with solvent at side chains of H3
and H4 that are predicted to lie in the hydrophobic (solvent-inaccessible) core of
the histone fold. He therefore concluded that the solution state of the H3-H4
histone fold is quite dynamic, in contrary to the rigid organization observed in all
available H3-H4-containing crystal structures. Interestingly, the corresponding
internal

residues

of

hydrogen/deuterium

the

CENPA-H4

exchange

and

heterodimer

therefore

showed

suggested

a

much
more

less
rigid

architecture (Black et al., 2004), which could later be attributed to increased
hydrophobicity of a number of CENP-A specific side chains extending into the
core of the histone fold (Sekulic et al., 2010). This difference in rigidity
furthermore lends an explanation to the curious observation that CENPA-H4
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readily crystallized as a tetramer whereas no crystals could be derived from free
H3-H4 tetramers despite intense efforts (B. Black, personal communication).
I reasoned that it would be possible to separate the mutations that
stabilize the CENPA-H4 core from mutations that are involved in CENPAspecific chaperone recognition. Unfortunately, no extensive single point
mutagenesis between H3 and CENP-A residues has been carried out to date.
Nevertheless, I identified a number of unique CENPA-H4 side chains in the
CENPA-H4 tetramer that had virtually no contact with its surface in the crystal
structure (Sekulic et al., 2010) (Figure 4.9B, blue; also see Figure 3.1). Their
counterparts in the H3-H4 tetramer had highly correlated positions, suggesting
that they contributed to the internal architecture of both heterodimers without
affecting their exposed surfaces. Importantly, H3.1/2 and H3.3 shared 100%
identify in those internal residues, arguing that they are not involved in variant
discrimination. Consequently, it seemed possible that introducing stabilizing
mutations into H3.3 would lower the H3.3-H4 heterodimer entropy without
affecting variant-specific properties.
I mutated a total of 7 residues in H3.3 towards their CENP-A
counterparts (creating a hybrid termed H3.37CENPA, Figure 4.9A). The resulting
DaxxHBD- H3.37CENPA-H4 complex behaved as wild type and could be purified to
homogeneity (Figure 4.9C). Within a primary crystallization screen of ~500
conditions, several hits were obtained, all containing sodium formate as a
precipitant. Crystals contained the stoichiometric complex (Figure 4.9D).
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Figure 4.9: Engineering of a more rigid H3.3-H4. Mutations were guided by
sequence comparison of H3.3 and the more rigid CENP-A.
(A) Alignment of H3.3, CENP-A and the engineered H3.37CENPA. Nonsynonymous
residues between H3.3 and CENP-A are highlighted in color; orange residues are
surface-exposed and thought to facilitate specific recognition of CENP-A by
chaperones; blue residues are completely buried in the hydrophobic core of the
CENPA-H4 fold. The latter 7 residues were mutated in the H3.3 sequence
towards the CENP-A counterpart in the H3.37CENPA (middle lane). (B) Location of
the mutated residues in the DaxxHBD-H3.3-H4 models; none of the mutations
affect the histone-chaperone interface. (C) Purification and (D) crystallization of
the DaxxHBD-H3.37CENPA-H4 complex with formate. (E) Optimized crystals
derived from this complex (top row, bottom right) and DaxxHBD183-445H3.37CENPA-H4 (bottom left).

129

	
  

130

	
  

Formate conditions could be optimized to yield few large singular crystals,
which looked extremely uniform by eye (Figure 4.9E). Subsequent crystallization
of a number of constructs revealed that in the presence of the 7 mutations in
H3.3, the extent of the Daxx HBD fragment or the presence of the histone tails
did not majorly influence crystal packing (Figure 4.9E, Table 4.1).
4.2.5.4 Alternate crystal forms of the DaxxHBD-H3.37CENPA-H4 complex with
greatly different diffraction limits.
Initial crystals of the DaxxHBD-H3.37CENPA-H4 diffracted to 10Å.
Crystallization with formate as a precipitant proved to be exquisitely robust to a
pH range between 6 and 8, and to additives such as salts, detergents and
alcohols. However, none of those refinements and additives improved diffraction
beyond 9Å. In addition, Varying the length of the Daxx HBD fragment or the
histone tails did not yield higher diffracting crystals either under any tested
formate condition (Table 4.1). Close distance of diffraction spots suggested a
large asymmetric unit with high disordered water content. Consequently, crystal
dehydration was attempted by raising the formate concentration slowly to 5 M in
a hanging drop, but diffraction was still limited to 9Å.
I therefore rescreened a more minimal complex (DaxxHBD183-398H3.37CENPA-H420-102, see Figure 4.10A) under ~500 new conditions (including the
full JSCG Core Suite) and found a second condition that contained 0.1 M Na/K
phosphate (pH 6.2) and 2.5 M NaCl to yield a single, large crystal. This crystal
diffracted to 3.5Å, with some imperfections (Figure 4.10C). Crystals could be
reproduced and are now under optimization (Figure 4.10B). Preliminary
rescreening of other complexes (e.g. with DaxxHBD183-417) under the phosphate
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condition did not produce crystals, suggesting that this condition might require
the truncated Daxx HBD.

Figure 4.10: A C-terminally truncated Daxx HBD yields crystals under an alternative salt
condition.
(A) Purification of the DaxxHBD183-398-H3.37CENPA-H420-102 complex over a Superdex 200
size exclusion column. (B) crystal growth at indicated protein concentrations in 0.1 M
Na/K phosphate pH6.2, 2.5 M NaCl. (C) Diffraction pattern of the single crystal in the
initial sitting drop screen.
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4.3 Outlook
With the current crystals diffracting to at least 3.5Å, it should be possible
to solve an initial structure of the DaxxHBD-H3.3-H4 complex. Phases may be
solved by molecular replacement with the histone moiety of Asf1 or HJURP
costructures, as the histone fold architecture is expected to be preserved in the
complex. As an alternative, the simple and efficient expression of the Daxx HBD
in inclusion bodies makes production of a Se-Met derivative feasible. The
resulting structure will be particularly valuable for understanding the specific
recognition of the H3.3 CRD by Daxx, given the subtle amino acid differences to
H3.1/2 (Figure 3.1).
Point mutants in the Daxx HBD will be designed that make contacts to the
CRD to see if altering the recognition interface interferes with the H3.3
specificity. In addition, different parts of the interface could be mutated in Daxx
in vivo to study their impacts on discriminating and chaperoning H3.3-H4
dimers.

133

	
  

5 HIRA and Daxx constitute two independent histone
H3.3-containing predeposition complexes‡
5.1 Introduction
Despite the inherent physical stability of the nucleosome particle (e.g. as
discussed in Section 1.3.3), the resulting chromatin structure must be highly
dynamic to allow access to the DNA-encoded information. H3-H4 and
H2A/H2B units are deposited and evicted from nucleosomes by different
histone chaperones and ATP-dependent chromatin remodelers. Histone
chaperones thereby serve two major functions: first, to buffer the pool of nonchromatin associated histones in predeposition complexes, and second, to
facilitate favorable histone-DNA interactions during the step-wise assembly of
the histone octamer-DNA complex from H3-H4 and H2A/H2B units (see section
1.3.5). Mutants of histone chaperones in S. cerevisiae, for example, cannot form
proper chromatin structure (Adkins and Tyler, 2004; Andrews et al., 2010; Sharp
et al., 2002). Metazoans have evolved histone variants to meet the diverse needs
for establishing and maintaining complex epigenetic information. Histone H3.3 is
a minor variant of the 'canonical' S-phase histones H3.1 and H3.2 in metazoans.

‡

This chapter has been published as: Elsaesser, S. J., and Allis, C. D. (2010). HIRA and Daxx

constitute two independent histone H3.3-containing predeposition complexes. Cold Spring Harb
Symp Quant Biol 75, 27–34.
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Figure 5.1: A highly conserved 'AAIG' motif in the core histone fold of metazoan H3.3.
Schematic representation of non-centromeric histone H3 variants in mammals. H3.1 and
H3.2 are commonly referred to as 'canonical' or S phase histone H3. Variable amino
acids are shown with residue number. Three unique residues of H3.3 from the 'AAIG'
motif at the base of helix 2 of the histone H3 core (purple, note that the isoleucine is
hidden in the helical depiction). The molecular structure of a representative H3-H4
dimer (H3 white, H4 green) has been adapted from the nucleosome structure
(PDB:1KX5), the H3:H3 interface of the H3-H4 tetramer is indicated.

However, its role as a replacement histone outside of S-phase is conserved to
lower eukaryotes, and accumulating evidence suggests that by virtue of a unique
amino acid motif, H3.3 engages in several variant-specific chromatin assembly
pathways. While the amino acid sequence of H3.3 is over 95% identical to
H3.1/2, the small 'AAIG' motif in the core histone fold (Figure 5.1) allows
targeting of the variant to specific genomic loci by a replication-independent
mechanism (Ahmad and Henikoff, 2002c; Goldberg et al., 2010). The existence of
identical H3 variants throughout the metazoan lineage underscores their
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importance as carriers of epigenetic information in somatic cells and the germline
(see Section 1.2.3). Reading out the subtle differences between H3.3 and H3.1/2
poses an intricate structural problem to variant-specific chaperones. Hence, a
number of recent studies have aimed to elucidate which proteins confer
specificity in chromatin assembly. By purifying H3.1 and H3.3-associated
complexes from HeLa nuclear extracts, the replication-independent histone
deposition factor HIRA was found to associate specifically with H3.3 (Tagami et
al., 2004). Using the same approach, others and we identified a different
polypeptide, the Fas death-domain associated protein Daxx, as an H3.3-specific
binding protein (Drané et al., 2010; Goldberg et al., 2010; Lewis et al., 2010). I
found that Daxx specifically interacts with the 'AAIG' motif of H3.3 in vitro and is
a bona fide H3.3-specific histone chaperone (Figure 2.3). The ATP-dependent
chromatin remodeler and 〈-thalassemia X-linked mental retardation protein
ATRX forms a complex with Daxx-H3.3-H4 that was essential for H3.3 chromatin
assembly in vivo (Goldberg et al., 2010; Lewis et al., 2010).

While I was able to detect HIRA in H3.3-associated fractions, this association was
unstable upon exposure to the more stringent biochemical conditions used to identify
Daxx (

Figure 2.2). Preceding my characterization of the putative histone-binding
motif (Section 3.2.3), this raised the question of whether HIRA and its associated
proteins Ubinuclein-1 and Cabin-1 were recruited indirectly, potentially via a
secondary interaction with Daxx or another as yet unidentified protein. I
addressed this issue by biochemically fractionating H3.3-containing subcomplexes from HeLa cells and purifying H3.3-associated proteins from mouse
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embryonic stem cells (ESCs) devoid of HIRA, Daxx or ATRX. I found that the
HIRA/Ubinuclein-1/Cabin-1 and ATRX/Daxx complexes are two separate
biochemical entities that independently associate with H3.3. We have previously
shown that HIRA is responsible for incorporation of H3.3 at genic regions
whereas ATRX is required for telomeric deposition of H3.3 (Goldberg et al.,
2010). HIRA and Daxx/ATRX therefore constitute two separate histone H3.3deposition machineries that act on distinct genomic loci.

5.2 Results
5.2.1 Biochemical fractionation of H3.3-containing complexes
Previous studies used double-affinity purification of FLAG-HA-tagged
H3.3 (e-H3.3) from nuclear extracts to isolate H3.3-associated factors (Drané et
al., 2010; Lewis et al., 2010; Tagami et al., 2004). However, this strategy did not
allow

me

to

identify

putative

sub-complexes

that

independently

co-

immunoprecipitate with H3.3. Thus, I developed an alternative biochemical
approach to fractionate H3.3-containing complexes from nuclear extracts based
on their affinity to a negatively charged heparin matrix. I noted that e-H3.3
eluted over a broad range of salt concentrations from immobilized heparin
(Figure 5.2A). While HIRA and CAF1 p150 complexes eluted with the bulk of
nuclear proteins at medium salt, Daxx only dissociated at higher salt
concentrations from the heparin column (Figure 5.2A). This approach therefore
provided me with a means to separate distinct subpopulation of e-H3.3 and
associated proteins. I combined fractions containing almost exclusively

137

	
  

HIRA/CAF1 p150 or Daxx and immunoprecipitated e-H3.3 (Figure 5.2B). HIRA,
but not CAF1 p150 copurified with H3.3. As Daxx was absent from the
immunoprecipitated material, I conclude that HIRA associates specifically with
H3.3, independent of Daxx. As a control, I heparin-fractionated e-H3.1 nuclear
extracts (data not shown) and performed immuoprecipitation from the
corresponding HIRA/CAF1 p150 fractions; this e-H3.1 immunoprecipitation
yielded CAF1 p150 (Figure 5.2B). Daxx coimmunoprecipitated with H3.3 from
the higher salt fractions in the absence of HIRA (Figure 5.2B). Thus, I was able to
isolate non-overlapping H3.3 sub-complexes from heparin-fractionated nuclear
extract containing either HIRA or Daxx.
In addition to HIRA, I found Cabin-1 and Ubinuclein-1 associated with the first
pool of e-H3.3-H4 (Figure 5.2C). HIRA, Cabin-1 and Ubinuclein-1 have been
previously found to form a complex in the presence and absence of H3.3-H4
(Drané et al., 2010; Tagami et al., 2004). Iterative alignment searches identified
Cabin-1 and Ubinuclein-1 as mammalian homologs of the yeast proteins Hir3
and Hcp2p, respectively, suggesting a HIRA complex analogous to the yeast Hir
complex. The control H3.1 immunoprecipitation yielded all three subunits of the
CAF1 complex, p150, p60 and RbAp46/48. Daxx co-precipitated with H3.3 from
the higher salt fractions without apparent stoichiometric partners (Figure 5.2C,
D), in agreement with our previous observation that the direct interaction of
Daxx with H3.3-H4 is not dependent on other proteins such as ATRX (Lewis et
al., 2010). In conclusion, I find that the known H3.3-associated proteins
fractionate into two biochemically distinct subcomplexes constituted by HIRA
and Daxx.

138

	
  

Figure 5.2: HIRA and Daxx constitute two biochemically distinct H3.3-containing
subcomplexes.
(A) Biochemical fractionation of nuclear H3.3 complexes: 200-800 mM KCl
fractions from a heparin column were probed for e-H3.3, HIRA, CAF1 and Daxx
by western blotting. (B) Affinity purification of e-H3.3 and e-H3.1 complexes. eH3.3/H3.1 complexes were immunoprecipitated from indicated pools and
analyzed by western blotting. Immunoprecipitation from the medium-salt e-H3.3
and e-H3.1 fractions yielded predominantly HIRA and CAF1, respectively; Daxx
coprecipitated with high-salt e-H3.3. (C) Silver staining of eluted CAF1, HIRA
and Daxx complexes from above. Indicated bands were all identified by MS
and/or verified by western blotting. (D) Coomassie stain of the Daxx complex to
estimate protein abundance.
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5.2.2 Genetic dissection of H3.3-containing complexes
Next, I assessed how the deletion of either HIRA or Daxx histone chaperones
affects H3.3 and its associated complexes in respective knockout mouse
embryonic stem cell (ESC) lines. I used a zinc-finger based genome editing
strategy to specifically tag one allele of the endogenous H3.3B gene in wild type
W9.5, HIRA-/-, Daxx-/- and HIRA-/- ESCs with a C-terminal HA tag (H3.3-HA)
(Goldberg et al., 2010), assuring endogenous expression levels of the tagged
histone. I found elevated levels of H3.3-HA in nuclear extracts of HIRA-/- ESCs
as previously reported (Meshorer et al., 2006), while the soluble pool of H3.3-HA
was reduced in Daxx-/- ESCs (Figure 5.3, left panel). I speculate that Daxx
buffers a considerable pool of H3.3 in the nucleus by forming a stable complex
with H3-H4 units. Overall H3 and H4 levels (accounting for the untagged H3.3,
as well as H3.1/2) in the nucleoplasm were unchanged, indicating that reduced
levels of H3.3 might be compensated by an increase in soluble H3.1/2. Levels of
chromatin-bound H3.3-HA were comparable in all cell lines (Figure 5.3, bottom).
As previously reported, ATRX levels were reduced in Daxx-/- cells (Lewis et al.,
2010). Unexpectedly, Cabin-1 was depleted in HIRA-/- nuclear extracts (Figure
5.3, left panel) and whole cell lysates (data not shown). Cabin-1 mRNA levels are
not perturbed in HIRA-/- cells (Goldberg et al., 2010), suggesting that the Cabin1 protein might be unstable and degraded in the absence of HIRA. A recent
study confirmed that Cabin-1, like Ubinuclein-1 contributes directly to the
function of the HIRA complex (Banumathy et al., 2009; Rai et al., 2011).
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Figure 5.3: HIRA and Daxx independently associate with nucleoplasmic H3.3.
Nuclear extracts were prepared as above from indicated mouse embryonic stem cell
lines (Lewis et al., 2010; Roberts et al., 2002), either parental or targeted heterozygous
H3.3B-HA knock-in (left panel). Protein levels in nucleoplasm (top) and insoluble
chromatin (bottom) were immunoblotted. e-H3.3 was bound to 〈-HA-Agarose, washed
and eluted with 1.5% SDS. Copurifying proteins were analyzed by western blotting
(right panel).
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5.2.3 HIRA and Daxx complexes independently bind H3.3
Based on our biochemical fractionation of H3.3-containing complexes, I
hypothesized that association of HIRA and Daxx with H3.3 are independent of
one another. I scrutinized this notion by immunoprecipitating H3.3-HA from the
above ESC nuclear extract. Indeed, HIRA copurified with H3.3-HA in Daxx-/cells and vice versa (Figure 3, right panel). ATRX coprecipitated with Daxx but
ATRX deletion did not influence binding of either histone chaperone, as expected
from our earlier studies (Lewis et al., 2010). ASF1 was constitutively associated
with H3.3-HA.
I therefore conclude that the HIRA and Daxx complexes independently
interact with H3.3 and likely maintain distinct pools of H3.3-H4 units in the
nucleus. This is in line with our recent observation that HIRA and ATRX/Daxx
deposit histones at distinct genomic locations: HIRA at genic regions (Goldberg
et al., 2010) and ATRX/Daxx at telomeres as well as pericentromeric
heterochromatin (Drané et al., 2010; Lewis et al., 2010). While my in vitro studies
confirmed that Daxx directly interacts with the H3.3 'AAIG' motif (Figure 2.3),
similar direct evidence is thus far missing for HIRA. As discussed in Section
3.2.3, the presence of a histone binding helix motif in the C-terminus is a first
indication of a direct binding element in HIRA. However, my finding that HIRA
consistently copurifies with H3.3 in a complex with Cabin-1 and Ubinuclein-1
(Lewis et al., 2010; Tagami et al., 2004) raises the possibility that these
components also contribute to binding and specificity.
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5.2.4 Do predeposition complexes represent independent histone
pools?
While H3.3 was originally characterized to be associated with actively
transcribed genes (Ahmad and Henikoff, 2002c), the discovery of new H3.3
chaperone pathways and heterochromatic target regions (Drané et al., 2010; Hake
et al., 2005; Lewis et al., 2010; Santenard et al., 2010; van der Heijden et al., 2007)
poses some intriguing questions: Does H3.3 carry out unique functions at distinct
genomic locations? How can a single replacement variant act activating or
repressing in a context-dependent manner? How do the specialized deposition
machineries contribute to the functional outcome of H3.3 incorporation?
The functional diversity of H3.3 could be explained if the distinct
predeposition complexes would represent independent pools of H3.3-H4 units.
Assuming that the exchange between those pools is slow due to the biochemical
stability of the complexes or their distinct spatial or temporal distribution during
the cell cycle, the associated histones could acquire specific posttranslational
modifications (PTMs) that might prime them for their respective functions at the
genomic target sites.

5.2.5 Distinct histone posttranslational modifications are present in
predeposition complexes
Histone variants have been found enriched in PTMs that correlate with
the local chromatin environment at their target sites (Hake et al., 2006). A set of
specific modifications has been identified for the soluble pool of histones
composed of newly synthesized histones but possibly also evicted histones
'recycled' from chromatin: ubiquitous H4K5/K12 diacetylation (H4K5/K12diAc)
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(Sobel et al., 1995) and H3K9 monomethylation (H3K9me1) on both H3.1/2 and
H3.3, as well as H3K9 dimethylation (H3K9me2) and H3K9 acetylation
(H3K9Ac) enriched on H3.3 (Loyola et al., 2006). Given the overall heterogeneity
of predeposition PTMs on the single H3.3K9 residue, I wondered if any of these
marks might be characteristic of a subset of predeposition H3.3 associated with a
specific chaperone complex.
Using heparin fractionation to separate e-H3.3-containing complexes
found in HeLa cells, we identified a subpopulation of e-H3.3 that was enriched in
H3K9Ac (Figure 5.4A), a modification that is thought to be established on nonnucleosomal H3 by the histone acetyltransferase Gcn5 (Adkins et al., 2007). As
the enrichment of H3K9Ac tracked well with the HIRA complex, we further
analyzed the PTMs present on histones within the CAF1, HIRA and Daxx
complexes (Figure 5.4B). We found that H3K9Ac on e-H3.3 associated with the
HIRA complexes but was undetectable in the Daxx complex. Notably, a mass
spectrometric analysis of the H3.3/Daxx-associated proteins in (Figure 5.2D)
yielded the H3K9 methyl transferases G9a and GLP, suggesting that H3K9 is
mono- or dimethylated (Wen et al., 2009) in this complex (see Appendix 9.1).
However, I have not followed up on this recent finding. Both Daxx and HIRA
complexes contained low levels of acetylated H4. e-H3.1 in the CAF1 complex
was enriched in H4 acetylation, with H3K9Ac present at a lower level than on eH3.3. With the differential H3K9 acetylation as a first indication, we conclude
that unique H3.3-H4 PTMs can be associated with predeposition complexes.
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Figure 5.4: H3.3 predeposition complexes are associated with distinct histone
posttranslational modifications.
(A) Western blot analysis of e-H3.3 lysine 9 acetylation (K9Ac) in the heparin salt
gradient. K9Ac on e-H3.3 is enriched in fractions that correspond to the HIRA complex.
(B) The CAF1, HIRA and Daxx complexes were analyzed for selected H3 and H4
posttranslational modifications. K9Ac is enriched on e-H3.3 within the HIRA complex
but undetectable in the Daxx complex.
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6 H3

variant-specific

antibodies

for

genome-wide

profiling of histone variants in primary cells or tissues
6.1 Introduction
The previous chapter has highlighted the diligence with which chromatin
assembly is controlled by histone chaperones. It is easy to imagine how the cell
could employ the site-specific installation of histone variants, carrying specific
predeposition PTMs, to modulate chromatin states. However, such model relies
on the assumption that the respective variant is sufficiently abundant at the site
of incorporation to dominate the chromatin state. Global abundance of H3
variants is thought to vary greatly amongst cell types and age (Hake et al., 2006;
Piña and Suau, 1987; Wu et al., 1982), likely impacting their enrichment at
specific loci. It has been difficult however, to quantitatively assess the abundance
of H3 variants in many cell types or primary tissues, as available methods to
separate and detect variants, such as triton-acid urea (TAU) gel electrophoresis,
HPLC and tandem mass spectrometry, require substantial amounts of protein
and have limited resolution. While specific antibodies for immunological
detection and quantification of a number of histone variants (i.e. CENP-A,
H2A.Z, H2A.X) are well established, no such reagents were available for the noncentromeric H3 variants when I started my thesis research.
Once quantified globally, can the relative abundance of histone variants
be determined genome-wide? While this seems a trivial question, current
methodologies are intrinsically blind to the abundance of histone variants or
PTMs relative to each other at a given genomic locus. The absolute abundance of
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histone marks can be quantified by mass spectrometry (Villar-Garea et al., 2008)
and next-generation ChIP-Seq technology allows assessment of the relative
distribution of a given mark along a genomic region. However, neither method
nor their combination can be used to infer what percentage of nucleosomes at a
fixed locus have a variant identity or carry a certain mark. In particular
comparison of ChIP-Seq read density merely yields enrichment scores between
distinct loci that cannot be quantitatively compared across different antibodies.
As introduced in Section 1.2.4, a wealth of studies has determined the H3.3
landscape in a number of different organisms and cell types (Chow et al., 2005;
Daury et al., 2006; Janicki et al., 2004; Jin et al., 2009; Mito et al., 2007; Nakayama
et al., 2007; Sutcliffe et al., 2009; Tamura et al., 2009; Wirbelauer et al., 2005).
Given the lack of specific immunologic reagents discussed above, prerequisite of
all these studies was the ability to genetically modify the cell line or organism to
introduce an epitope-tagged version of H3.3. While most studies relied on the
addition of an exogenous H3.3 locus, work by my colleague Dr. Aaron Goldberg
allowed tagging of one of two endogenous H3.3 loci by zinc-finger mediated
recombination in mouse embryonic stem cells (Goldberg et al., 2010). In either
case the caveat remained that total H3.3 profiles were inferred from the
distribution of the measurable, epitope-tagged subpopulation. Given the cellcycle dependent chromatin dynamics, this inference is however only valid if
expression patterns and cell-cycle dependent abundance between the tagged and
untagged H3.3 population are sufficiently similar. Furthermore, no analogous
genomic tagging of H3.1/2 species seems feasible in mammalian cells due to the
number of H3.1/2 genes.
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It was therefore desirable to develop immunologic reagents that would allow the
specific detection and discrimination of H3.1/2 and H3.3. In collaboration with
Trinette Chuang/EMD Millipore, I devised variant-specific peptide epitopes for
the in-house generation of rabbit polyclonal antibodies at EMD Millipore. I
further tested resulting sera, characterized candidate antibody fractions, leading
to two new highly specific rabbit polyclonal products for H3.1/2 and H3.3.

6.2 Results
6.2.1 Generation of H3 variant-specific rabbit sera and purified
antibodies
The amino acid sequences of major-type and replacement histone H3.3
(Figure 6.1A) are identical in all metazoans with very few exceptions. We
intended to create antibodies that recognize a specific epitope in either variant.
Two candidate regions for the design of immunogen peptides were considered,
one in the tail (aa 31) and one around the chaperone recognition domain CRD (aa
87-90). The latter has three unique amino acids between the variants and
therefore seemed more suited for the generation of a highly variant-specific
antibody. As the only difference between mammalian H3.1 and H3.2 is located 6
residues downstream of the CRD, we expected to generate an antibody that
would recognize both subtypes in addition to the major-type H3 in most other
metazoans (identical to mammalian H3.2).
Peptides were kept short to avoid the presence of too identical sequences
that would promote cross-reactivity. As the CRD is at the base of an 〈-helix in H3,
we included some of the downstream residues to promote a native conformation
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of the peptide, which could facilitate the generation of antibodies that can
immunoprecipitate native, folded protein (Figure 6.1A). Bleeds from all of the
rabbits immunized with the H3.3 peptide tested positive against the epitope.
However, none of the H3.1/2 bleeds showed any reactivity against the H3.1/2
immunizing peptide (Figure 6.1B, top). In a second trial, with a N-terminally
elongated peptide, two bleeds contained H3.1/2-specific antibodies. I further
tested positive bleeds on human and mouse whole cell lysates to determine the
extent of cross-reactivity with other cellular proteins. The cleanest bleeds were
further affinity-purified with the immunizing peptide and, if necessary, depleted
with a corresponding peptide from the other variant. The purified antibodies
showed no cross-reactivity against the respective other histone variant or other
histones (two examples shown in Figure 6.1C,D). No major crossreacting bands
were observed when tested on nuclear lysates (Figure 6.1D). Preliminary analysis
against histone CRD point mutants further suggested that the H3.3 antibody
recognizes the unique residue G90, whereas the tested H3.1/2 antibody has a
more composite specificity against the H3.1/2 CRD (Figure 6.1E).
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Figure 6.1: Development of H3 variant-specific, rabbit polyclonal antibodies.
(A) Schematic of the three non-centromeric H3 variants in mammals. Only
regions that vary between those variants are shown. Despite the difference in
position 96, major-type histones H3.1 and H3.2 are thought function in the same
deposition pathways. Position 31 in the tail and the chaperone recognition
domain (CRD) 87-90 distinguish them from the replacement variant H3.3. (B)
Peptide immunogen design for the production of antibodies specific to the
H3.1/2 and H3.3 CRD. Unique region is shown in red, the cysteine for adjuvant
conjugation is shown in green. Number of rabbits that produced antibodies
against the unique (red) region is given, as well as total number of immunized
animals. (C, D) Specificity of purified antibodies against His-tagged full-length
recombinant histones H3.1, H3.2 or H3.3 and point mutants thereof. (E) H3
variant-specific antibodies tested for specificity and cross-reactivity with other
nuclear proteins. Western blots with the indicated purified antibodies against
recombinant histone H3-H4 tetramers and two mouse embryonic stem cell (ESC)
nuclei (control, treatment; kindly provided by L. Banaszynski) are shown.
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6.2.2 Antibody-based estimation of relative H3 abundance
As discussed above, determination of histone variant protein levels in
primary tissues has been technically challenging. It is therefore unknown or
uncertain for many interesting cell types, how much of the cellular histone H3 is
contributed by which variant. In particular, post-mitotic cells such as neurons
and germ cells do not use replication-dependent assembly and produce
exclusively H3.3 (Wu et al., 1982). It has, for example, been observed that rat
brains accumulate H3.3 (Piña and Suau, 1987). However, accurate determination
was not possible, and despite advances in methodology this question has not
been addressed, to date.
I therefore aimed to quantitatively assess H3.3 levels in a representative, postmitotic cell type, the mature spermatozoan (in a collaboration with Dr. Shahin
Rafii and Ying Liu). I established a co-western blot of H3.3 and H4, as well as
H3.1/2 and H4 to serve as a per-lane loading control (Figure 6.2A). A
comparison between human spermatozoa and a highly proliferative murine ESC
line that contains only 10-20% H3.3 as determined by HPLC (L. Banaszynski,
unpublished data) suggests an opposite ratio in the spermatozoan (Figure 6.2A).
A more accurate determination required an external standard curve. To this end,
I prepared recombinant H3.2-H4 and H3.3-H4 tetramers and also mixed them in
25%/50%/75% ratios. This panel should allow quantification of the western blot
signal in relation to the stoichiometric H4 loading control. A preliminary
quantification experiment is shown in Figure 6.2B, suggesting that H3.3 levels
are in the range of 75% of total H3. More precise quantification was, however,
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not possible, due to the weak staining of the H3.1/2 antibody and imperfect
match in total histone between sample and controls.

Figure 6.2: Estimating the relative abundance of H3 variants using western blot.
(A) Simultaneous detection of histone H3 variants and H4 as a loading control. A
comparison of H3 variant content of a postmitotic (human spermatozoa) and fast
dividing (mouse embryonic stem) cell type shows that the postmitotic cells contain
much more H3.3 and less H3.1/2 than the embryonic stem cells. (B) A recombinant H3H4 standard can be used to estimate the relative abundance of H3 variants. Recombinant
H3-H4 tetramers were mixed at the indicated ratios. Comparison with the standard
curve suggests that human spermatozoa contain more than 50% H3.3.

6.2.3 Chromatin

immunoprecipitation

with

H3

variant-specific

antibodies
Given the excellent antibody specificity observed in western blotting,
especially the absence of crossreacting nuclear proteins, the antibodies proved
potential for a wider application range such as ChIP (Egelhofer et al., 2010). One
concern for immunoprecipitation of chromatin was the accessibility of the
antibody epitope, as the CRD is covered by DNA in the nucleosome structure.
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Native conditions (mononucleosomes generated by MNase) could be too mild to
unwind or relax DNA sufficiently to allow antibody binding. Crosslinking ChIP
(formaldehyde treatment and subsequent sheering of the DNA by sonication)
allows higher salt and detergent concentrations to reveal buried epitopes on the
nucleosome but, vice versa, crosslinking could trap the epitope inside the core.
Therefore, I initially carried out trials for both methods.
For assessment of the 〈-H3.3 antibody, I was able to use our published
H3.3 data from murine ESCs as a benchmark (Goldberg et al., 2010). As this
study relied on a genetic knock-in of a HA-tag on the endogenous H3.3B locus,
the distribution of the HA-tagged H3.3 was expected to closely reflect the
distribution of total endogenous H3.3. I was therefore able to test and compare
immunoprecipitation efficiency of the 〈-H3.3 antibody in published conditions
for native and crosslinking (xlink) ChIP (Goldberg et al., 2010) by probing known
H3.3-enriched loci by qPCR. No enrichment was observed in native ChIP
conditions as determined by qPCR, whereas 〈-H3.3 ChIP after crosslinking and
sonication consistently reproduced enrichment previously observed with 〈-HA
ChIP, albeit with ~50% loss in signal over background (data not shown).
Therefore, the CRD epitope was likely buried under native conditions but
accessible in the crosslinking protocol. The loss in signal over background in
comparison to the HA signal could either be due to incomplete epitope
accessibility, difference in affinity (HA antibodies bind extremely tightly), or it
could reflect a biologically significant difference of looking at a tagged
subpopulation versus the total H3.3.
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Next, I sequenced a representative 〈-H3.3 xlink ChIP sample using the
Illumina GAII platform. Genome-wide correlations between 〈-H3.3 and 〈-HA
H3.3 ChIP were excellent (data not shown), and patterns at individual loci
matched well (Figure 6.3A). Characteristic patterns of H3.3 incorporation, such
as the enrichment of H3.3 at transcription start sites (TSS) and towards the 5’ end
of active genes were reproduced (Figure 6.3B, compare to (Goldberg et al., 2010)).
As suggested by qPCR, the peak height over background was consistently
reduced in the 〈-H3.3 ChIP compared to native 〈-HA H3.3 ChIP. Again, technical
or biological effects could explain this phenomenon. However, comparison of
native and xlink 〈-HA H3.3 suggests that the crosslinking method adds some
intrinsic noise (Goldberg et al., 2010). Nevertheless, the H3.3 antibody proved to
reproduce data that previously has been dependent on the use of a tagged
species and therefore represents a valuable tool to study H3.3 distribution in
untagged cell lines, primary cell lines and tissues. The conservation of the
epitope makes it universal for studying H3.3 deposition across metazoans.

Validation of the H3.1/2 antibody represented a more difficult task. Due
to the repetitiveness and large number of major-type histone genes, no genomictagging strategy has been tackled to date. Instead, H3.1/2 has been either
expressed exogenously from an inducible promoter (Mito et al., 2005), or the
replication-independent H3.3B gene has been converted into a tagged H3.1/2
species (Goldberg et al., 2010). In both cases, the tagged H3.1/2 expression was
not cell-cycle regulated and therefore did not mirror the endogenous H3.1/2.
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Figure 6.3: ChIP-Seq of endogenous H3.3 in mouse embryonic stem cells with H3.3
specific antibody.
(A) Comparison of H3.3 profiles derived from 〈-HA ChIP in H3.3-HA-knockin cell lines
(Goldberg et al., 2010) and 〈-H3.3 ChIP. 〈-HA ChIP was carried out from MNased
chromatin (native ChIP), 〈-H3.3 ChIP from formaldehyde treated and sonicated
chromatin (xlink ChIP) inputs. The chromosomal neighborhood of ribosomal protein
gene Rps19 (left) and a close-up view on its gene locus (right) is shown. (B) 〈-H3.3
antibody yields characteristic profiles of transcription-dependent genic enrichment
comparable to 〈-HA H3.3 ChIP (Goldberg et al., 2010). Profiles of high, medium, low
expressed genes (as in (Goldberg et al., 2010)) were averaged over transcription start
site, gene body and end. ChIP-Seq libraries in (A) were prepared by K.M. Noh.

It could only be speculated that as a consequence of this exogenous expression,
the tagged H3.1/2 species was found enriched at typical H3.3-rich regions, albeit
much lower than H3.3 (Goldberg et al., 2010; Mito et al., 2005).
The intuitive expectation for H3.3-rich regions would instead be a
depletion of H3.1/2. As discussed above, the extent of this depletion would
depend on the relative abundance of H3.3 versus H3.1/2. Given the small
fraction of H3.3 in murine ESCs (10-20%), it could be expected that the remaining
80-90% of H3.1/2 would be broadly distributed, mostly resembling input. It was
therefore not possible to confirm H3.1/2 depletion a priori by qPCR
measurements. The same epitope accessibility considerations applied to the
H3.1/2 antibody as discussed for H3.3. Therefore, an xlink 〈-H3.1/2 ChIP was
carried out in parallel with a pan-H3 ChIP under the same conditions as a the 〈H3.3 ChIP. ChIP-Seq libraries were prepared for the input, H3.1/2 and pan-H3
ChIP (sequencing data for pan-H3 ChIP not yet available). Sequencing was
carried out on a Illumina HiSeq platform that registers more than 100 million
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reads per lane and allows reasonably dense read coverage even of large
mammalian genomes.
Inspection of the H3.1/2 ChIP profile by eye confirmed a broad overlap
with Input signal. Intriguingly, regions of high H3.3 enrichment did show a
discernable depletion in the H3.1/2 profile (Figure 6.4A). To acquire a more
unbiased view of the H3.1/2 landscape, I averaged the reads over lists of high,
medium and low expressed genes as above (Figure 6.3B). In contrast to the
activity-dependent enrichment for H3.3, I was able to observe an activitydependent depletion of H3.1/2 over the TSS as well as the whole gene body
(Figure 6.4B). This was not a consequence of a decrease in DNA recovery from
those regions as the input profiles were not dependent on gene activity (Figure
6.4C). In conclusion, these data suggest that the 〈-H3.1/2 antibody indeed
specifically ChIPs endogenous H3.1/2 and that, despite low global abundance of
H3.3, some regions of H3.3 enrichment are effectively depleted in H3.1/2. Even
in fast cycling stem cells, some genomic regions are therefore predominantly
occupied with H3.3, suggesting that its incorporation could imply a mechanism
to profoundly affect the local chromatin environment.
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Figure 6.4: ChIP-Seq of endogenous H3.1/2 in mouse embryonic stem cells with
H3.1/2 specific antibody.
(A) Example of a transcribed region (the ncRNA gene Gas5) where H3.3
enrichment coincides with a significant depletion of H3.1/2 over input. (B) 〈H3.1/2 antibody is depleted from highly transcribed gene bodies and promoters.
Profiles of 〈-H3.1/2 ChIP and crosslinked input at high, medium, low expressed
genes were averaged over transcription start site, gene body and end. Compare
depletion of H3.1/2 (top graph) with input (bottom graph) and H3.3 enrichment
(Figure 6.4). ChIP was carried out by L. Banaszynski.
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6.2.4 Estimation of locus-specific H3 variant content
Given the potential importance of H3.3 ‘hotspots’ in the genome, I wanted
to identify regions that contain predominantly or exclusively H3.3 in an unbiased
manner. From Figure 6.4A (in particular from the left zoomed tracks) it is
apparent that most H3.3 ‘peaks’, even the highest ones, coincide with
considerable H3.1/2 occupancy, therefore a typical peak-finding algorithm
applied to the H3.3 track does not necessarily yield regions with concurrent
H3.1/2 depletion. Instead, the fraction of the number of H3.3 reads of total H3
reads is an indicator for the relative enrichment of H3.3. To yield the total H3
reads, I calculated the sum of H3.3 and H3.1/2 reads (weighted 20:80 to reflect
the global ration of the variants) over fixed 128bp windows. I then expressed
H3.3 and H3.1/2 as a fraction of this total. The fraction value lies between 0 and
1, with 1 (=100%) meaning that every nucleosome at the given position has the
variant identity.
Continuous profiles were drawn from these 128 bp windows for the H3.3 and
H3.1/2 fractions (as ratios, they add up to 1 at any given window) in Figure
6.5A. The top track represents the sum of H3.3 and H3.1/2 reads, i.e. the total H3
occupancy. This track should match the pan-H3 ChIP track (not yet sequenced).
As apparent from the H3.3 ratio profile, transcription start site (TSS) and
transcription end site of Gas5 feature regions of 100% H3.3 content (i.e. no H3.1/2
reads). Such H3.3 ‘hotspots’ might appear by chance if the H3.1/2 track does not
contain any reads in a 128 bp window due to insufficient sequencing depth and
therefore can only be considered significant if they appear recurrently. Therefore,
I averaged the H3.3 profile over the gene categories described above. An activity-
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dependent H3.3-enrichment centered over the TSS was apparent from those
averaged plots (Figure 6.5B). However, the average ratio for H3.3 did not exceed
0.25, therefore TSSs of the high expression gene set contain on average less than
¼ H3.3. H3.3 has been shown to be enriched in CpG islands (Goldberg et al.,
2010; Mito et al., 2005), I therefore plotted the average H3.3 ratio over all
annotated CpG islands (Figure 6.5C). Interestingly, while the nucleosome
occupancy dips (CpG islands disfavor nucleosomes (Ramirez-Carrozzi et al.,
2009)), the H3.3 ratio peaks at ~50%, suggesting that H3.3 is an abundant
component of CpG islands in murine ESCs.
In a more unbiased approach, ~10 000 peaks were called from the H3.3
ratio track (Cistrome, (Liu et al., 2011)) with a significance cut-off of p=10-6. The
called peaks had an average H3.3 ratio of 0.9. Therefore, the corresponding
regions were almost exclusively occupied by H3.3. 20% of these peaks fell in the
TSS (Figure 6.5D, top), but not in regions immediately adjacent to the TSS (Figure
6.5D, bottom). Therefore, those H3.3 hotspots are highly localized to TSSs. About
50% of the H3.3 hotspots were found in intergenic regions and await further
analysis. So far, we have only considered annotated regions of the genome. As
H3.3 has been detected at repetitive regions, i.e. telomeres and centromeres
(Drané et al., 2010; Goldberg et al., 2010), I extended my analysis of H3.1/2 and
H3.3 density to a number of repetitive regions. I calculated the enrichment over
input of repetitive sequences by counting the occurrence of ~20 bp motifs unique
to the respective repeat element in ChIP as well as input samples. The resulting
ratio (ChIP/input) is given in Figure 6.5E. Repetitive elements were moderately
enriched in H3.1/2 and depleted in H3.3, except for telomeres, which were
enriched in H3.3 (~3-fold over input). Immunofluorescence in murine ESC
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revealed H3.3 foci at telomeres, suggesting that H3.3 might constitute the major
H3 variant in this region. However, the ChIP-Seq data does not support this
notion, as no depletion of telomeric sequences in the H3.1/2 reads is observed.
An H3.3 fraction calculated analogous to the method described above for the
annotated regions of the genome yields a value of ~25% at telomeres.
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Figure 6.5: Genome-wide integration of H3.1/2 and H3.3 signals yields an
estimate of relative H3.3 abundance at specific genomic loci.
(A) Calculation of a continuous fraction value across the genome for H3.1/2 and
H3.3. Reads from H3.3 and H3.1/2 ChIP-Seq runs were binned and divided by
the sum thereof to yield a fraction (0-1) value that corresponds to the relative
abundance of the respective variant. (B) H3.3 fraction at transcription start site
(TSS) corresponds to gene activity. Average H3.3 fraction does not exceed ¼ over
~10,000 most highly expressed genes. (C) Nucleosome occupancy (as measured
by sequencing MNase-treated chromatin input) dips at the center of CpG islands,
however the remaining nucleosomes are highly enriched in H3.3 (averaging to
50% of total H3). (D) The 10,000 most significant maxima in H3.3 ratio (>= 90%)
are highly enriched over promoter regions but not the adjacent gene body.
Percentage overlap with annotated promoters (top) and adjacent 1kb regions
(bottom) is compared to their total occurrence in the annotated genome. (E) H3.3
enrichment but no H3.1 depletion from telomeric repeats. Enrichment of
repetitive sequences in 〈-H3.1/2 and 〈-H3.3 ChIP. Occurrences of one ore more
(where standard deviation is given as error bars) of ~20 bp sequences unique to
the given repeat class counted in the unmapped portions of the respective 〈H3.1/2 and 〈-H3.3 ChIP-Seq dataset. Ratio of reads counted in ChIP dataset
versus input is shown on a log scale.
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6.3 Outlook
Based on my preliminary results described in this chapter, the H3.3 and
H3.1/2 antibodies developed in collaboration with EMD/Millipore will provide
powerful tools to profile histone variants in a multitude of cell types across
metazoans. Their compatibility with standard formaldehyde-crosslinking ChIP
protocols will allow their use for primary tissues and samples of small quantities.
In the long term, it will be interesting to find out if H3.3-deposition
mechanisms are conserved in all metazoans. So far, data from Drosophila and
C. elegans and mouse suggest overlapping themes in H3.3 deposition (Ahmad
and Henikoff, 2002c; Goldberg et al., 2010; Mito et al., 2005; Ooi et al., 2006),
however the absence of a Daxx homolog in C. elegans also suggests significant
differences. Going down the evolutionary tree, it will be particularly interesting
if genome-wide patterns of H3 variants are conserved even to the simplest
eukaryotes, implying a vital role for multicellular organisms.
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7 Discussion
7.1 A model for the different pathways of H3.3 chromatin
assembly
The biochemical characterization of distinct H3.3 deposition machineries
discussed in Chapters 2 and 5 (as well as in (Goldberg et al., 2010)), allows us to
construct a model for the journey of histones from synthesis to incorporation at
specific genomic locations. Newly synthesized histones in the cytosol are likely
immediately chaperoned by abundant 'general' histone chaperones such as ASF1
and/or NASP (Figure 7.1, top). Furthermore, H4 is diacetylated on K5 and K12.
ASF1-bound H3.3-H4 dimers then serve as substrates for various assembly
pathways. While a Daxx-H3.3-H4 complex has been reported in the cytosol
(Drané et al., 2010), HIRA seems to be exclusively localized to the nucleus and
has not been found in a cytosolic complex with H3.3-H4 (Lorain et al., 1998;
Tagami et al., 2004). Although ASF1 is ubiquitously detectable with H3.3-H4
(Drané et al., 2010; Tagami et al., 2004), our biochemical data suggest that it is not
a required component of HIRA and Daxx predeposition complexes (Figure
5.2C,D), (Lewis et al., 2010).
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Figure 7.1: Predeposition complexes mediate H3.3 chromatin assembly.
A model for the flow of histones from their synthesis in the cytosol (top) to their
target genomic regions in the nucleus (bottom). Newly synthesized histones
H3.3-H4 are chaperoned by ASF1 and a cytosolic pool of Daxx. HAT1 acetylates
H4K5/K12 in the cytosol. Predeposition complexes HIRA.com and Daxx.com
chaperone distinct pools of H3.3-H4. (1) HIRA.com mediates deposition of H3.3
at promoters and transcribed regions together with RNA polymerase (RNAP)associated FACT and Spt6 histone chaperones (2) HIRA.com deposits histones at
facultative heterochromatin in senescent cells. Histone methyltransferases
(HMTs) establish repressive chromatin state (3) Daxx.com cooperates with ATRX
and possibly other factors in incorporating H3.3 into pericentric heterochromatin
and telomeres. The chromatin-bound deposition complex might also contain the
histone chaperone Dek and the histone deacetylase HDACII (4). An unknown
factor delivers H3.3 to regulatory elements (RE). (5) In the absence of Daxx.com
or HIRA.com, H3.3 associates with the replication-dependent CAF1 complex that
mainly deposits histones after the DNA polymerase (DNAP) replication fork.
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7.1.1 The HIRA complex and histone deposition at transcribed gene
bodies and promoters
HIRA histone chaperone activity has been well studied in Xenopus egg
extracts, where it is necessary and sufficient for replication-independent
chromatin assembly on exogenous DNA (Ray-Gallet et al., 2007; Ray-Gallet et al.,
2002; Tagami et al., 2004). However, in vivo it accounts for only a subset of
replication-independent chromatin assembly (Figure 7.1, pathway 1), namely
within transcribed regions, at promoters and some regulatory elements (RE)
(Goldberg et al., 2010).
Evidence from yeast showing that the Hir complex and Asf1p genetically and
physically interact with the Set2 methyltransferase suggests that histone
deposition might be functionally linked to H3K36 trimethylation. Histone
deacetylases remove predeposition acetylation marks from nucleosomes after
RNA polymerase passage.
H3.3 enrichment in gene bodies was consistently lost in HIRA-/- ESCs,
but gene expression patterns and the transcription elongation mark H3K36me3
were only mildly affected (Goldberg et al., 2010). Several other histone
chaperones including Spt6 and FACT have also been implicated in histone
exchange during transcription. Thus, the purpose of the transcription-associated
H3.3 deposition and possible compensatory mechanisms in the absence of HIRA
have yet to be defined.
The homology of HIRA to the yeast Hir corepressor complex subunits
Hir1/2p suggests that its histone deposition activity might suppress basal
transcription (Anderson et al., 2009; Spector et al., 1997). Furthermore, it will be
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necessary to define the roles of the remaining complex members Cabin-1 and
Ubinuclein-1. Cabin-1 has recently been shown to act as a corepressor at p53
target genes and it will be interesting to see if this activity requires HIRA (Jang et
al., 2009). Ubinuclein-1 cooperates with HIRA in a chromatin assembly pathway
specific to the establishment of facultative heterochromatin domains in senescent
cells (Figure 7.1, pathway 2) (Banumathy et al., 2009).

7.1.2 Daxx and ATRX assemble H3.3 chromatin at pericentric
heterochromatin and telomeres
A considerable fraction of H3.3 is localized to telomeres in murine ESCs,
and we have recently shown that this enrichment is dependent on the
Daxx/ATRX complex, but not HIRA (Goldberg et al., 2010; Lewis et al., 2010).
While Daxx readily assembles H3.3-H4 chromatin in vitro, ATRX is required in
vivo to target Daxx and H3.3-H4 to the telomeres (Lewis et al., 2010), as well as to
pericentric heterochromatin (Drané et al., 2010). A diffusible Daxx-H3.3-H4
complex therefore likely delivers histones to an ATRX-containing complex
associated with telomeric chromatin (Figure 7.1, pathway 3) (Wong et al., 2010).
The chromatin-bound complex might furthermore contain the histone
chaperone Dek and histone deacetylase HDACII as suggested by biochemical
studies (Hollenbach et al., 2002), to prime a repressive chromatin state. This
notion is supported by our finding that H3.3 does not carry the 'activating' K9Ac
mark in the Daxx complex, but potentially acquires K9me1 or K9m2 methylation
mediated by the G9a/GLP methyltransferase (Figure 5.4B, Figure 9.1). Recent
data suggested two alternative, but not exclusive, models of how the
ATRX/Daxx complex is recruited to telomeres. First, an intrinsic affinity of the
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ATRX protein for a unconventional DNA hairpin structure, called G-quadruplex,
that is prone to occur at repetitive elements, in particular the G-rich telomeric
repeat (Law et al., 2010); second, the recognition of the heterochromatic
H3K9me3 mark that decorates most repetitive elements in heterochromatin, but
also euchromatin, through the ATRX ADD domain (Dhayalan et al., 2011;
Eustermann et al., 2011; Iwase et al., 2011). Failure of H3K9me3 establishment
could therefore lead to similar consequences as the genetic knockouts of ATRX
and Daxx that we have been studying. Importantly, through stimulation of
H3K9me3 at sites of H3.3 incorporation and subsequent recognition of the mark
by the ATRX ADD domain (Figure 7.2), this could establish a feedback
mechanism in a similar manner to the epigenetic propagation of centromeres
discussed in Section 3.1.1. Such a mechanism might contribute to maintenance of
heterochromatin as suggested by the increase in TERRA transcription upon
ATRX deletion (Goldberg et al., 2010) that could ultimately lead to genomic
instability exemplified by the occurrence of DNA damage and γ-H2A.X repair
foci (Wong et al., 2010)) in the absence of ATRX. I will detail possible connections
between epigenetic instability and genomic instability in Section 7.4. Notably,
Daxx is a highly conserved histone chaperone that appeared with the emergence
of metazoans. Unlike the H3.3-chaperone activity of HIRA that is shared in yeast,
Daxx therefore likely evolved to diversify the functionality of H3.3 within the
more complex chromatin structure of higher eukaryotes. A specific example is
the asymmetric incorporation of histone H3.3 between male and female
pronucleus in the fertilized egg (Loppin et al., 2005; Torres-Padilla et al., 2006).
Specific incorporation of H3.3 into the paternal genome is required for
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establishing heterochromatin in the decondensed sperm nucleus (Santenard et
al., 2010). It is tempting to speculate that Daxx has taken on this and other
metazoan-specific challenges.

Figure 7.2: Model for ATRX/Daxx function at telomeres.
(A) The ATRX/Daxx complex is recruited to heterochromatin via H3K9me3 recognition
by the ADD domain of ATRX or through recognition of DNA structures that occur in
nucleosome-depleted repetitive elements. Deposited H3.3 nucleosomes prime H3K9me3
through pre- or codeposition methylation of H3K9 to the mono- or dimethylated state.
(B) Consequence of Daxx or ATRX knockout include a desilencing of transcripts from
repetitive elements, as well as genomic lesions, both associated with genomic instability.
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7.1.3 H3.3 deposition at regulatory elements
Many DNA sequences with regulatory functions, including transcription
factor binding sites (TFBSs), insulator elements and origins of replication (ORFs),
are characterized by fast histone exchange dynamics. These epigenetic regulatory
elements acquire newly synthesized histones and are constitutively enriched in
H3.3 (Deal et al., 2010; Goldberg et al., 2010; Jin et al., 2009; Mito et al., 2007;
Nakayama et al., 2007). Neither HIRA nor ATRX deletion significantly altered
the global incorporation of H3.3 at these sites (Goldberg et al., 2010), suggesting
that a yet unknown assembly pathway is used. While 'general' histone
chaperones such as ASF1 or NASP could provide the histones for ATPdependent chromatin remodelers that occupy these locations, it is important to
note that this pathway is also specific to H3.3 (Goldberg et al., 2010). We
therefore speculate that either Daxx, Dek or yet unknown factors mediate the
deposition of H3.3 at regulatory elements (Figure 7.1, pathway 4). Dek has
recently been found to cooperate with ATP-dependent chromatin remodelers
and act as a coactivator for nuclear receptors (Sawatsubashi et al., 2010).
Intriguingly, H3K4 monomethylation is another hallmark of regulatory
elements and it correlates well with exchange hotspots and H3.3 enrichment in
genome wide analyses. It remains elusive which histone methyltransferase
activity is responsible for establishing the H3K4me1 mark, but we speculate that
methylation and histone exchange are functionally linked at these genomic
regions.
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7.1.4 Alternate pathways for H3.3 deposition
As apparent from the imperfect discrimination that can be observed in
pure in vitro assays with variant-specific chaperones (Drané et al., 2010; Lewis et
al., 2010), only the interplay and competition of variant-specific histone
chaperones can explain the exquisite specificity of H3.3 incorporation observed
in vivo. Whereas in unperturbed systems, H3.1 and H3.3 associate exclusively
with their cognate chaperone systems (CAF1, HIRA and Daxx, respectively), we
did observe CAF1 copurifying with e-H3.3 in the absence of Daxx and HIRA
(Figure 7.1, pathway 5) (Lewis et. al. 2010, Drane et. al., 2010). A more
comprehensive set of histone mutations along the lines of Figure 3.5 and
molecular structures will help to define the overlapping or distinct binding
surfaces used by various pathways. Furthermore, there is evidence that low
levels of H3.3 are broadly incorporated into chromosomes by the replicationdependent machinery in Drosophila cells (Ahmad and Henikoff, 2002c; Schwartz
and Ahmad, 2005). Therefore, similar to the single yeast H3.3-like histone, H3.3
might represent a universal variant for replication-dependent and independent
deposition pathways that is simply outnumbered by the large pool of H3.1/2
present during S phase. Additionally, studies in flies suggest that H3.1/2 can
take over some, but not all, functions of H3.3 (Hödl and Basler, 2009; Sakai et al.,
2009).
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7.1.5 Conclusion
As illustrated by the replacement histone H3.3 and the centromeric H3, a
rapidly emerging literature points to remarkable complexity for the use of
relatively minor histone variants in punctuating epigenomes in organisms
ranging from yeast to man. Multiple predeposition and assembly systems are
called upon to deposit histone variants in select genomic locations. While these
variants often differ in only a small number of amino acids, mounting evidence
suggests that, once assembled, they carry out specialized functions that remain
poorly defined. It has been proposed that selective use of histone variants may
contribute to a ‘nucleosome code’ (Bernstein and Hake, 2006), providing
additional

variation

to

that

provided

by

chromatin

remodeling

and

posttranslational modifications. We look forward to future experiments
identifying and characterizing the predeposition complexes that engage these
variants, giving the field more mechanistic insights into how these variants make
their complicated journeys from synthesis to distinct chromatin functions.

7.2 Nucleosome dynamics, histone variants and cellular memory
“Every cell contains within its chromosomes all the information
necessary for the manufacture of every protein in the entire organism. […]
Each could be doing what the other does, but it doesn't. What determines
what information gets used? What switches on certain genes in the DNA?
What is the difference in the chromosomes of those two cells? That's what
we want to find out.” - Vincent G Allfrey, 1980
1980)
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How do all the pathways of replication-independent chromatin assembly
outlined above integrate with other mechanisms known to modulate chromatin
states? Prerequisite for the incorporation of new histones is the eviction of old
ones. The ATRX/Daxx complex has chromatin remodeling activity but it has not
been shown yet that the complex can ‘switch’ nucleosomes as has been shown for
the SWR1 remodeler that exchanges canonical H2A for the histone variant
H2A.Z (Luk et al., 2010). Rather, a multitude of DNA transactions directly or
indirectly create dynamic chromatin. Transcription destabilizes or evicts
nucleosomes through DNA torsion stress and transcription factors recruit ATPdependent chromatin remodelers to promoters or regulatory elements. Therefore
one might speculate that H3.3 deposition is merely a consequence of dynamic
chromatin (Ahmad and Henikoff, 2002a; Deal et al., 2010; Henikoff and
Shilatifard, 2011). As part of dynamic chromatin, H3.3, like typically ‘activating’
histone PTMs such as H3 and H4 acetylation, could however contribute to a
cellular memory that would predispose transcriptionally active regions for a new
transcription cycle after replication (Henikoff et al., 2004). However it will be
important to dissect if, in replenishing nucleosome free regions, H3.3 acts
predominantly as a substrate to the assembly pathway or in addition can adopt a
unique role once incorporated into chromatin. An argument has been made that
H3.3 could create intrinsically unstable nucleosomes (Jin and Felsenfeld, 2007; Jin
et al., 2009), however in vitro data does not support such a model (Flaus et al.,
2004; Thakar et al., 2009). Instead, the observed instability could reflect the
properties of dynamic chromatin that, in part, are determined by DNA sequence
(Deal et al., 2010; Ramirez-Carrozzi et al., 2009). It should be pointed out,
however, that the unique serine in position 31 of H3.3, phosphorylated or not,
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could affect a number of ‘readers’ and ‘writers’ in the vicinity (such as for H3K27
or H3K36).
It has been argued that chromatin states in general do not determine gene
expression outcome and solely reflect the consequence of DNA-templated
processes (Bryant et al., 2008 2011). In particular, when chromatin states are
implicated in the maintenance of cell identity, it has to be considered if cell-type
specific ‘master’ transcription factors ultimately set the cell identity. The
reprogramming of somatic cells to pluripotent stem cells by four core stem cell
transcription factors is a pivotal example of this concept (Takahashi and
Yamanaka, 2006). An important consideration in this respect is how chromatin
affects transcription factor binding. There is a conundrum in transcription factor
biology – DNA sequence cannot accurately predict the occupancy of a
transcription factor binding site with its cognate transcription factor, owing to
the fact that there are orders of magnitude more nonspecific binding sites in the
genome than the estimated number of transcription factor molecules (Stratmann
and Schibler, 2011). A mechanism to ‘assist’ a transcription factor to find its cell
type-specific binding sites would solve this problem, and only recently such a
mechanism has been shown to rely on chromatin changes (Voss et al., 2011). In
this particular example, the hyperdynamic chromatin state around a
transcription factor binding site, once primed through a binding event, maintains
accessibility to subsequent binding events of the same or different transcription
factors. It is therefore warranted to postulate that some properties of chromatin,
which will likely include histone PTMs and histone variants or a combination
thereof, contribute to cell identity through an epigenetic propagation mechanism
(Moazed, 2011).
179

	
  

7.3 Defects in H3.3 deposition pathways are associated with a
wide spectrum of human diseases
Given the dynamic state of chromatin, replication-independent chromatin
assembly pathways might be expected to have an important role in faithful
maintenance of gene expression and developmental programs (Ahmad and
Henikoff, 2002a). Indeed, mutations or deletions of histone chaperones are
associated with a number of diverse developmental disorders as detailed below.
The

HIRA

gene

falls

in

the

22q11.21

locus

deleted

in

the

DiGeorge/CATCH22 syndrome, a craniofacial developmental disorder (Lamour
et al., 1995). As a number of candidate genes in the locus might contribute to the
syndrome’s etiology, it has not been possible to dissect individual gene
functions. However, HIRA deletion in mice is embryonic lethal with early defects
in mesodermal and cardiac development, establishing potential links with the
defects observed in CATCH22 patients (Roberts et al., 2002).
Familial mutations in the ATRX gene give rise to a blood disease and
neurological disorder called X-linked 〈-thalassemia mental retardation (ATR-X)
syndrome (Gibbons, 2006; Picketts et al., 1996; Xue et al., 2003). The causal
genetic alterations ultimately affect the expression of genes (such as the 〈-globin
locus) that are megabases apart from the mapped locus or even on different
chromosomes. ATRX therefore acts as an epigenetic modifier of remotely located
factors that control blood cell and neuronal development, plasticity and
excitability. Strikingly, conditional deletion of the ATRX gene in mice impairs the
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development in a similar fashion (Ritchie et al., 2008; Seah et al., 2008). ATRX has
been identified as a Snf2-family ATP-dependent chromatin remodeler that
localizes to pericentromeric and telomeric heterochromatin (McDowell et al.,
1999; Picketts et al., 1996). Patient mutations are found both in its catalytic core as
well as the so-called ADD domain that directly binds the heterochromatic
trimethylated H3K9me3 (Argentaro et al., 2007; Dhayalan et al., 2011;
Eustermann et al., 2011; Gibbons, 2006; Iwase et al., 2011; Ooi et al., 2007).
Mutations in the ADD H3K9me3 recognition domain are associated with
impaired DNA cytosine-methylation in heterochromatin but also with gene
expression changes in the vicinity of heterochromatin domains (Gibbons et al.,
2000). Considering its ubiquitous expression and broad nuclear distribution
along heterochromatin, it is surprising that major symptoms of familiar ATRX
mutations are confined to the brain and the hematopoietic system. It is
interesting to speculate that in the absence of replication-dependent mechanisms
in postmitotic neurons, replication-independent chromatin assembly becomes
crucial for maintaining chromatin structure and in particular the dense
packaging of heterochromatin (Ahmad and Henikoff, 2002a).
Daxx has been identified as a mandatory subunit of the ATRX chromatin
remodeling complex (Drané et al., 2010; Lewis et al., 2010; Xue et al., 2003) and
therefore likely plays an essential role in ATRX biology. Daxx and ATRX
knockout mice show phenotypically similar embryonic lethality (Ishov et al.,
2004; Michaelson et al., 1999; Xue et al., 2003). Our recent findings that Daxx links
ATRX remodeling activity to the deposition of the histone variant H3.3 first shed
light into the mechanism of the ATRX/Daxx complex as an epigenetic modifier
(Goldberg et al., 2010; Lewis et al., 2010). No Daxx or histone H3.3 mutations
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have been identified thus far in ATR-X patients, however at least one known
mutation in ATRX might compromise its ability to bind Daxx (Fichera et al.,
1998; Gibbons et al., 2008; Tang et al., 2004). Germline polymorphisms likely exist
in the DAXX gene, as well, and future targeted studies might reveal mutations
that associate with syndromes similar to ATR-X.
Daxx has been originally described as a component of the proapoptotic
death receptor pathway (Yang et al., 1997) and since then has been implicated in
a variety of pro- and antiapoptotic functions in the nucleus and cytoplasm
(Salomoni and Khelifi, 2006). From the variety of functions and molecular
interactions associated with the Daxx proteins it is apparent that future research
on the role of Daxx will require careful testing and a mechanistic dissection. The
functions of individual domains of the Daxx protein will have to be dissected to
learn if phenotypes can be attributed to a specific domain or rely on cooperation
of multiple domains. In particular, it will be interesting to see if the apoptotic
regulation is mechanistically related to the histone H3.3 chaperone function.

7.4 A sound genome in sound chromatin – Epigenetic stability is
important for genomic stability.
Constitutive heterochromatin encompasses all major repetitive elements
in eukaryotic genomes, in particular the abundant centromeric α-satellite and
telomeric repeat elements. Aberrant transcription in repeat regions is thought to
cause genome instability through the reactivation of retrotransposons, but likely
also through to other less well-understood mechanisms. Therefore, defects in
heterochromatin silencing have been attributed to genomic instability (Fry et al.,
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2006; Mostoslavsky et al., 2006; Oberdoerffer and Sinclair, 2007). However, direct
links between such epigenetic defects and human cancers have been rare. This
has dramatically changed in very recent years, namely through novel
technologies, in particular exome sequencing – the targeted sequencing of all
protein coding regions in the human genome. The systematic discovery of
somatic mutations has redefined a number of well-known chromatin
components as potent tumor suppressors in specific types of tumors (Dalgliesh et
al., 2010; Jones et al., 2010; Parsons et al., 2011; van Haaften et al., 2009; Varela et
al., 2011; Wiegand et al., 2010). Inactivating mutations in those epigenetic factors
seem to occur frequently early in neoplasia, facilitating subsequent genomic
alterations. We have termed these early, highly tissue-specific, epigenetic tumor
suppressors ‘backseat drivers’ of cancer, as opposed to the well-studied
oncogenes ‘drivers’ that are activated later and common to many diverse types of
tumors (Elsässer et al., 2011)
One particularly intriguing study used exome sequencing to explore the
genetic etiology of pancreatic neuroendocrine tumors (PanNET) - a class of
tumors that frequently arise from islet cells of the pancreas (Jiao et al., 2011). In
addition to well-studied tumor suppressors PTEN and TSC2 in the mTOR
pathway, the authors found that more than 60% of PanNETs are mutated in
either MEN1 (a histone methyltransferase), ATRX or DAXX. Simultaneous
mutations of ATRX and DAXX were never observed in the same tumor,
suggesting that inactivation of one was sufficient to drive those tumors.
Subsequent work by the Meeker and Papadopoulos groups found that
ATRX/DAXX mutations correlated with vastly elongated telomeres, indicative of
an activation of the alternative telomere lengthening (ALT) pathway (Heaphy et
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al., 2011), affirming our speculation that ATRX and Daxx are essential for the
maintenance of telomere integrity (see Section 7.1.2). Interestingly, other recent
reports highlight a role for heterochromatin-mediated silencing of transcription
through repetitive elements in tumor suppression: aberrant overexpression of
centromeric α-satellite repeats and LINE-1 retrotransposons are found in a
variety of epithelial cancers (Ting et al., 2011). Most surprisingly, the potent
tumor suppressor and E3 ubiquitin ligase BRCA1, well studied for its
detrimental heritable mutations leading to breast and ovarian cancer, has now
been shown to organize heterochromatin (Zhu et al., 2011).

Figure 7.3: Chromatin regulators mutated in pancreatic neuroendocrine tumors.
Epigenetic regulators Menin and ATRX-Daxx promote genome integrity and maintain
cell identity through the modification of chromatin structure by chromatin remodeling,
variant histone nucleosome assembly and histone posttranslational modifications. Loss
of these pathways may play a critical role in the development of neuroendocrine tumors
arising from the pancreatic islet.
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BRCA1 mutations lead to desilencing of centromeric satellite repeats, likely
through a defect in histone H2A ubiquitinylation. Cumulative evidence from
these diverse studies suggests that proper maintenance of chromatin states is
absolutely essential for genome maintenance. In light of these discoveries, I am
looking forward to future studies on how the H3.3-deposition activity of
ATRX/Daxx cooperates with other well-studied components of heterochromatin
such as the H3K9 methyltransferase SUVH39 and the H3K9me3 binder HP1. The
study of PanNET tumors will yield unprecedented insight into the in vivo
function of the ATRX/Daxx complex. Molecular and structural details of these
proteins will help to mechanistically explain these findings and guide further
experiments in vivo.
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8 Methods
8.1 Molecular Biology
8.1.1 Ligation-independent cloning for E. coli expression
For generation of all expression constructs, ligation-independent cloning (LIC)
strategies were used. LIC vectors for N-terminal GST-His6-TEV (pRUTH2) and
His6-MBP-TEV (pRUTH3) fusions were derived from pMCSG7 (Stols et al., 2007)
and novel LIC site for an N-terminal His6-TEV tag was designed by Dr.
Alexander Ruthenburg in the pET-based pRUTH5 vector (Figure 8.1). 1 µg vector
was linearized at its unique LIC restriction site (SspI for pRUTH2/3, BseRI for
pRUTH5/pRSFDuet-LIC) and purified by agarose gel electrophoresis and gel
extraction (Qiagen). The insert was created by amplifying the coding region of
interest with primers containing the LIC overhangs in a 20-50 µL PCR reaction
(NEB Phusion), followed by a PCR purification column (Qiagen). Long 5'
overhangs for LIC were created by limited 3' resection with T4 Polymerase in the
following reaction:
T4 Pol digest (20-30 min at RT, 10 min at 80°C)
~28 µl vector or insert (column-purified)
0.8 µl of 100 mM dNTP as follows
pRUTH2/3 vector:

dGTP; PCR insert:

pRUTH5/pRSF vector:

dCTP; PCR insert:

dCTP
dGTP
0.3 µl BSA (NEB)
3.3 µl T4 Pol buffer (NEB 2)
1 µl of T4 DNA Polymerase (NEB).
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For transformation, 0.3-1 µL vector was mixed with 1-3 µL insert (both
components at RT) and incubated at RT for 10-20 min. 1 µL of 50 mM EDTA was
added and after 5 min, the mix was transferred onto 25-50 µL competent cells
(Invitrogen BL21(DE3)Star or Rosetta(DE3)pLysS).

Figure 8.1: Ligation-independent cloning strategy for pRUTH5 and pRSFDuet-LIC
(courtesy of Dr. A Ruthenburg)

8.1.2 LIC-compatible coexpression vectors for E. coli
For coexpression in E. coli, I created a pRSF-Duet derivate, transferring the
pRUTH5 LIC site into the first ORF by restriction cloning, yielding pRSFDuetLIC. A bicistronic insert for H3 and H4 expression was generated by 2-step PCR
and cloned into the second ORF of pRSFDuet-LIC via restriction sites, yielding
pRSFDuet-LIC/H4/H3.3. This vector allows expression of a His-tagged protein
in the first ORF with the two untagged histones. Cloning protocol for the LIC site
is analogous to pRUTH5 described above. Both pRSFDuet-LIC and pRSFDuet187

	
  

LIC/H4/H3.3 are further compatible for coexpression with pET-based vectors,
including pMCSG7 and pRUTH2/3.

8.2 Protein analysis
8.2.1 SDS-PAGE
One-dimensional polyacrylamide gel electrophoresis (PAGE) was carried out as
described with either 15% ProtoGel (Molecular Diagnostics, EC-890) (Gallagher,
2006) gels or 4-20% Precast TGX Gels (Bio-Rad 456-1091). Further, proteins were
either transferred onto a PVDF membrane or stained using 0.02% Coomassie G250, 10% Ethanol, 5% Acetic acid.

8.2.2 Protein transfer to PVDF membrane
Proteins were blotted onto a polyvinylidene difluoride (PVDF) membrane with a
Trans-Blot® SD Semi-Dry Transfer Cell system (BioRad 170-3940). Transfer times
of 30 min to 3 hours were used depending on the size of proteins that were to be
transferred.

8.2.3 Western blotting
PVDF Membranes were blocked with 5% fat-free milk in TBS-T (TBS, 0.05%
Tween) under agitated movement on a rocking platform for 60 min. Primary
antibodies were prepared in the respective dilution in 5% non-fat milk in TBS-T.
Membranes were incubated on a rocking platform with primary antibody over
night at 4°C and washed 4 x 5 min with TBS-T. Then, membranes were incubated
with secondary HRP-conjugated antibody 1:2000 in TBS-T for 1 h at RT on a
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rocking platform. Membranes were washed 5 x 5 min with TBS-T before ECL
detection.

8.2.4 Antibodies
Commercial antibodies used in this study were as follows: α-FLAG-HRP
(SIGMA), α-HA-HRP A190-107P (Bethyl), α-HIRA WC119 and WC15 clones
(Peter Scambler), α-HIRA (H300) sc-48774, α-p150 sc-10772 (Santa Cruz), α-Daxx
sc-7152 (Santa Cruz), α-p60 NB500-212 (Novus), α-Cabin1 ab3349 (Abcam), αATRX H-300 (Santa Cruz), α-ASF1a/b 4A1/3 (Santa Cruz), α-HDAC1 2E10 #05614 (Millipore).
Commercial histone (modification) antibodies: α-H3 ab1791 (Abcam), α-H3K9Ac
#07-352 (Millipore), α-acetyl-H4 #06-598 (Millipore), α-H4K5Ac #06-759
(Millipore).
For ECL detections, Goat Anti-Rabbit IgG (H+L)-HRP Conjugate (BioRad #1721019) and Goat Anti-Mouse IgG (H+L)-HRP Conjugate (BioRad #172-1011) were
used.

8.2.5 ECL Detection
Immunoblotted bands were visualized by enhanced chemiluminescent (ECL)
detection (Amersham) as described in the manufacturer’s handbook. Incremental
luminescent images were recorded with a CCD camera (Fujifilm LAS-3000).
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8.3 Cell culture
8.3.1 Mammalian cell culture
293T cells were grown in DMEM supplemented with 10% FBS, 1x
Penicillin/Streptomycin (Invitrogen 15140-122) at 37˚C, 5% CO2 and 100%
Humidity. Murine embryonic stem cells (ESCs) were cultured on gelatin (flasks
precoated with 0.1% Gelatin/PBS and dried) in KO DMEM (Invitrogen 10829018) supplemented with 15% ES-grade FBS (Gibco 10439-024), 2 mM LGlutamine

(Gibco

25030-081),

0.1

µM

2-mercaptoethanol,

1x

Penicillin/Streptomycin (Invitrogen 15140-122) and LIF (homemade) at 37˚C and
5% CO2.

8.3.2 Insect cell culture
Sf9 cells were grown in Grace’s Insect Cell Medium (Invitrogen 11605-102)
supplemented with 1x Penicillin/Streptomycin (Invitrogen 15140-122) in a
humidified 30˚C incubator. For large-scale expression, Sf9 cells were grown in
baffled 0.5-2L flasks shaking at 80 rpm at 30˚C.

8.4 Recombinant protein production
8.4.1 Recombinant histones
Individual histones were expressed and purified as described in the point-bypoint

protocol

in

Appendix

9.3.

Equimolar

ratios

of

H3/H4

or

H3/H4/H2A/H2B were mixed in refolding buffer (4 M Guanidine, 50 mM
MOPS pH 7, 2 M NaCl, 5 mM EDTA, 15% Glycerol) to reconstitute histone
tetramers or octamers, respectively. Tetramers were dialyzed against 500 mM
190

	
  

NaCl, Octamers against 2 M NaCl, MOPS pH 7, 1 mM EDTA. Octamers were
purified on a Superdex 200 gel filtration column.

8.4.2 GST-Fusion proteins
GST-Fusion

proteins

were

expressed

from

pRUTH2

plasmids

in

Rosetta(DE3)pLysS cells in either LB or TBA (Appendix 9.3) medium at 20˚C
overnight. The cells were lysed in 50 mM Tris pH 7.5, 500 mM NaCl, 1 mM
EDTA, 5 mM DTT, 0.8 mM PMSF in an EmulsiFlex-C5 (Avestin) and spun for
30 min at 30 000 g. Soluble fusion proteins were bound to Glutathion Sepharose
(Amersham), washed with 20 mM Tris pH 7.5, 1 M NaCl, 1 mM EDTA, 5 mM
DTT. GST fusion protein eluted in 20 mM Tris pH 7.5, 25 mM Glutathione, 500
mM NaCl, 0.5 mM EDTA, 5 mM DTT (prepared fresh and titrated).

8.4.3 Recombinant Daxx-H3.3-H4 complex
For coexpression of Daxx and histones H3.3-H4, the full ORF of Daxx was cloned
into pRSFDuet-LIC/H3.3/H4 to yield pRSFDuet-Daxx/H3.3/H4. The vector
encodes a N-terminal His-tag for Daxx, whereas H3.3 and H4 are untagged. This
construct was transformed into Rosetta(DE3)pLysS. The complex was expressed
in TBA (Appendix 9.3) medium at 20˚C overnight. The cells were lysed in 50 mM
Tris pH 7.5, 500 mM NaCl, 10 mM 2-mercaptoethanol, 0.8 mM PMSF in an
EmulsiFlex-C5 (Avestin). Lysate was cleared by centrifugation for 30 min at 30
000 g. Supernatant was bound to Ni-NTA resin (Qiagen). Resin was washed with
20 CV lysis buffer and bound complex was eluted with 50 mM Tris pH 7.5, 500
mM NaCl, 250 mM Imidazol.
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For subsequent cation exchange chromatography on a Mono S 5/50 GL column
(Amersham), eluate was diluted 1:5 with 50 mM Tris pH 7.5 and filtered through
a 0.45 µm filter immediately before loading onto the column. Bound proteins
were eluted with a gradient of 100 mM – 2 M NaCl in the same buffer.

8.4.4 Recombinant DaxxHBD-H3.3-H4 complex for crystallography
Various DaxxHBD constructs were cloned into the pRUTH5 or pRSFDuet-LIC
vectors for N-terminal His6-TEV tag. Proteins were expressed in inclusion bodies
for 4-6 hours at 37˚C in TBA and purified as described in the point-by-point
protocol in Appendix 9.3. Equimolar ratios of DaxxHBD, H3 and H4 were mixed
in refolding buffer (4 M Guanidine, 50 mM MOPS pH 7, 2 M NaCl, 5 mM EDTA,
15% Glycerol) to reconstitute the DaxxHBD-H3.3-H4 complex. The mixture was
renatured by dialysis against 50 mM MOPS pH 7, 1 M NaCl, 1 mM EDTA, 10%
Glycerol. After 24-48 hours, insoluble precipitate was removed by centrifugation
(30 min at 30 000 g) or filtering through a 0.45 µm filter. Soluble complex
concentration (Amicon Ultra, Millipore) was determined by measuring the
absorption at 280 nm against dialysis buffer on a Nanodrop 2000 (Thermo
Scientific) using the extinction coefficient calculated by ProtPram. Recombinant
TEV protease was added to the complex in a 1:100 mass ratio to cleave the His6tag. If cleavage did not proceed to completion after 6 hours at 4˚C, another 1:100
(w/w) aliquot of TEV was added followed by incubation for 6 hours at 10˚C.
Complex was then concentrated to 10-20 mg/mL and applied to a size exclusion
chromatography column (16/60 or GL 10/300 Superdex 200 for more or less than
5 mg total protein, respectively. The size exclusion column was equilibrated and
run in crystal screening buffer (10 mM MOPS pH 7, 500 mM NaCl, 0.1 mM
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EDTA, 0.1 mM PMSF, 5 mM DTT or 1 mM TCEP) DaxxHBD-H3.3-H4 peak
fractions were pooled and concentrated (Amicon Ultra, Millipore).

8.4.5 Recombinant full-length Daxx and ATRX–Daxx
Full length human ATRX (isoform 2) and full length human Daxx were cloned
into pFastbac1. ATRX was cloned with a C-terminal FLAG epitope, and Daxx
was cloned with an N-terminal FLAG epitope. Sf9 cells were used to generate
recombinant ATRX–Daxx complex and Daxx. Proteins were purified on M2
agarose followed by SMART Mono Q and Superdex 200 chromatography.

8.5 Crystallography
8.5.1 Commercial and custom 96-well screens
Commercial screens were manually set up in 2 mL deep well blocks. Screens
used in this study were
Qiagen JCSG+ Suite (130720), Qiagen PACT Suite (130718),
Qiagen JCSG Core I-IV Suites (130924, 130925, 130926,
130927), Qiagen pHClear (130709), Qiagen Anions
(130707), Qiagen Cations (130708),
Hampton SaltRx (HR2-107 + HR2-109), Hampton Index
(HR2-144), Hampton Crystal Screen (HR2-110 + HR2-112)

For custom screens, a liquid handling robot (Formulator, Formulatrix) was used
to set up 2 mL deep well blocks or 80 µL well solutions directly in a screening
plate.

8.5.2 Robotic setup for sitting drops vapor diffusion
96-well format sitting drops were set up on MRC 2 Well Crystallization Plates
(Swissci) using a mosquito® liquid handling robot (TTP Labtech). 80 µL
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precipitant solution was transferred to each well using a multichannel pipette. In
primary screens one or two drops were set up with 0.15 µL protein + 0.15 µL well
solution. Volumes for refinement screens were increased to 0.25 µL protein + 0.25
µL well.

8.5.3 Hanging drop vapor diffusion setup
Hanging drops were set up in 24-well EasyXtal plates (Qiagen), using 0.5 – 2 µL
of protein and well solutions.

8.5.4 Cryocrystallography and X-ray data acquisition
Crystal cryoprotection conditions were optimized by raising the precipitant
concentration or adding 15-20% glycerol compared to the original well solution
or mother liquor composition. Cryoprotection solutions were tested for the
appearance of salt rings in the x-ray diffraction of a flash-frozen drop. Crystals
were harvested from sitting or hanging drop and equilibrated in cryoprotection
solution for 1 minute before flash freezing in liquid nitrogen or directly in the
cryostream. Crystal quality was assessed on a Rigaku HighFlux HomeLab x-ray
diffraction system.

8.5.5 Dynamic and Multiangle Light Scattering
Dynamic light scattering (DLS) of protein solutions were measured in a 10 µL
cuvette in a DynaPro instrument (Wyatt).
Multiangle light scattering (MALS) was measured in line with a HPLC sizeexclusion column setup (SEC-MALS). A DAWN® HELEOS™ DLS (Wyatt)
instrument was directly connected to an Agilent 1100 HPLC system equipped
with a Superdex 200 GL 10/300 column (Amersham). 100 µL of sample (5
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mg/mL) was injected and DLS signals recorded for 25 mL at 0.5 mL/min flow
rate.

8.5.6 Reversed-phase analysis of complex
The complex was dialyzed against 0.1% acetic acid, 5 mM 2-mercaptoethanol and
lyophilized before loading on the reversed phase column. A C8 column (220 x 4.6
mm Aquapore RP-300 (PerkinElmer) was used on an Beckman Coulter System
Gold 126 HPLC system. A linear gradient of 30-70% B (solvent A: 5% acetonitrile,
0.1% trifluoroacetic acid; solvent B: 90% acetonitrile, 0.1% trifluoroacetic acid)
was applied over 30 min at 1.0 ml/ min flow-rate.

8.6 Biochemical purification of native complexes
8.6.1 Double-affinity purification from nuclear extracts
Nuclear extract was prepared from 2x109 cells (Dignam et al., 1983) and diluted
to 150 mM KCl. The first immunoprecipitation was carried out with 300 µl antiFlag resin (Sigma A2220) for 4h at 4ºC. The resin was transferred to a disposable
column, washed with 30 volumes of wash buffer (20 mM Hepes•HCl pH7.9, 750
mM NaCl, 0.2 mM EDTA , 5 mM 2-mercaptoethanol, 10% Glycerol, 0.01% NP-40,
0.4 mM PMSF) by gravity flow. Histone complexes were eluted in Flag-elution
buffer (0.25 mg/mL Flag3 peptide, 20 mM Hepes•HCl pH7.9, 150 mM NaCl, 0.2
mM EDTA, 5 mM 2-mercaptoethanol, 10% Glycerol, 0.01% NP-40, 0.4 mM PMSF)
and incubated with 50 µL goat anti-HA agarose (Bethyl 190-107) for 4h at 4ºC.
The immunoprecipitated material was washed with 10 volumes wash buffer (see
above, 1 M NaCl) and eluted in 50uL 20 mM Glycine pH2.5, 150 mM NaCl.
Samples were subsequently run on a SDS PAGE.
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8.6.2 Affinity-purification of H3.3 complexes from murine ESCs
Nuclear extracts were prepared as described (Lewis et al., 2010) from murine
ESCs (Goldberg et al., 2010 2010). Immunoprecipitations were carried out in 20
mM Hepes•HCl pH7.5, 150 mM NaCl, 10% Glycerol, 0.2 mM EDTA, 2 mM
MgCl2 in the presence of DNAse and RNAse, washed 5x with wash buffer (20
mM Hepes•HCl pH7.5, 250 mM NaCl, 10% Glycerol, 0.2 mM EDTA, 0.01% NP40) and either eluted with FLAG peptide or 1% SDS. Eluted material was
separated by SDS PAGE and analyzed by western blotting.

8.6.3 Transient transfection and pulldown from 293T cells
A pTRIP vector (containing lentiviral integration sites and large T antigen
replication origin for episomal propagation) containing the H3.2 or H3.3 gene
with C-terminal Flag-HA-tag (courtesy of Dr. Beth Duncan) were used. Point
mutations were introduced using the AccuPrimer Pfx Polymerase Mastermix
(Invitrogen) with mutagenic complementary primers as used in standard
QuikChange™

reactions

(designed

with

PrimerX,

http://www.bioinformatics.org/primerx).
For transfection, 293T cells were seeded in 6-well plates at 2x105 cell/well. After
12-24 hours, cell were transfected with 2.5 µg plasmid with Transit LT1 reagent
(Mirus) according to the manufacturers manual. Cell were harvested after 48
hours by scraping and tituration in warm DMEM medium and pelleted. Cell
pellet was washed with PBS and subsequently with hypotonic buffer (15 mM
HEPES pH7.5, 30 mM KCl, 5 mM MgCl2). For lysis, cell pellet was resuspended
in 250 µL hypotonic buffer supplemented with 0.02% NonidentP-40, 0.8 mM
PMSF, 1x EDTA-free Protease Inhibitor Cocktail (Roche), 10 µg/mL RNAse I.
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Lysis was allowed to proceed for 15 with rotation at 4˚C. 22 µL 5 M NaCl was
added (final 400 mM NaCl) under agitation to extract nuclear proteins. Extract
was rotated for 15 min at 4˚C and spun 30 min at 4˚C at 20 000 g. Supernatant
was diluted with 300 µL hypotonic buffer and was incubated with 25 µL AntiHA Affinity Gel (SigmaAldrich E6779) for 4 hours at 4˚C. Beads were washed 2x
5 minutes with hypotonic buffer + 250 mM NaCl. Bound proteins were eluted
with 1x laemmli SDS sample buffer (63 mM TrisHCl pH 6.8, 10% Glycerol, 2%
SDS). DTT was added to eluate to 1% before boiling and running on an SDS
PAGE.

8.7 In vitro binding and functional assays
8.7.1 GST-Pulldown assays
10 µg of histone tetramer was mixed with 10 µg GST fusion proteins in binding
buffer (20 mM Hepes•HCl pH7.5, 200 mM NaCl, 0.1% (w/v) BSA, 5 mM 2mercaptoethanol, 0.01% NP-40, 10% Glycerol) and incubated for 30 min at 4ºC.
25 µL Glutathione Sepharose 4B resin (GE) were added an rotated for 30 min.
The resin was washed 3x with 1 mL W500 (20 mM Hepes•HCl pH7.5, 500 mM
NaCl, 5 mM 2-mercaptoethanol, 0.1% NP-40, 10% Glycerol), 3x 1 mL W200 and
eluted in 20 mM Hepes•HCl pH7.5, 200 mM NaCl, 30 mM Glutathione.

8.7.2 Peptide pulldown
An excess of N-biotinylated peptide was bound to 20 uL High Capacity
Streptavidin Agarose (Pierce). The resin was washed extensively with PBS and
binding buffer (20 mM Hepes•HCl pH7.5, 200 mM NaCl, 0.1% (w/v) BSA, 5 mM
2-mercaptoethanol, 0.01% NP-40, 10% Glycerol). 10 µg of recombinant Daxx was
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incubated in 500 µL binding buffer with 20 uL resin for 4 h at 4ºC. The resin was
washed 6x 5 min with wash buffer (20 mM Hepes•HCl pH7.5, 200 mM NaCl,
5 mM 2-mercaptoethanol, 0.01% NP-40, 10% Glycerol). Peptide and bound
protein were eluted in 1x SDS Loading Buffer and separated on a 10-20% Tricine
gel (Invitrogen). Proteins were transferred onto a PVDF membrane and stained
with Colloidal Gold Total Protein Stain (Bio-Rad).

8.7.3 Cystein chemical crosslinking
Bismaleimidoethane (BMOE, Pierce 22323) and 1,4-Bismaleimidobutane (BMB,
Pierce 22331) were dissolved at 20 mM concentration in DMSO. In each reaction,
10 µM H3.3-H4 dimers or DaxxHBD-H3.3-H4 trimeric complex were present in
100 µl reaction volume. The reaction buffer was 20 mM MOPS pH7, 150 mM
NaCl, 1 mM EDTA, 0.5 mM TCEP. BMOE or BMB was rapidly added from stock
solution to a final of 20, 50 or 100 µM concentration. Reactions were incubated for
30 min at room temperature, and stopped by adding 6x laemmli sample buffer
including 1% DTT, boiled and run on a SDS PAGE.

8.7.4 Copper(II)-based oxidation of disulfide bonds
A 100 mM Cu(II)-Phenanthroline3 (CuP) solution was made from CuCl2 and
three molar equivalents of 1,10-Phenanthroline (Sigma 131377). H3.3-H4 dimers
or DaxxHBD-H3.3-H4 trimeric complex were reduced with 50 µM TCEP and
diluted at least 1:10 to 10 µM in the final reaction buffer (20 mM MOPS pH7, 150
mM NaCl). 0.1 mM CuP was added and the reaction was incubated for 30 min at
4˚C. 6x laemmli sample buffer without reducing agents was added and sampled
were loaded on an SDS PAGE without boiling.
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8.7.5 Plasmid supercoiling assay
Histones and histone chaperones were mixed and incubated on ice for 30 min in
20 µL assembly buffer AB1 (10 mM HEPES pH 7.5, 40 mM KCl, 60 mM NaCl, 2
mM MgCl2, 0.5 mM EGTA). 300 ng pBluescript II KS+ was prerelaxed with
recombinant human topoisomerase I (Promega) in 10 µL AB1 for 90 min at 37ºC
and added to the protein mix followed by 90 min incubation at 37ºC. The
assembly reaction was stopped by addition of 0.5 µg Proteinase K and 0.3% SDS
final and subsequent incubation for 10 min at 55ºC. 150 ng of purified plasmid
was run on a 1.2% Agarose gel in either 1x TAE or 1x TPE, 25 µg/mL
Chloroquine for 10h at 3V/cm. Gels were stained with SYBR Gold (Invitrogen)

8.7.6 Mononucleosome assembly assay
Recombinant Daxx-H3.3/H4 complex was reconstituted and purified from free
histones by ion exchange chromatography. 50-200 µg Daxx-H3.3/H4 was mixed
with 100 ng DNA in 20uL assembly buffer AB1. Reaction was incubated 30 min
at room temperature and analyzed on a 6% PAGE in 0.5x TBE. Gel was stained
with SYBR Gold, subsequently transferred onto a PVDF membrane and probed
for H3 by standard western blotting procedures.

8.7.7 Mononucleosome assembly for remodeling assay
Equimolar amounts of H3.3 histone octamer and a 194 bp PCR product
containing the 601 positioning sequence (1) were mixed in R2000 (20 mM Tris
pH7.5, 2 M NaCl, 1 mM EDTA, 10% Glycerol, 1 mM DTT, 0.4 mM PMSF) and
dialyzed against 100 mL R2000 diluted with 900 mL R0 (20 mM Tris pH7.5, 0 M
NaCl, 1 mM EDTA, 10% Glycerol, 1 mM DTT, 0.4 mM PMSF) gradually over 24
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h. Mononucleosomes were further dialyzed against R50 and stored at 4 °C with
1× Protease Inhibitor Cocktail (Roche). Mononucleosome mobilization assays
were performed by adding ATRX-Daxx (150 ng) or ACF (50 ng) to the assembled
194 bp (200 ng) template with ATP. Reactions were performed at 37C for the time
indicated. Reactions were quenched with a Stop solution (12% sucrose, 5 mM
EDTA, 0.5 µg dA⁄dT). Reactions were analyzed by native 5% acrylamide, 0.5×
TBE at 4 C.

8.7.8 Plasmid histone deposition assay
Sf9 cells were infected with baculoviruses encoding for human Daxx–FLAG and
human ATRX– FLAG. Proteins were purified by M2 affinity chromatography
and loaded onto a SMART Superdex 200. Fractions containing ATRX–Daxx
complex were pooled and mixed with either H3.1/ H4 or H3.3/H4 tetramer.
Daxx-mediated histone deposition assays: Daxx (9 µg) and H3.1/H4 or H3.3/H4
(550 ng) tetramers, and ATRX–Daxx (2 µg) with H2A/H2B (550 ng) dimers were
slowly added to the reaction mixture during the 30˚C incubation (0.1 µg × 5
points during 4 hr incubation).
NAP1 (7.5 µg) and H3.1/H4 or H3.3/H4 tetramers (550 ng) were mixed together.
ATP (3.25 mM), MgCl2 (4.6 mM), phosphocreatine (30 mM), creatine
phosphokinase (2.5 ng), ACF (0.5 µg) and a circularized PCR fragment from
pG5ML (1 µg) were subsequently added to the reaction. The reaction was
incubated at 30˚C for four hours. H2A/H2B (550 ng) were added to the reaction
during incubation.
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8.7.9 ChIP and DNA dot blot
Crosslinking ChIP was performed as described (2). Daxx (M-112, sc-7152) and
Atrx (H-300, sc-15408) antibodies were obtained from Santa Cruz Biotechnology,
Hira antibody (ab20655) from Abcam. To examine telomere enrichment, ChIP
and input DNA from 129⁄SvEv, Daxx-/-, Atrxflox and Atrx-/- ESCs were blotted
with Minifold-I Dot-Blot System (Schleicher & Schuell). Blotting membrane was
probed with a TTAGGG repeat probe or BamHI repeat probe as described (3).

8.8 Bioinformatics
8.8.1 Homology Modeling
Homology Modeling was carried out using a local installation of Rosetta 3.3
(http://www.rosettacommons.org/). The Backrub module was used with
following parameters:
-backrub:ntrials 50000
-resfile resfiles/mutations.resfile
-nstruct 5
-initial_pack

PDB files were prepared with PyMol (http://www.pymol.org/) The residue file
mutations.refile contained a list of all residues in the chains to mutate with
wither the NATAA flag to keep the original residue or the PIKAA flag followed
by the new amino acid (1 letter code) in the following format:
NATRO
start
ResNumber Chain NATAA
ResNumber Chain PIKAA AminoAcid

201

	
  

8.8.2 ChIP-Seq analysis
ChIP-Seq data was essentially processed as described {Ruthenburg, 2011}. Reads
were mapped with Bowtie (http://bowtie-bio.sourceforge.net/). Bam files were
sorted

and

cleaned

of

PCR

duplicates

with

Picard

(http://picard.sourceforge.net/). Continuous wiggle profiles were created using
IGVTools

(http://www.broadinstitute.org/igv/igvtools)

count

function

extending reads to the 150bp average fragment length. Wiggle files were
normalized to 50 Mio reads with a perl script:
#!/usr/bin/perl –w
open(IN,"$ARGV[1]");
open(OUT,">$ARGV[2]");
while(<IN>) {
if (/^\d+/){
chomp;
@_=split;
printf OUT "%d\t%.4f\n",$_[0],$_[1]/$ARGV[0];
}
else{
print OUT $_;
}
}

To

create

tracks

for

IGV

(http://www.broadinstitute.org/igv/home)

visualization, normalized wig files were tiled with igvtools tile command.
Normalized wig files were also used for accumulation plots with the Cisregulatory

element

annotation

system

(CEAS,

http://liulab.dfci.harvard.edu/CEAS/). Cumulative and ratio tracks were
created from wig files by concatenating columns in an interval file (wigBed)
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through the cistrome online analysis portal (http://cistrome.org/ap/) and
afterwards converted back to wig with the following unix shell script:
#!/bin/sh
SPAN=$3
S=$1
R=$2
rm -f ${R}
head -45 ${S} | egrep "^browser|^track" > ${R}
#grep "^chr" ${S} | cut -f1 | sort -u > chr.list
cat chr.list | while read C
do
echo "variableStep chrom=${C} span=${SPAN}" >> ${R}
awk '{if (match($1,"^'"${C}"'$")) { print } }' ${S} | sort -k2n awk
'
{
printf "%d\t%g\n", $2+1, $8/$5
}
' >> ${R}
done

For repeat analysis, nonmapped reads were extracted from bam files with
bam2fastq

(http://www.hudsonalpha.org/gsl/software/bam2fastq.php).

Occurrences of the repeat sequences were counted with the unix grep –c
command.

8.8.3 Other bioinformatic software packages/online services
Extinction coefficient and pI

http://web.expasy.org/protparam/

Secondary structure prediction

http://www.compbio.dundee.ac.uk/www-jpred/

Protein charge plot

http://mobyle.pasteur.fr/

Protein alignments

http://www.jalview.org/

DNA alignments/HYLIP

http://ugene.unipro.ru/

Maximum Likelihood Parsimony

http://mobyle.pasteur.fr/

203

	
  

9 Appendix
9.1 Mass Spectrometry of native Daxx-H3.3-H4 complex

Figure 9.1: MS/MS identification of proteins associated with the Daxx-H3.3-H4
predeposition complex.
Daxx complex purification as described in Figure 5.2. FLAG-tagged H3.3 (e-H3.3) was
immunoprecipitated from the high salt fraction of the heparin gradient (see Section
5.3.1). The methyltransferase complex G9a/GLP was found in the H3.3-associated
material.

9.2 Biochemical characterization of the HIRA complex
HIRA shares homology with the S. cerevisiae Hir1 (N-terminal betapropeller) and Hir2 (C-terminal Tup1-like domain) proteins. As Hir1 and Hir2
participate in a quaternary complex with Hir3 and Hpc2, it is likely that HIRA
forms a complex as well. By sequence homology to Hir3 and Hpc2, Cabin1 and
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Ubinuclein-1 (UBN1), respectively, are likely candidates (Balaji et al., 2009) and
both proteins have been described to interact with HIRA (Banumathy et al., 2009;
Tagami et al., 2004). However, the putative HIRA complex has not been
empirically defined. Therefore, an affinity purification of the HIRA complex
from HeLa cells was carried out with subsequent Mass Spectrometric analysis.
A mixture of two monoclonal α-HIRA antibodies (WC119 and WC15) was
immobilized on a 1 mL Protein G Sepharose column with DMP. HIRA and
associated proteins were coimmunoprecipitated from HeLa nuclear extracts
(20 mL, from 6L HeLa cells). Nuclear extracts (100 mM NaCl, 25 mM HEPES
pH7.9) were first run over an empty Protein G Sepharose column (negative
control) and then over the α -HIRA column with subsequent extensive washing
(Figure 9.2A). Loosely bound proteins were dissociated with a NaCl gradient
(100-500 mM). HIRA and strongly associated proteins were eluted at low pH
(100 mM Glycine pH2.5). Aliquots of a-HIRA washes and elution, as well as the
control Protein G elution, were separated by SDS PAGE and analyzed by tryptic
digestion and MS/MS fingerprinting (Figure 9.2B). Selected tandem mass
spectrometry data were confirmed western blots (Figure 9.2C). Complete
complexes represented by significant peptides of all subunits in the MS/MS data
are shown in Figure 9.2D.
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Figure 9.2: HIRA complex coimmunoprecipitation from HeLa nuclear extract.
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The total length of each lane from the SDS PAGE in Figure 9.2B was
divided into 10 segments that were analyzed separately by tryptic digest and
tandem mass spectrometry. Peptides were matched with the human proteome
database by the MASCOT search engine. Hits were further analyzed individually
by the following criteria:
- Proteins with less then three matching peptides were discarded
- The molecular weights of each identified protein was verified against the
SDS PAGE segment it was identified in. Only proteins within a reasonable
molecular weight range were further analyzed.
- Proteins that were also identified in the eluate of the Protein G column
(negative control) were disregarded.
Known interactions of candidate proteins were retrieved from databases
(BioGRID, STRING) to identify known complexes the might interact with HIRA
By the criteria above, the most significant 50 proteins identified in the 500 mM
wash fraction and the pH 2.5 elution are listed in Figure 9.3.

The remaining eluate from the α-HIRA affinity column was subjected to
further fractionation by ion exchange chromatography (Figure 9.4B) and gel
filtration (Figure 9.4C). Not the separation of a higher migrating species of HIRA
on both columns that does not correlate with the remaining complex members. I
speculate that it is a cell cycle-dependent hyperphosphorylated form of HIRA
(Hall et al., 2001). The phosphorylated form does no longer interact with the
other complex members, which explains why it is no longer localized to
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chromosomes (Hall et al., 2001). The remaining proteins could stay as a complex
on chromatin and define genomic HIRA binding sites.
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Figure 9.3: Mass spectrometry of HIRA complex and associated proteins.
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Figure 9.4: Biochemical fractionation of the HIRA complex.
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9.3 A simple method for purifying recombinant histones‡
9.3.1 Introduction
Purified recombinant histones expressed in E. Coli, and nucleosomes
assembled with them, have proven to be extraordinarily powerful reagents for
studying chromatin biology and biochemistry. The production of purified
recombinant histones was an essential prerequisite to high-resolution crystal
structures of the nucleosome core particle (Davey et al., 2002; Luger et al., 1997),
as well as crucial reagents in landmark histone modification enzyme (Wang et
al., 2001) and chromatin remodelling biochemistry (Hamiche et al., 2001).
Although much has been gained from the reductionist approach employing
histone peptides as surrogates for full-length histones in their native contexts,
there are countless examples of chromatin modification activities that require
full-length histones, chaperone-complexes, nucleosomes, or nucleosomal arrays.
The explosion of interest in epigenetics and chromatin biology has drawn
laboratories outside of the field into working with histone and nucleosome
reagents. Here we report improved methods for preparation of purified
recombinant core histones of S. cerevisiae, X. Laevis, and H. sapiens in E. coli, and
modest simplifications of the nucleosome assembly process to make this protocol
more accessible to non-specialists.
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The chromatin field has a checkered history of mismatching the organism
from which a given protein or complex is derived with the source of recombinant
histones employed—indeed the source of histones in many cases is still the
original Xenopus laevis histone constructs. Although amenable to large-scale
protein production necessitated by crystallographic material demands, this
protocol requires both HPLC and FPLC instruments and columns and yields
protein of only modest purity. Indeed this histone preparation may co-purify
with unwanted nucleic acid and minor protein impurities from the E. coli
expression host, and the use of 7 M urea in the course of this purification, even
when freshly deionized, may lead to protein carbamylation adducts. Extreme
care must be taken to avoid protein carbamylation that occurs as urea containing
buffers spontaneously decompose into ammonium cyanate, which in turn, reacts
with the amino terminus and lysine residues of histones.

A salient improvement on this procedure in terms of technical ease was
afforded by Tanaka and colleagues, by expression of the human core histones as
protease cleavable hexahistidine fusion proteins (Tanaka et al., 2004). However,
significant drawbacks to this approach remain: as this preparation continues the
use of urea, the potential carbamylation issue was not resolved, more
importantly, the cleaved purified histones retain additional vector encoded
amino acid “scars” and thereby differ at the N-terminus relative to native
histones. A number of recognition modules appear to recognize the N-terminus
itself (Ruthenburg et al., 2007), consequently, these additional amino acids may
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compromise the utility of these histones in termini-sensitive downstream
applications.

The expression and purification conditions described here were designed
to circumvent the above conditions and allow scalable and streamlined
production of all four core histones from various species. We make use of a series
of pET-based vectors that encode a cleavable N-terminal His-tag. The use of TEV
and R3C protease sites allows site-specific processing to yield a scarless, native
N-terminus for all major histone species.
As in previous described methods, we purify histones from inclusion
bodies. Thorough wash conditions help to remove nucleic acids and
proteinacious impurities from the histone pellet. A subsequent nickel-affinity
purification step in 6 M Guanidine hydrochloride yields pure and concentrated
denatured histone. We provide alternate protocols for direct octamer assembly
from those histones with subsequent tag cleavage, or individual processing.
Either method yields highly pure, native histone octamers that can be used for
nucleosome assembly. We also describe optimized workflows to produce H3-H4
tetramers and H2A-H2B dimers.

9.3.2 Reagent Setup
Terrific Broth Autoinduction Medium (TBA)
Make a 50x Autoinduction Stock '5052' by dissolving 250 g glycerol, 25 g glucose
and 100 g a-lactose in 1L ddH2O. Sterile filter solution. Autoclave a 1x TBsolution (12 g Tryptone, 24 g Yeast extract, no glycerol). Add 20 mL '5052' per
liter autoclaved TB- just before inoculation. Add 1 mL of kanamycin stock
(mg/mL) per liter TBA. Add a single drop of Antifoam A concentrate (viscous
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solution, mix well before pipetting and use 1 mL pipette tip) to avoid excessive
foam formation during shaking.

Resuspension buffer (R)
Make a solution containing 50 mM Tris•HCl pH 8, 5 mM EDTA. Add 0.8 mM
PMSF to prechilled buffer R just before use. You will need 40 mL per 1L culture.

Lysis Buffer (LW)
Make a solution containing 50 mM Tris•HCl pH 8, 250 mM NaCl, 5 mM MgCl2.
You will need 40 mL lysis buffer per 1L culture. Add 0.8 mM PMSF to prechilled
buffer L just before use.

Inclusion Body Wash Buffer (IW)
Make a solution containing 50 mM Tris⋅HCl pH 8, 250 mM NaCl You will need
~100 mL buffer IW per 1L TBA culture. Add 0.8 mM PMSF to prechilled buffer
IW just before use.

10% (w/v) Triton X-100 Stock solution
Weigh in 5 g Triton X-100 detergent in a 50 mL Falcon Tube, add ddH2O to
50 mL, mix by slow rotation at room temperature. Store protected from light.

Denaturing Buffer DB
Always make a fresh solution of this buffer, containing 50 mM Tris•HCl pH 8.0,
500 mM NaCl, 6.3 M Guanidine•HCl, 5 mM 2-mercaptoethanol. As proteins are
efficiently unfolded in this buffer, protease inhibitors are now obsolete.
To make 100 mL of D500 buffer, weigh in 60 g Guanidine•HCl in a beaker. Add
5 mL of 1 M Tris•HCl pH 8.0 and 10 mL of 5 M NaCl. Add water to 80 mL total
volume and stir at room temperature until Guanidine is fully dissolved. Use pH
meter do check that pH is between 7.6 and 8.0. There are batch-to-batch
variations in residual HCl in various commercial Guanidine•HCl that are often
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sufficient to perturb the final pH - adjust with concentrated HCl or NaOH if
necessary. Add ddH2O to 100 mL and 35uL 2-mercaptoethanol.

Denaturing Wash Buffer DWB
Always make a fresh solution of this buffer, containing 50 mM Tris•HCl pH 8.0,
1 M NaCl, 4.2 M Guanidine•HCl, 5 mM 2-mercaptoethanol, as described above.

Denaturing Elution Buffer DEB
Always make a fresh solution of this buffer, containing 50 mM Tris•HCl pH 8.0,
1 M NaCl, 4.2 M Guanidine•HCl, 300 mM imidazole, 5 mM 2-mercaptoethanol,
as described above.

Octamer refolding buffer ORB
Make a 20 mM Tris pH 8, 2 M NaCl, 1 mM EDTA solution.
Supplement with fresh reagents to: 10 mM 2-mercaptoethanol, 1 mM PMSF

Tetramer refolding buffer TRB
20 mM Tris pH 6.5, 500 mM NaCl, 1 mM EDTA, 10% (v/v) glycerol
Supplement with fresh reagents to: 10 mM 2-mercaptoethanol, 1 mM PMSF
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9.3.3 Procedure

Schematic of general procedure for purifying individual histones

Expression of histones  TIMING 1 d
1) Inoculate 5-50 mL overnight culture in LB from fresh transformation plate.
2) Inoculate 1 L TBA expression culture with 5 mL volume of the dense LB
culture. Shake at 37 ˚C until the culture reaches OD600 ~0.7. Add 1 mL IPTG
Stock solution. Shake for another 4-6 hours at 37 ˚C.
3) Harvest cells by spinning down TBA culture 15 min at 4000 rpm.
4) Resuspend pellet in 30-40 mL resuspension buffer R, transfer to 50 mL Falcon
tube and spin down for 15 min at 4000rpm. Discard supernatant (can be turbid).
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5) If not immediately proceeding to lysis, resuspend pellet in 5 mL lysis buffer,
divide into two 50 mL Falcon tubes and flash-freeze in liquid nitrogen. Store at 80˚C. PAUSE POINT

Bacterial lysis with emulsiflex (1+ liters culture)  TIMING 1h
6) Resuspend fresh or frozen cell pellet in buffer L (freshly supplemented with
0.8 mM PMSF, final volume 40 mL per 1 L culture)
7) Run bacterial suspension twice through Emulsiflex or French press. If lysate
remains viscous, repeat. High inclusion body content should look milky or
opaque but not viscous. ‘Residual sample viscosity signifies either incomplete
lysis or a significant unsheared genomic DNA in the sample— both pitfalls will
impinge upon downstream processing.

Inclusion Body Purification  TIMING 3 h
CRITICAL STEP Glass beads will greatly facilitate resuspension of the
inclusion body pellet and allow efficient washing steps.
8) Add ~1 mL glass beads (0.5-1 mm diameter) to each 50 mL tube of lysate.
9) Centrifuge the lysate (15 min x 15,000 g, 4°C) in oak ridge SS-34 centrifuge
tubes, or others rated to 30,000 g with screw caps—one tube per liter of original
culture volume greatly facilitates resuspension and downstream processing.
10) Set aside supernatant lysate, histones will pellet quantitatively in the
inclusion bodies. You should recover a rubbery to brittle pellet.
11) Add 5 mL of LW, supplemented with 1% Triton X-100 and 0.8 mM PMSF.
Resuspend inclusion bodies by vigorous vortexing.
12) Add another 30 mL of LW to inclusion body suspension, rotate for 10 min at
4°C.
13) Pellet the inclusion bodies (15 min x 15,000 g, 4°C).
14) Add 5 mL of IW, supplemented with 0.8 mM PMSF. Resuspend inclusion
bodies by vigorous vortexing.
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15) Add another 30 mL of IW to inclusion body suspension, rotate for 10 min at
4°C.
16) Pellet the inclusion bodies (15 min x 15,000 g, 4°C).
PAUSE POINT Inclusion body pellet can be transferred to 50 mL Falcon Tube
before last spin, pelleted by centrifugation for 30 min x 4000rpm, flash-frozen in
liquid nitrogen and stored indefinitely at -80°C.

ALTERNATE PROTOCOL: Autoinduction and enzymatic lysis for small-scale,
parallel expression (1L or less)  TIMING overnight + 4 hours
1) Inoculate 5-50 mL TBA from fresh transformation plate (evening).
2) Shake at 37 ˚C overnight.
3) Harvest cells by spinning down TBA culture 10 min at 4000 rpm in 50 mL
Falcon tubes.

Example of autoinduction expression of H3 and H4 (left, hours after inoculation given).
Inclusion bodies contain predominantly pure histone (right)

4) Supplement lysis buffer LW with 2% Triton, 0.8 mM PMSF, 500 µg/mL
Lysozyme, 10 µg/mL DNase.
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5) Resuspend fresh cell pellet in 25 mL supplemented buffer LW at room
temperature. Lysate will become viscous due to genomic DNA released from the
cells.
6) Rotate bacterial suspension at room temperature until lysate does not contain
any cell fragments and becomes evenly milky with low viscosity.
CRITICAL STEP Complete lysis and mechanical or enzymatic breakdown of
DNA before pelleting insoluble material is essential to remove nucleic acids and
contaminating proteins from inclusion bodies. The lysis process can be assisted
by tip sonication on ice.
7) Add ~500 uL glass beads (0.5-1 mm diameter) to each 50 mL tube of lysate.
8) Centrifuge lysate for 30' at 3220 g (Eppendorf Centrifuge 5810, or at maximum
speed with similar swinging bucket tabletop centrifuge). Carefully take off
supernatant without disturbing white pellet and resuspend pellet in 25 mL IW
by vortexing.
9) Pellet the inclusion bodies for 30' at 3220 g (Eppendorf Centrifuge 5810).
Discard supernatant and resuspend pellet in 25 mL IW by vortexing.
10) Pellet the inclusion bodies for 30' at 3220 g (Eppendorf Centrifuge 5810) and
discard supernatant.
PAUSE POINT Inclusion body pellet can flash-frozen in liquid nitrogen and
stored indefinitely at -80°C. Continue with step 17).

Inclusion body extraction and denaturing Nickel Affinity Purification 
TIMING 4 h
17) Soak inclusion bodies in 1 mL DMSO and loosen pellet by vigorous
vortexing.
18) Add 25 mL D500 to the suspension, vortex, then and slowly rotate at 4°C for
~1 hour.
19) Spin down insoluble material (15 min x 30,000 g, 4°C), continue with
supernatant.
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CRITICAL STEP Residual insoluble material should be clear and gel-like, a
white firm pellet hints to incomplete resolubilization of the histones. In this case,
repeat extraction with another 25 mL D500.
20) Equilibrate 2-5 mL Ni-NTA resin with 10 mL D500 in a 50 mL
chromatography column and drain buffer.
CRITICAL STEP Adapt Ni-NTA volume to expected yield. The capacity for
histones under denaturing conditions is usually close to the maximum capacity
indicated by the manufacturer (typically 20 mg/mL resin bed volume). Histone
H2A, H2B and H3 typically yield > 100 mg per liter TBA/LB culture, H4 between
10 and 50 mg.
21) Add D500 inclusion body supernatant to Ni-NTA and slowly rotate 0.5-1
hour at 4°C.
22) Drain column, apply 25-50 mL D500. (optional: verify that you are not
saturating the affinity resin by saving the flow through for gel analysis. In some
cases, there is sufficient residual histone in the flow though for a second round of
Ni-chromatography, in which case, the flow through may be flash frozen and
stored at -80° until needed.)
23) Wash with 2 x 15-20 mL D1000.
24) Elute 3x with 2 bed volumes of DEB. Ni-NTA should change color to deep
blue and can be reused or regenerated according to manufactures protocols.
Quantify eluate by 280 nm extinction measurement against elution buffer (see
box). Add 5 mM EDTA to the eluate to prevent leached Ni-mediated his-tag
aggregation. PAUSE POINT Eluate can be stored at -20°C or used for
refolding directly.
25) Dialyze histones in a 3.5k MWCO membrane against ddH2O, 1% (v/v) acetic
acid, 0.2 mM PMSF, 5 mM 2-mercaptoethanol for 24 hours.
26) Quantify histones against dialysis solution, add Tris pH7 to 100 mM for tag
cleavage or lyophilize.
CRITICAL STEP Quantify protein concentration in eluate and check purity on
gel (See Box). Check for DNA contamination by OD260/280 reading.
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Octamer preparation  TIMING 3 d
For determining the appropriate mixing ratios, you will need all four core
histones H2A, H2B, H3 and H4 in a D1000 or DEB solution. You can use the
individual Ni-NTA elution directly (concentrate in spin concentrator if the
concentration is <1 mg/mL) or reconstitute solutions from individual
lyophilized core histones.
27) Accurately determine the protein concentration by measuring the 280 nm
absorption against an identical buffer reference in triplicate (or the concentrator
flowthrough).
28) Mix histones in a ratio 1.1:1.1:1:1 H2A:H2B:H3:H4. Your target protein
concentration should be within 0.5 and 5 mg/mL.
29) Add glycerol to 15% final and NaCl to 2 M final, transfer the histone mix to a
3.5k MWCO membrane dialysis bag.
30) Dialyze for >12 h against 1-2L of ORB
31) If the reconstitution is performed with tagged histone, take out dialysis bag
and add a 20 µg TEV, 5 µg R3C per mg total protein.
32) Dialyze against fresh 1-2L of ORB for 24 h.
33) Check cleavage of all four tags on gel. If there is uncleaved histone left, add
another 20 µg TEV and/or 5 µg R3C per mg total protein.
34) Purify octamer on Superdex 200 column with ORB or desired final buffer.

H3-H4 Tetramer preparation TIMING 3 d
27) Mix histones in a ratio 1:1 H3:H4. Your target protein concentration should be
within 0.5 and 5 mg/mL.
28) Add glycerol to 15%, transfer the histone mix to a 3.5k MWCO membrane
dialysis bag.
29) Dialyze for >12 h against 1-2L of TRB
30) Take our dialysis bag and add a 10 µg TEV per mg total protein.
31) Dialyze against fresh 1-2L of TRB for 12 h.

222

	
  

32) Check cleavage of tags on gel. If there is uncleaved histone left, add another
10 µg TEV and incubate for 12h at 4¬C.
33) Purify octamer on Superdex 200 column with TRB or desired final buffer.
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